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Abstract 
 
The diversity of nature including biopolymers, organisms, or active 
molecules and the fact that these natural systems can be transformed to be 
used for other purposes, enables a myriad of promising starting points for 
new developments. Here, Elastin-like recombinamers (ELRs) as a class of 
intrinsically disordered recombinant proteins that exhibit features like a 
lower critical solution temperature (LCST), thermosensitive 
hydrophobicity, self-assembly, together with the possibility to introduce 
other peptide-based functionalities, stand out.  
The present work coveres the steps of the value chain of ELRs from 
nucleotide fragments, over DNA transfection, protein production, 
purification, chemical modification and application of the final protein. 
Including the utilization of related methods ranging from genetic engineering, 
microbiology, physico-chemical characterization and modification to in-vitro 
cell culture and manipulation. 
One part of the tesis is focused on the generation of new proteolytically 
cleavable ELRs modified with methacrylamide groups as a substrate for a 
new zymographic technique enabling the detection of proteases. The 
present method uses the advantage of the spatial design of the ELR for the 
detection of proteases in a zymography-like manner. As a prerequisite, the 
ELR should consist of at least three domains, a degradable group (peptidase 
target), a mechanism of detection, and a stable cross-link to the acrylamide 
matrix. For better integrity with the matrix an additional block, which is not 
a target to most of the peptidases was implemented, as a spacer, to augment 
the molecular weight and to minimize sterical hindrance between cross-links 
and degradable groups. The presented method has the potential as a 
protease screening, which gains significance directly proportional to the 
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number of protease targets (ELRs) used. The presented in-well zymography 
(IWZ) method has a high throughput potential, therefore, further substrates 
are currently developed to generate a library of substrates that allow 
discovering new cleavage patterns of proteases, and might have relevance 
to detect abnormalities in clinical samples. 
 
In the following, the low complexity of these polypeptides is used as a model 
for the investigation of hydrophobic contributions to self-assembly. In this 
work, an upper critical solution temperature (UCST)-type phase separation 
was obtained upon adding hydrophobic cholesteryl side-chains, which leads 
to the formation of stable hydrogels. Circular dichroism, dynamic light 
scattering, and viscosity measurements indicate reversible UCST gelation of 
a pseudo-zwitterionic species, with retention of the ELR secondary 
structure. Furthermore, the gelation process could be associated with 
micelle-derived nanofiber formation to yield a porous or laminar structure 
in a process that is either time- or concentration-dependent. Herein we 
present a model system that sheds light on the diversity of effects resulting 
from the incorporation of cholesteryl side-chains into proteins by relating 
structural changes to macroscopic observations. 
 
In addition, a cellular coating based on hydrophobic interactions of an 
elastin-like recombinamer (ELR) with the cell membrane is presented. It is 
well documented that biophysical properties such as net charge, 
hydrophobicity, and protein-driven cell-ligand (integrin binding) interactions 
influence the interaction of polymers, proteins or peptides with model 
membranes and biological cells. Most studies to enhance membrane-
substrate interactions have focused on the introduction of positively charged 
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groups to foster electrostatic interactions with the negatively charged 
membrane. Herein we present an antagonistic approach based on ELRs with 
varying amounts of hydrophobic cholesteryl groups (ELRCTAs). The ability of 
membranes to stabilize cholesteryl groups is hypothesized to assist the 
coordination of hydrophobic ELRs with the membrane. The main objective 
was to generate a defined cellular coating of a recombinant protein that 
allows for total sequence control and less host, or batch-to-batch, variation 
as a substitute for existing coatings like alginate, polyelectrolytes, collagens 
and fibronectin. We used an in vitro cell-binding assay to quantify cell-
membrane interactions, with the substrates showing enhanced cellular 
recognition and matrix distribution with an increasing number of cholesteryl 
groups incorporated. These novel materials and the versatile nature of their 
protein sequence have great potential as cellular markers, drug carriers, or 
hydrophobic cell-binding domains. 
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Introducción  
 
La adquisición de un conocimiento profundo de biomateriales requiere 
comprender su papel en diversas aplicaciones, tanto en ingeniería de tejidos 
como en nanotecnología. Dentro de las distintas estrategias destinadas al 
desarrollo de aplicaciones biomédicas, cabe destacar el uso de materiales 
que mimetizan las propiedades y características propias que se encuentran 
en materiales naturales1. En primer lugar, los materiales empleados para 
aplicaciones médicas deben de cumplir una serie de requisitos como la 
biocompatibilidad, pero además deben aportar funciones específicas para su 
uso, como estabilidad mecánica, o la posibilidad de ajustar la degradación del 
propio material. 
Los primeros materiales empleados en biomedicina fueron distintos metales 
o cerámicas, ya conocido por las antiguas civilizaciones2. Tras esto, con el 
avance de la química macromolecular aparecieron los polímeros sintéticos 
como el ácido poli(láctico-co-glicólico) (PLGA) o el ácido poliláctico (PLLA). 
En las últimas décadas el desarrollo de la ingeniería genética y de la 
tecnología del ADN recombinante ha permitido generar nuevos materiales 
proteicos, los cuales representan un gran paso en la fabricación de 
materiales biomiméticos3,4.  
De este modo, se abría un extenso abanico de posibilidades para el uso del 
biomaterial más abundante, y probablemente más complejo que podemos 
encontrar en la naturaleza, las proteínas. En los últimos años, la ciencia ha 
hecho un gran avance en la elucidación estructural de proteínas, y sigue 
avanzando en el estudio de las relaciones entre estructura y función3,4. Este 
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conocimiento permite no sólo modificar la secuencia de un material tan 
complejo como las proteínas, e incluso mejorarlas. 
Dentro de esta clase de biomateriales recombinantes, encontramos la 
familia de proteínas inspirada en la secuencia de aminoácidos de la 
tropoelastina natural, que es el monómero soluble de la elastina5–11. De 
forma simplificada nos referimos a esta familia de proteínas es como 
recombinámeros tipo elastina (“elastin-like recombinamers”, ELRs, en 
inglés). Las ventajas en el uso de la tropoelastina como “proteína madre”, 
son las funcionalidades ésta como biocompatibilidad, elasticidad y 
comportamiento termo-sensible que conduce a procesos de auto-
ensamblado12. Además, la secuencia subyacente de amino ácidos a estas 
propiedades es bastante simple desde el punto de vista de la complejidad de 
las proteínas. Dicha secuencia está basada en la repetición del pentapéptido 
L-Valina-L-Prolina-Glicina-X-Glicina (VPGXG), en el que X (denominado 
aminoácido invitado) puede ser cualquier aminoácido, excepto L-Prolina7,13–
17. Dependiendo del número de repeticiones y de la composición del amino 
acido invitado, X, se pueden crear una gran variedad de ELRs. Debido a su 
carácter recombinante, es posible fusionar secuencias de ADN que codifican 
distintos péptidos y proteínas. Así se puede combinar bloques de 
pentapéptidos con distintos aminoácidos invitados, en el lugar X, en la misma 
molécula del ELR. Además, es posible añadir secuencias peptídicas como 
secuencias biodegradables18,19, o con dominio de adhesión celular20,21 para 
generar materiales ‘a la carta’ de la aplicación deseada. 
 
Objetivos 
 
El objetivo de esta tesis es demostrar que la versatilidad de estos 
recombinámeros se puede aumentar meidante modificación química y 
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genética para la configurar la degradación, el autoensamblado y la interacción 
con células de los ELRs. El trabajo desarrollado en esta tesis aborda todo el 
proceso de diseño, producción, purificación, caracterización y aplicación 
directa de los nuevos ELRs. Para ello, se han utilizado una amplia variedad 
técnicas de ingeniería genética, microbiología, física, química junto con los 
correspondientes cultivos celulares. 
A. La tecnología del ADN recombinante permite un control total sobre el 
diseño de ELR, y de este modo la inserción de distintas secuencias 
biofuncionales, como secuencias sensibles a proteasas. Mediante el 
control de la disposición espacial de este tipo de secuencias proteolíticas 
queremos demostrar la biodegradación especifica de ELRs. Además, la 
capacidad de biodegradación selectiva será aplicada para la 
biofabricación de sustratos para detección zimográfica.  
 
B. Debido a la degradabbilidad controlable de los ELRs, su uso será 
estudiado como sustrato selectivo para la identificación de enzimas 
proteolíticas. Por lo tanto, siguiendo el estudio de la aplicación de ELRs 
para técnicas zimográficas diseñaremos un nuevo método de detección 
de proteasas con potencial para sistemas de inspección avanzados de 
alto rendimiento. 
 
C. Se ha demostrado que los biomateriales modificados con colesterol 
exhiben fuertes interacciones intermoleculares. Así, aplicaremos estas 
interacciones en un sistema de ELRs para generar fuerzas 
intermoleculares que desencadenen el autoensamblado de los ELR. 
 
D. Además, gracias a la capacidad de interacción de los grupos colesterol 
con membranas lipídicas, estudiaremos la capacidad de ELRs ricos en 
colesterol para mejorar la interacción de los éstos con ciertos tipos 
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celulares implicados en la captación de lípidos, para aumentar el 
recubrimiento de células vivas con proteínas ELR. 
 
Metodología del Diseño de ELRs con grupos proteolíticos (A y 
B) 
 
Con el objetivo de utilizar ELRs como sustrato de zimografía de geles (IGZ) 
más específicas, se pueden fusionar secuencias de degradación enzimática, 
por ejemplo la secuencia que contiene el hexapéptido L-Valina-Glicina-L-
Valina-L-Alanina-L-Prolina-Glicina (VGVAPG), y cuya L-Alanina con 
especificad a la enzima elastasa, aumentando la biodegradabilidad de los 
ELRs, que es de gran importancia en el remodelado del tejido22. Además 
concentraciones altas en proteasas también son típicamente efectos 
secundarios de cáncer promovando la infiltración de tejido23. Pese a que la 
degradación enzimática es más estudiada en el campo de la regeneración 
tisular, la degradación de sustratos basados en proteínas también puede ser 
utilizada para desarrollar técnicas de detección de proteasas, enzimas 
capaces de degradar proteínas. Una de las técnicas más conocido es la 
zimografía de gelatina24. El método funciona como una electroforesis de 
poliacrilamida en que la gelatina se añade al gel, si la muestra electroforética 
en ese gel contiene una enzima con actividad proteolítica, la gelatina será 
degradada en el lugar que corresponde al peso molecular de esta proteasa. 
En el caso de la gelatina este método está bien establecida por los 
metalloproteasas de la matriz MMP2 y MMP925.  
Sin embargo, aparte de gelatina, otras proteínas naturales pueden utilizarse 
como substrato de la zimografía, y de este modo aumentar la variedad de 
secuencias degradables presentadas a las enzimas. Por otro, lado esa 
variedad en su secuencia depende de muchos factores, como el organismo 
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de origen o el proceso de purificación. Así, aunque de la gelatina se conocen 
muchos elementos estructurales, se desconoce su secuencia completa. Por 
lo que, los resultados pueden ser confusos, e inclusos erróneos debido a 
que no se conozca la secuencia proteolítica que está siendo degradada por 
la enzima. En esta tesis utilizamos ELRs como substrato para zimografia que 
presenten únicamente un grupo proteolítico, y que tengan una secuencia 
conocida, para investigar la degradación con una selección de MMPs 1 a 20. 
Esto facilita el uso de dicho ELRs en un nuevo método de zimografia dentro 
de una placa (in-well zymography (IWZ). 
 
Resultados (A y B) 
 
Los resultados mostraron que las diferencias en las concentraciones de 
peptidasas se pueden medir con zimografía utilizando ELRs como sustrato. 
Además, el uso de ELRs permitió la detección de proteasas de degradación 
inespecífica tipo serina, las cuales son indetectables en sustratos clásicos 
como la gelatina.  
Más concretamente, los resultados revelaron que, a diferencia de métodos 
zimográficos clásicos, la ELR-IGZ permite la detección de las enzimas 
metaloproteasas MMP2 y MMP9. La sensibilidad hacia MMP9 fue casi diez 
veces mayor con ELREla + FN que en gelatina, mientras que el control negativo 
ELR sin ninguna región proteolítica no fue degradado. El cambio a IWZ 
reduce la complejidad en comparación con IGZ mediante la eliminación de 
la separación electroforética y la desnaturalización de la muestra. La 
sensibilidad se limitó a un 10% respecto al control no degradado. Se pudo 
detectar patrones distintos de degradación de cada MMP y se redujo la 
cantidad necesaria para la cuantificación de 50-500 ng (en IGZ) a 10 ng por 
muestra. 
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Los resultados permitieron clasificar las enzimas proteasas en cuatro grupos 
diferentes respecto a los sustratos empleados: 1) sin degradación (MMP 2, 
3, 10, 14, 16, 19 y 20); 2) mediada por FN (MMP1, 13, 16); 3) mediada por 
ELA (MMP7); 4) no específica (MMP 8,9, 12, 17).  
 
Conclusiones (A y B) 
 
Se demostró que la producción de sustratos para IGZ basados en ELRs y 
secuencias proteolíticas. Los cuales permiten la incrustación en matrices de 
gel, y la detección con CBB. Empleando dos grupos de degradación 
diferente, se revelaron diferencias en la especifidad frente proteasas tipo 
serina y distintas MMPs. Cabe mencionar que el sustrato ELR-Control, al 
carecer de secuencias específicas de degradación, no fue digerido por 
ninguna de las MMPs seleccionadas, pero sí se detectó su ligera degradación 
en presencia de tripsina. La degradación del control pudo deberse a la 
presencia de lisinas que son son un punto de corte preferente para las 
proteasas tipo serina, además las lisinas, debido a su cadena lateral catiónica,  
son sensibles a la tinción con CBB.  
Por otro lado, presentamos un nuevo método de detección de proteasas 
mediante la adaptación de la IGZ en una zimografía de placa de pocillo 
(IWZ), lo que permite una lectura rápida y cuantitativa. Este nuevo método 
proporciona una técnica de detección capaz de determinar diferencias en 
patrones de degradación de metaloproteasas (MMP1-20) con sólo dos 
secuencias de degradación. El control positivo y negativo sirvió como un 
circuito de retroalimentación adicional en términos del patrón derivado. 
Complementariamente, este método de cuantificación permitiría seguir la 
cinética de degradación de cada una de las enzimas sobre los sustratos 
específicos. La especificidad de los sustratos basados en ELRs aporta varios 
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avances a las técnicas zimográficas basadas en gel, por ejemplo gracias al 
control de los motivos de degradación se pueden elaborar dispositivos de 
reconocimiento de enzimas proteolíticas basado en un sistema binario. 
 
Metodología de la Modificación de ELRs con grupos 
hidrofóbicos (C) 
 
El interés por los biomateriales autoensamblados ha aumentado 
considerablemente en las últimas décadas debido a su compleja disposición 
espacial y a que puedan controlar la exposición de distintas funcionalidades. 
Las implicaciones directas de la estructura en el autoensamblaje en 
polímeros de bloque anfifílicos y proteínas, junto a la posibilidad de generar 
interacciones hidrofóbicas26,27 e hidrofílicas28,29, ha permitido cierto grado de 
control sobre estructuras jerárquicas, como micelas esféricas o cilíndricas, 
vesículas, membranas bimoleculares e hidrogeles30–33. Además, propiedades 
tales como la respuesta frente a estímulos como cambios de temperatura27,34 
o pH35, han dado como resultado la aplicabilidad de estos materiales en la 
ingeniería de tejidos36, sistemas para la administración de fármacos35–38, 
dispersantes de polímeros39, agentes gelificantes físicos40 o biosensores41–43. 
La capacidad de respuesta térmica es la característica más investigada y 
mejor controlada para los copolímeros de bloque27,34 y, como tal, ha ganado 
un mayor interés en el diseño de proteínas recombinantes de vanguardia, 
especialmente a la luz de los hallazgos de Urry con respecto a la LCST de 
péptidos miméticos de elastina44–47. Además, debido a que los ELRs permiten 
distintos diseños modulares combinando bloque análogos con dominios de 
diferente hidrofilicidad, se han estudiado como modelos para comprender 
el plegamiento, el autoensamblaje y la función de otras proteínas naturales 
más complejas48–50. 
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Aunque se espera que el comportamiento de separación de fases del tipo 
de temperatura de solución crítica superior (UCST) en el agua51–54 
contribuya a la creación de materiales poliméricos intrínsecamente 
ordenados55–59, también se han observado ejemplos de proteínas 
intrínsecamente desordenados que exhiben separación de fases de tipo 
UCST55–59. Como la abductina y la resilina, que exhiben una UCST y 
LCST60,61, sin embargo, hasta la fecha no se ha observado una UCST tras la 
modificación química de las proteínas recombinantes, especialmente las 
ELRs. En este sentido, hemos aumentado la interacción hidrófoba de las 
proteínas mediante la adición de cadenas laterales de colesterol, que se sabe 
que fomenta las interacciones intermoleculares en los polímeros, 
aumentando el orden en la proteína y hemos investigado cómo se ve 
afectada la estructura secundaria de la proteína. Para una mejor 
comprensión de los determinantes de la gelificación inducida 
hidrofóbicamente, los ELR resultantes de la modificación con grupos 
colesterol (CTA) se caracterizaron en detalle; concentración crítica de 
micelas, ángulo de contacto, dispersión dinámica de la luz, dicroísmo 
circular, imágenes SEM y TEM. Se descubrió que los CTA resultantes (CTAx 
(x = número de grupos de colesterol)) constituyen un grupo de materiales 
novedoso y peculiar, los cuales presentan dos Tts y gelificación fría a 
temperaturas inferiores a UCST.  
 
Resultados (C) 
 
Debido a la naturaleza intrínsicamente desordenada de los ELRs, la 
formación de estructuras cristalinas para su análisis mediante espectroscopía 
de rayos X no es posible. Además su alto peso molecular dificulta 
enormemente su evaluación mediante espectroscopía de RMN, de este 
modo, se estudió mediante CD la estructura secundaria de los distintos 
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ELRs modificados con grupos colesterol. La similitudes estructurales 
observadas entre los estados del CTA5 por encima de la LCST y por debajo 
de la UCST confirmaron la hipótesis de que el colesterol contribuye al 
autoensamblado de los ELRs por debajo de la temperatura de transición. 
De este modo, demostramos por primera vez que el comportamiento 
UCST puede ser inducido por modificaciones de la cadena lateral en ELRs. 
Para la caracterización de la gelificación fría (característica del los ELRCTAx), 
se investigaron soluciones de mayor concentración utilizando técnicas de 
reología oscilatoria y de flujo. En general, no se observó gelificación en 
ausencia de grupos laterales colerterol. Comparando el módulo de 
almacenamiento, se observó que éste aumentó en función del número de 
grupos colesterol (31 Pa para ELRCTA1 y 60 Pa ELRCTA5). De los resultados 
obtenidos se puede derivar el comportamiento de fase de ELRCTA5 con dos 
transiciones alrededor de 10 y 20 °C con una región intermedia de 
solubilidad, caracterizada por la ausencia de estructuras secundarias paralela 
y antiparalela (relajada).  
 
Metodologia Interacción celular de colesteryl ELRs (D) 
 
La bicapa de membrana es una barrera física que define la frontera de las 
células y divide el interior en distintos compartimentos con funciones 
especializadas. La naturaleza anfifílica de la membrana conduce a una 
superficie externa cargada negativamente y a un núcleo hidrófobo dentro de 
la membrana, que sirve como anclaje para proteínas de membrana y 
transmembrana62. En consecuencia, las células tienen la capacidad de unirse 
a sustratos mediante la unión de integrinas, interacciones electrostáticas, 
enlaces de hidrógeno o interacciones hidrofóbicas63. Además, la membrana 
contiene una variedad de compuestos y proteínas que son cruciales para la 
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función celular. Una de las moléculas más abundantes en la membrana es el 
colesterol, que se encuentra dentro de la membrana debido a su 
hidrofobicidad. El colesterol representa hasta el 20% de la masa de la 
membrana63 y es responsable de la integridad de membrana además de 
participar en procesos de señalización celular. El colesterol, entre los 
muchos componentes lípidos de las membranas celulares de los mamíferos, 
es un regulador clave de la fluidez de la membrana y contribuye a la 
formación de caveolas y al mantenimiento del microdominio de las 
caveolas64,65. Las caveolas son dominios especializados de la membrana 
plasmática que se encuentran en la mayoría de los tipos de células66. Sin 
embargo, son más abundantes en células como adipocitos, células 
endoteliales, fibroblastos y células musculares67. Además de la influencia de 
la fluidez de la membrana, el colesterol es importante para la estructura y la 
función celular, es esencial en la locomoción y sirve como precursor 
metabólico para varias moléculas de señalización, incluidos los 
oxiesteroles68, los esteroides68 y los ácidos biliares65,69,70. La mayoría de los 
sustratos o hidrogeles se centran en motivos de unión a integrinas, en 
particular el motivo de RGD, para generar unión celular o la infiltración. Sin 
embargo, los materiales sintéticos con residuos de RGD unidos 
covalentemente luchan por cumplir con los resultados de los materiales de 
proteínas ECM nativas71. Otra investigación para la fabricación de 
construcciones de tejido 3D se ha centrado en la ingeniería de la lámina 
celular62, los liposomas magnéticos72, las perlas celulares73 y las células que 
contienen capas de gel74–76. En particular, la creación de nanodominios y 
microdominios específicos para distintos tipos celulares o específicos de 
tejido utilizando interacciones biológicas, como avidina-biotina77–80, 
anticuerpo-antígeno81,82, lectina-polisacáridos83,84 o proteínas ECM como 
fibronectina, colágeno y / o gelatina74,75,85–89, ha sido prometedora y permite 
la "manipulación jerárquica de células" in vitro85,88,90,91. 
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Seleccionamos grupos colesterol como anclajes hidrófobicos debido que 
simulan la situación intramembranosa y facilitan la movilidad y distribución 
de las proteínas en la membrana. Para una mejor interacción del material de 
colesterol con la membrana, se estudió en tipos celulares ricos en caveolina 
como son las células derivadas del endotelio de la vena umbilical humana 
(HUVEC) y las células del músculo liso aórtico humano (HASMC), que están 
involucradas en la absorción de lípidos del fluido sanguíneo y en procesos 
tales como estenosis. Para ello, se modificaron varios ELRs con grupos 
colesterol y se estudió el potencial de estos grupos hidrófobos como 
anclajes intramembranosos para recubrimientos celulares. En este sentido, 
hemos desarrollado un recubrimiento celular basado en interacciones 
hidrófobas con la membrana celular. Para eludir las variaciones de proteínas 
naturales como variaciones específicas al organismos de origen, se utiliza un 
recombinante similar a la elastina análogo de ECM como proteína modelo 
para el recubrimiento inductivo de tejido. El objetivo principal es la creación 
de un recubrimiento proteico para células basado en una monocapa bien 
distribuida.  
 
Resultados (D) 
 
Los diferentes sustratos se probaron para determinar su efecto sobre la 
proliferación celular durante 7 días usando el ensayo AlamarBlue® a 
concentraciones de 375 y 750 nM. Los HUVEC no mostraron diferencias 
significativas en la proliferación en todas las condiciones, mientras que para 
los HASMC, el tratamiento con una alta concentración de los ELRs ELRCTA0 
y ELRCTA1 condujo a la disminución de la proliferación con el tiempo. 
Se observó que el número de eventos de células fluorescentes aumentó de 
ELRCTA0 a ELRCTA5, del 10% al 80% (HUVEC), o del 20% al 85% (HASMC), 
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respectivamente. Las células HASMC interactúaron en mayor medida con 
ELRCTA0 a ELRCTA3 , aumentando de un 20% a 60% respectivamente,  mientras 
que la eficiencia de recubrimiento de estos ELRs permaneció por debajo del 
30% para las células HUVEC. Además, las imágenes confocales de células 
tripsinizadas después de la incubación revelaron un cambio en la distribución 
de los ELRs en la membrana celular en función  del contenido en colesterol, 
variando desde partículas de tamaño micrométrico aglomeradas (sin 
colesterol) hasta puntos submicrométricos altamente dispersados (con 
colesterol). 
 
Conclusiones (C y D) 
 
Hemos demostrado que las propiedades novedosas, como el 
autoensamblaje y la gelación termorreversible, se pueden controlar 
mediante la modificación selectiva de IDPs poliméricas, lo que resulta en 
materiales altamente innovadores que pueden exhibir un comportamiento 
UCST y LCST, donde el plegamiento y la formación de estructuras 
secundarias ordenadas se ve favorecida tanto por encima de la LCST como 
por debajo de la UCST. En base a nuestros resultados, los grupos de 
colesterol parecen actuar como mediadores estructurales, en este caso 
como estabilizadores de micelas en condiciones impulsadas por la entropía 
por encima de la LCST o como conectores de micelas expuestas en 
condiciones impulsadas por la entalpía por debajo de la UCST. En ambos 
casos, los grupos de colesterol aceleran la organización estructural de los 
ELR con el tiempo. El hecho de que se obtengan estructuras secundarias 
similares con grupos de colesterol orientados hacia adentro o hacia afuera 
(por debajo o por encima de la UCST y LCST, respectivamente) podría 
deberse al esqueleto del ELR subyacente, que gobierna los motivos 
estructurales a los que se puede acceder. 
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Hasta donde sabemos, los restos hidrofóbicos que funcionan como anclajes 
de membrana celular para proteínas aún no se han investigado. Dado que 
no se observó ningún efecto citotóxico en los tipos celulares seleccionados 
a concentraciones bajas, con un resultado > 60% de células marcadas, el 
presente sistema puede conducir a una mejor comprensión de las 
interacciones hidrofóbicas membrana-sustrato y al desarrollo de nuevos 
recubrimientos celulares impulsados por la hidrofobicidad, proporcionando 
una alternativa a los recubrimientos actuales. Además, estos nuevos 
materiales y su versatilidad en términos de secuencia tienen un alto potencial 
como marcadores celulares, portadores de fármacos o dominios de unión 
celular hidrófobos.
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1 Introduction 
 
 
1 Introduction 
 
1.1 Biomimetic Materials 
 
Building on the discoveries and experiences of our ancestors is one key 
driver of mankind’s progression and technical evolution, saving us from 
reinventing the wheel over and over again. Biomimicking pursues the same 
target to build on the results of several millions of years of evolution, which 
have forged nature close to perfection generating a diversity of biological 
systems with extraordinary properties92. The goal is not just to copy natural 
systems, but rather to deduce synergetic potential with known technologies 
to improve certain applications. The diversity of nature including 
biopolymers, organisms, or active molecules and the fact that these natural 
systems can be transformed to be used for other purposes, enables a myriad 
of promising starting points for new developments1. 
 
Taking a closer look at biomimetic materials, one class of biopolymers stands 
out in terms of diversity, taylorability and applicability. These are protein 
based materials, where the properties are based on the arrangement of the 
amino acid residues3,4. Natural proteins consist of up to 20 different amino 
acids and an unspecified number of amino acids (n) which opens possible 20n 
arrangements for a distinct number of amino acids n. Since this number 
becomes rather big with protein size, a fundamental understanding of the 
biophysical properties imparted by certain peptide structures is crucial. The 
resulting structural complexity and limited computing power made it 
inevitable to deduce structural relations by manipulating single amino acids 
in known structural resolved natural amino acid sequences. The number of 
natural protein sources and their diversity already facilitated their use in 
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novel materials and applications. The advancements in exogenous protein 
expression, in the past decades enabled the creation of de novo proteins with 
new or enhanced properties, which were a priori designed to comprise 
specific functionalities3,4. The primary goal of protein polymer science is to 
alter protein sequences to obtain unique properties in a single molecule 
either in terms of structure or functionality which satisfies a need in 
biomedicine, or nanotechnology amongst others.  
 
When considering the effect on structure of protein sequences alteration,  
covalent and noncovalent interactions, such as peptide and disulfide bonds, 
interactions or van der Waals forces, have to be taken into account12. 
Moreover, spatial arrangements can foster intermolecular interaction which 
can lead to aggregation or self-assembly events. In general, many structure 
function relation known in polymers can be translated to protein based 
materials, such as alternating- or block-copolymers by using as monomers, 
amino acids of differing hydrophilicities, which in turn result in comparable 
structural observations like micelles, vesicles, micro phase separation, or 
even macroscopic hydrogels93. furthermore, current advances in 
biotechnology and recombinant protein expression facilitate the generation 
of desired protein motifs in a defined and accurate way towards an 
increasing understanding of protein structure and function relationship. 
 
1.1.1. Natural Elastin 
 
The prerequisite for materials to be used in biomedicine is biocompatibility 
and bioactivity, when desired and controlled, which make proteins a suitable 
candidate. Especially, in tissue engineering, extra cellular matrix (ECM) 
components are in focus of current research94. Here, elastin has to be 
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highlighted. Elastin is a fibrous and insoluble protein that constitutes one of 
the most important structural and functional components of the ECM, 
allowing for high deformations without damage95. It is abundant in the lungs 
(3-7 %), skin (2-3 %), blood vessels (28-32 %) and elastic ligaments (50 %)96, 
where elastic properties are required. Elastin whose main function is to 
provide elasticity to organs and tissues, is an excellent example of how all 
the properties displayed by biological materials and systems are determined 
exclusively by the physicochemical properties of the monomers and their 
sequence97,98. Elastin possesses several extraordinary characteristics, such as 
an ability to undergo high deformation without breaking and subsequent 
recovery of the original conformation once the stress disappears99,100. This 
energy-conserving process allows for billions of relaxation-stretching cycles 
of the elastic fibers101. Several peptide sequences like VPGVG, VPGG, 
VGVAPG in elastin’s soluble precursor tropoelastin have been found to be 
responsible for the elastic behavior102, which have been used to circumvent 
the insolubility of native elastin. In the beginning elastin mimetic 
proteins/peptides, derived from chemical solid phase synthesis have been 
used, and since the late 90s are produced by genetic engineering 
strategies103–107. Investigation of short peptide sequences originating from 
tropoelastin by D. Urry further deduced a sub-structure of elastin, the so-
called α-elastin, to be responsible for the thermal behavior of elastin. In 
aqueous solution, α-elastin is able to transition from a disordered state to 
an ordered state where the molecules are capable of aggregating, resulting 
in a sticky and dense separated phase as a result of a temperature 
increment7,13–17. 
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1.1.2. Elastin bio-inspired polypeptides (Elastin-like 
Recombinamers) 
 
The translation of this properties into novel proteins by conservation of a 
reduced sequence, a repetitive pentapeptide, which has been shown to be 
responsible for the elastic behavior in elastin, led to a new class of 
recombinant proteins called elastin-like proteins (ELPs) or recombinamers 
(ELRs)5–11. The term ELR will be used throughout this work to avoid 
confusion. The most used sequence is a pentapeptide, which is responsible 
for the beta helical shape, based on the discoveries by Urry et al.. 
Interestingly, the fourth position of the pentapeptide can be altered with any 
amino acid besides proline, without loss of beta helical secondary 
structure7,13–17. This led to the  class of pentapeptide of the structure 
VPGXaaG (namely poly(Val-Pro-Gly-Val-Gly), where Xaa is any natural 
amino acid except proline).  
 
In natural elastin, lysine residues act as intermolecular crosslinking nods by 
desomsin formation, which are in part responsible for mechanical stability 
and poor solubility108 and more efficient recombinant genetic engineering 
methodologies103,104,106,107. The spatial incorporation of lysine in the four 
positions of the elastin mimetic pentapeptides (VPGXG VPGKG VPGXG)n, 
permits spatially controlled chemical or enzymatic crosslinking106,109,110. 
Moreover, genetic engineering based strategies facilitate the alteration of 
peptide chain length, consensus repeat sequence, as well as the introduction 
of additional functional groups or oligopeptide units that modulate the 
biological, thermodynamic, and mechanical properties of the peptide 
polymer. The synthetic design adapted from the native sequence, and its 
repetition enhances the bioproducibility of the resulting protein. The genetic 
15 
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engineering further allows for the incorporation of other biological relevant 
moieties into the elastin-mimetic peptide. The appropriate choice of peptide 
sequence has led to the development of recombinant proteins that have 
been processed into elastomeric hydrogels, thin films104, thermoreversible 
gels111, lyotropic, or smectic mesophases112,113, and lamellar crystallites114. 
Moreover, the sequences of the obtained proteins are uniform and 
completely controlled. In summary, the approaches that have been 
described to date have provided important insights into the physiochemical 
behavior of bioelastic systems under a variety of environmental conditions 
and have led to novel processing strategies for creating elastomeric 
hydrogels for drug delivery and other applications. Whereas little work has 
been done on the use of elastin mimetic proteins for detection or sensing 
applications.  
 
1.1.2.1 Properties and Characteristics 
 
All functional ELRs present reversible lower critical solution temperature 
(LCST) in aqueous solution with sharp responsiveness115, according to 
Urry’s model the polymer chains undergo a hydrophobic folding and 
conformational transition that leads to phase separation108,116. The 
underlying mechanism is the water ELR interaction which in Urry’s definition 
is characterized by highly ordered, hydrogen-bonded shells of water 
molecules, which surround nonpolar residues of the polymer in a clathrate-
like organization, which enables the “hydrophobic hydration” (Figure 1b). 
With increasing temperature, the mobility of water molecules is increased, 
which at the transition temperature (Tt) results in a disruption of the 
“hydrophobic hydration”, initiating folding of the polypeptide by 
hydrophobic forces. The molecular structure of ELR pentapeptides leads to 
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the formation of β-turns (Figure 1C) which in the polypeptide result in β-
spirals formed by consecutive β-turns117. As a consequence, the 
hydrophobic groups are exposed to the solvent phase leading to phase 
separation. Due to the hydrophilicity of the ELRs the segregated phase might 
still retain more than 60% of water by weight and has viscoelastic 
properties118. 
 
 
Figure 1: a) Structural changes of VPGVG oligopeptide below and above their LCST. b) Water in 
the clathrate-type structured state. c) Type II β -turn in the VPGVG pentapeptides119. 
 
In most proteins an increase in temperature causes loss of order (unfolding 
– denaturation), remarkably ELRs behave in a distinct way. Nonetheless, 
taking enthalpic and entropic events into account, this abnormality does not 
contradict the second law of thermodynamics. 
The loss of clathrate interactions, is compensated by approximately just one 
third with Van der Waals forces of the hydrophobic aggregation of the 
17 
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polypeptides119, therefore the folding is not driven by enthalpy. With respect 
to entropy, the order in the polypeptide is increased with folding, which as 
well is unfavorable. But considering the whole system, the rupture of water 
clathrate structures does increase the entropy of the whole system by the 
release of water molecules into a disordered “free” state. This process of 
folding and unfolding water is completely reversible in water. 
 
1.1.2.2 Factors to influence ELR properties 
 
It has been proven that the amino acid sequence has a great influence on the 
LCST of ELRs120. Substitutions of the amino acid at the fourth position (Xaa) 
of the pentamer modify the LCST, to an extent that depends on the polarity 
of the amino acid side chain.  
The transition temperature of an ELR sequence based on (VPGXG)n can be 
controlled and adjusted to the desired applications by the selection of X 
(hydrophobic AA decrease, hydrophilic AA increase Tt)120, the segment 
length n (longer ELR sequences have lower Tt)121,122, concentration (higher 
concentrations of ELR decrease Tt)121, and by extrinsic factors like pH48, salt 
concentration, or solvents123–125. 
 
Intrinsic Factors 
 
Manipulation of the X position and the chain length have the biggest 
potential to tailor the Tt121,122. The substitution of the X position affects the 
Tt with respect to the hydrophobicity of the inserted AA (Figure 2)126.  
Trp > Tyr > Phe > Leu  ̴ Ile  ̴ Met > Val > Ala > Gly 
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Figure 2: Dependence of Tt on the guest residue in poly penta-peptide of the structure poly[fv (VPGVG), 
fx (VPGXG)]. fv and fx represent the mole fractions of the respective co-monomers (fv + fx = 1)127. 
 
As a rule of thumb an increase in the polarity, causes an increase in Tt and a 
decrease in ΔHT. 
Incorporation of an acid or a basic amino-acid (acid: Glu, Asp; basic: Lys, 
Arg, Asn or Gln) are also pH sensitive, and the ionization degree of those 
amino-acids will have an important effect on the Tt as can be seen in Figure 
2. In this sense, above its characteristic pKa (for acidic AA), or below its 
characteristic pkb(for basic AA), , the residue is charged, resulting in an 
increasing of the mean polarity, which leads to an increase in the Tt127. 
 
The effect of chain length is of interest for very short oligopeptides, where 
the Tt decreases with increasing chain length, but can be neglected for 
polypeptides composed by more than 100 pentapeptides according to 
Meyer et al.128. 
19 
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Figure 3: Tt as a function of the number of pentapeptides for three different types of ELRs at 25µM 
in PBS. Reproduced from Meyer et. al.128. 
 
It is worth to mention, that none of the three intrinsic factors, 
(concentration, guest residue and chain length) should be considered 
independently in order to alter Tt, since the conjunction of the three 
together will determine the final Tt. 
 
Extrinsic Factors 
 
The effect of different salt anions and their concentration on the Tt of ELRs 
has been extensively studied by Cho et al.49 as depicted in Figure 4. The 
effect of salt concentration on ELRs can be best explained with the 
Hofmeister series129,130, anions to the left of Cl- (kosmotropes) have a strong 
tendency to salt out polymers/ proteins from solution, as well as cations to 
the right of Na+. “Salting in” ions (chaotropes) provoke opposite effects. 
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Figure 4: Effect of Hofmeister anions on the transition temperature of ELRs. Figure adopted from 
49. 
 
CO32- > SO42- > S3O32- > H2PO4- > F- > Cl- > Br- > NO3- > I- > SCN- 
NH4+ > Cs+ > Rb+ > K+ > Na+ > Li+ > Ca2+ > Mg2+ 
 
It is believed, that kosmotropic anions polarize the water molecules which 
are involved in hydrogen bonding to the amide group of the ELR employed. 
The direct interaction between the anions and the water molecules, 
weakens ELR-water interaction, causing a decrease in Tt and solubility. 
Whereas, chaotropic anions directly interact with amide moieties by ion 
binding, causing a salting-in effect129,130.  
The most commonly used salt is NaCl which has been found to cause a 
significant concentration-dependent decrease in Tt and an increase in the 
transition enthalpy in ELR-water systems119. The effect on the thermal 
behavior of the ELR can be compared to an increase in the hydrophobicity 
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of the recombinamer chain, fostering a better organization of the 
recombinamer in the folded state. 
Besides salt changes, pH changes can result in changes in the degree of 
ionization of the ELR, which is more pronounced when polar guest amino 
acids are present 48.  
Biotechnology provides us with a powerful set of tools that can be used to 
successfully control the physicochemical features of the amino acid side 
chains and their association131,132, or to include any protein based 
functionality like protease active sides, which become important when 
degradation of the scaffold has to be adjusted, e.g. to the growth rate of new 
tissue133.  
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1.2 Biosynthesis of ELRs 
 
Biosynthesis of proteins uses the natural route of protein production by 
inserting a DNA fragment specific for the protein of interest into the protein 
expression chain of an organism. The very susceptible process of protein 
expression requires very close control of DNA manipulation, which is 
obtained by recombinant DNA techniques2. The manipulation of DNA, 
insertion into an expression vehicle (vector), the insertion into a producing 
organism and the purification of the final protein is a time and resource 
intense process, nonetheless it is without alternative for the generation of 
larger amino acid sequences, where synthetic peptide production reaches 
its limit.  
Despite the time and effort required for the synthesis of genetically encoded 
polypeptides and the restriction to natural amino acids, the use of genetic 
engineering to obtain recombinant proteins has several advantages over 
their synthetic counterparts. Bioproduction provides a facile route for the 
design of novel protein polymers composed of repetitive amino acid 
sequences or peptide blocks whose structural complexity imparts distinct 
mechanical, chemical or biological properties2. The accentuate reduction on 
the production costs, the time reduction in large scale bio-production, the 
greater control over product sequence, size and uniformity, higher yields 
and the possibility of achieving structural complexity into an assortment of 
bio-inspired materials with distinct mechanical, chemical or biological 
properties, summarize some of them.  
Related to the establishment of this recombinant technology for the creation 
of protein-based materials, a new term, namely recombinamer134, has been 
implemented to evoke the oligomeric and recombinant nature of protein 
polymers produced by genetic engineering techniques. Following this new 
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terminology, from now onwards, recombinant protein polymers will be 
referred to as recombinamers in the present work. The biosynthesis of a 
recombinamer can be drafted in four main steps, namely 1) design of the 
codifying gene for the protein, 2) obtaining the monomeric gene and 
construction of the multi-block, 3) transformation of a bacterial strain for 
expression with the selected positive plasmid and 4) bio-production of the 
recombinant polypeptide and subsequent purification135. 
 
1.2.1 Design of the codifying gene 
 
At the gene design stage it proved necessary to try to overcome the 
contradiction that exists between the use of the most common and 
appropriate codons that identify highly repeated amino acids and the need 
not to overload or even impoverish the cell translation system to the point 
of collapse136,137. If heterologous prokaryotic systems are used, the problem 
arising from their limited use of the genetic code, which varies with species, 
must be taken into account. The problem arising from the creation of a gene 
formed by a long sequence that codes for multiple and/or small artificial 
fragments have also to be taken into account. Finally, the high recombination 
frequency commonly found when the exogenous DNA contains repeats of 
highly similar domains also has to be overcome138,139. 
This stage involves the use of automated DNA synthesizers together with 
recombinant DNA techniques. The production of polymers with multiple 
repeats necessarily involves the production of a gene that codes for them 
which, depending on the length of the sequence, may require the prior 
synthesis of a polynucleotide-based monomer that can be connected linearly 
in the correct direction135. 
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The production of sufficient amounts of the monomeric gene containing the 
correct sequence for producing the repeat nucleotide sequences that code 
for the various polypeptides required a culture of the appropriate clones 
and digestion of their plasmids. This allows for high yields of monomer 
required for the controlled ligation, concatenation or concatenamerisation 
reaction to obtain oligomerized genes in a simple manner140,141.  
Although this approach may appear to be wasteful in terms of time, in vivo 
synthesis guarantees the production of the correct sequence in large 
amounts and also offers additional advantages, such as control of the 
monomeric gene prior to oligomerisation and the ability to subsequently 
modify the sequence by either directed mutagenesis or by the creation of 
copolymers prior to oligomerisation. 
 
1.2.2 Construction of the multi block 
 
Polymerisation of the monomeric nucleotide sequences may be undertaken 
by, but is not limited to, concatenation, in other words random ligation of 
the monomeric blocks; the iterative/recursive method, a step-by-step 
technique for preparing oligomers from monomers; or by the Seamless 
cloning method, a definition that refers to the possibility to select a specific 
sequence that is translated into the desired amino acid at the cut-off 
point140,141. 
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Figure 5: Condensed summary of recombinant gene oligomerization in a vector with 2 restriction 
enzymes.  Adapted from142. 
 
Concatenation allows the synthesis of polymers from oligomers by the 
unidirectional, linear head-to-tail attachment of the DNA segments that 
make up the monomer, although such attachment is only possible if the ends 
of the segments are single-stranded, protuberant and cohesive amongst 
themselves but not with themselves. Thus, the single stranded head end of 
the monomer will be complementary to, and will only hybridise with, the 
tail end of another identical monomer. These ends cannot therefore be 
palindromic, as currently occurs when they are generated by the restriction 
endonucleases routinely used in genetic engineering, where the recognition 
and cleavage sites occur sequentially, but must be different143. 
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Various modifications of the concatenation technique have been developed 
considering the specific requirements. Monomers with cohesive, single-
stranded ends were obtained by the hybridisation of oligomers, by the 
joining of short oligonucleotides (linkers) and also by digestion with specific 
endonucleases 
The iterative/recursive method is a step-by-step technique used to prepare 
oligomers from monomers that allow both, the addition sequence and the 
number of blocks to be joined during each growth stage to be controlled, 
thereby allowing ad hoc polymer production. This method requires the 
creation of sequences at the ends of the segment that code for the protein-
based monomer, which are recognised by two different endonucleases and 
whose cleavage produces complementary, but not palindromic, ends144. By 
this approach DNA monomers are oligomerized exclusively “head-to-tail” 
by enzymatic ligation, which ensures the translation of the sense strand into 
the polypeptide of interest and allows to fully control the polypeptide length 
(compare Figure 5). This monomeric sequence is cloned in a plasmid that 
serves as a gene amplification vector and provides both the following cloning 
vector when digested with a single enzyme and the clone insert when 
cleaved by two enzymes145. 
 
The Seamless cloning method removes the relationship between the design 
of the sequence for the insert that codes for the monomer and the 
sequences recognised by the endonucleases that generate it. This strategy is 
possible due to the existence of a limited number of type II restriction 
enzymes that recognise a specific, non-palindromic sequence that does not 
coincide with the cleavage site. This unique characteristic eliminates the 
drawbacks resulting from the need to include unusual sequences into the 
polymer in order to allow the generation of cohesive ends that allow 
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concatenation and also means that fragments that join in a unidirectional 
manner can be achieved in single digestion. 
 
Type IIS endonucleases SapI and EarI 
 
Sap1 and Ear1 are two type IIS endonucleases that recognize similar non-
palindromic sequences only varying by the fact that the Sap1 sequence is 
extended by one nucleotide (Figure 6).  
 
Figure 6: Illustration of the recognition sequences of Ear1 and Sap1 type IIS endonucleases. 
 
The fact that the Ear1 recognition sequence is fully presented in the Sap1 
recognition site, implies that Ear1 is capable of digesting the Sap1 region, 
whereas Sap1 does not cut the Ear1 region when the preceding nucleotide 
differs from guanine. Additionally, the resulting asymetric ends with three 
nucleotides (N in Figure 6) generated with Sap1 or Ear1 digestion have the 
same size and orientation. 
The existence of a constant displacement between the recognized sequence 
and the exact cleavage place, which is characteristic for type IIS restriction 
endonucleases, allows for the insertion of nucleotides of any order143. This 
makes this pair of restriction enzymes an ideal candidate for the seamless 
cloning technique, since the additional base of the restriction site (“seam”) 
are not part of the extracted final gene (Figure 7)145. 
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Figure 7: Ligation-based DNA assembly using restriction endonucleases. a) DNA assembly using 
conventional type II endonucleases requires a type II recognition site at the junction between the two starting 
pieces of DNA. The junction remains in the product, precluding the construction of arbitrary DNA 
sequences. b) DNA assembly using type IIS endonucleases, which allow the generation of overhangs of any 
arbitrary sequence, and thus sequence-independent construction. Reproduced from130. 
 
In summary, two prerequisites are necessary for the successful application 
of the iterative recursive method using Sap1 and Ear1: 
 
1. A singel SapI restriction site within the vector to perform vector 
linearization and to create protruding ends at the end of the gene for the 
addition of subsequent genes.  
2. Two EarI sites flanking the gene in the vector allowing for the extraction 
of the gene segment and even the oligomerized genes after applying 
oligomerization. 
For these reasons, the iterative nature of the gene design results in fully 
controlled gene constructs  
 
1.2.3 Gene expression and recombinant production 
 
Once the final gene construction is achieved, it is cloned into an expression 
vector for the transformation of suitable bacterial strains for expression. 
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The biosynthesis of an ELR ends with the bioproduction of the recombinant 
protein followed by its purification. 
Due to availability, fast reproduction rates, and its well-known constraints, 
Escherichia coli (E.coli) has become one of the most popular organisms for 
heterologous overexpression of polypeptides146. In this regard, expression 
vectors tailored to the conditions found in E.coli have to be used to obtain 
good yields.  
One of the most widely used promoters is the T7lac promoter which is 
suitable for the concomitant recombinant gene construction. The T7 
promoter is a target to the RNA polymerase T7 and the lac operator 
indicates the regulation by lac repressor (lacI)143. For optimal performance 
the encoding sequence of the repressor has to be present in both the vector 
and the chromosome of the organism (native form lacUV5). The repressor 
avoids the basal expression of the recombinant protein by acting over T7lac 
and lacUV5 promoters in the response of glucose and lactose levels of the 
media. So that only when glucose is absent, and lactose is present, the 
expression of T7 RNA polymerase is induced.  
Once the gene of interested is inserted in the expression vector in the above 
mentioned process, the vector has to be transfected into a bacterial strain 
containing a chromosomal copy of the gene of the T7 RNA polymerase. 
 
1.2.4 Purification 
 
After protein/recombinamer expression it has to be purified and separated 
from endogenous bacterial proteins. Here, caution has to be paid to the 
released peptidases from the bacteria, which potentially could degrade the 
protein of interest, especially when protease sensitive sites are 
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incorporated, therefore the addition of protease inhibitors is crucial. For 
the separation of proteins chromatography, especially affinity 
chromatography is the standard method. A drawback of affinity 
chromatography is, that the protein of interest needs to be marked with a 
recognizable region (e.g. a his-tag) and that the yield is limited to the 
efficiency and capacity of the purification column147.  
The physico-chemical properties of ELRs with their inverse temperature 
transition (ITT) behavior has enabled a new route of purification by repeated 
precipitation of the ELR and resolubilization followed by dialysis, a process 
that was named inverse temperature cycling (ITC)148,149. ITC is able to 
generate much higher yields without the need for further special equipment 
and has paved the way to the novel approach of recombinant purification, 
where even other proteins of interest can be linked to an ELR domain solely 
for purification purposes150. Furthermore, ITC protocols are compatible 
with state of the art endotoxin removal methods146. 
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1.3 Protein - interactions 
 
The predominant matrices for tissue regeneration, which were also the first 
applied in humans151 are hydrogels. Due to the high water content, the 
resemblance of natural tissues, biocompatibility and stimuli-responsiveness, 
they have gained raising interest in the last 40 years152,153. Traditional 
methods of hydrogel synthesis are lacking an exact control of cross-linking 
points, chain length and sequence. Thus, the three dimensional structure 
reveals deficiencies that might impair the mechanical properties of the 
material154. These problems have been addressed by the development of 
novel polypeptide-based responsive hydrogels, including block-
copolypeptides155, or recombinant copolypeptides flanked by two coiled-coil 
blocks111,156 and recombinant segments of elastin, silk and collagen157–159.  
A prerequisite to formation of ECM analogous matrices from ELRs is to 
integrate crosslinking motifs that lead to a stable hydrogel. This cross-link 
can be either of physical or covalent nature, whereas the feasible cross-
linking mechanisms are as versatile as the ELRs themselves. They reach from 
ionic and hydrophobic interaction and the reaction of complementary 
groups to bioinspired protein crosslinks160,161. 
ELRs have the potential to create a material that is not just biocompatible 
and has certain mechanical properties, but also one that interacts with the 
organism to improve the nativeness of regenerated tissue. The repetitive 
ELR pentapeptide (VPGXG) itself does not facilitate adhesion but the 
extraordinary design allows for the integration of adhesive (like RGD)20,21 
and degradable sequences18,19, as well as for the integration of temperature 
or biological triggers.162–164 All these strategies can provide very close 
control over the length and the molecular weight of the proteins by the 
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selection of the cross-link sites, which usually correspond to the lysine 
groups106,165. 
 
1.3.1 Physical ELR interactions 
 
Several strategies can be applied to foster physical ELR interaction. Among 
those the following have been described. 
 
1.3.2 Ionic interactions 
 
The ionic cross-linking motifs are based on ELR segments of opposite 
charge, or by introducing chelating capacities for multivalent cations into the 
ELR backbone that can be further controlled by salt concentrations.  
Peptide sequences of alternating charge and with complementary ionic sides 
have been shown to perform well to physically crosslink. They are classified 
in different moduli, depending on the size of the equally charged ionic blocks 
(1-4 aminoacids). Modulus I, – + – + – + –+; modulus II, – – + + – – + +; 
modulus III – – – + + +; and modulus IV – – – – + + + +. A modulus I 
sequence reported by Holmes et al.166 showed a salt induced in-situ 
gelation167. The complexation of ions is obtained by including glutamic and 
aspartic acid residues into the ELR sequence accompanied by the addition 
of Ca2+ ions, such hydrogels can be stabilized at room temperature and at 
physiological pH168 and react sensibly towards chelating agents which reduce 
the number of accessible Ca2+. Another approach by Yeo et al.169 was to add 
monosaccharides to the side chains of the ELRs which are capable to form 
stable complexes with potassium. Furthermore, blends of ELR/Chitosan 
have shown to form stable films in the presence of sodium ions170. 
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1.3.3 Hydrophobic interaction of amphiphilic blocks and 
graft copolymers 
 
Self-assembly of amphiphilic blocks and graft copolymers. Hydrogels can be 
obtained through aggregation among hydrophobic segments of multi- block 
copolymers of ELRs. The hydrophobic functionalities are provided by 
alkylrich amino acids like alanine (Ala), leucine (Leu), isoleucine (Ile), valine 
(Val), phenylalanine (Phe), tryptophan (Thp), tyrosine (Tyr) or methionine 
(Met). These ELR based amphiphilic blocks have been shown to be stable in 
vivo159,171,172. Furthermore, it is common to find protein polymers 
characterized by alternating blocks of essentially hydrophilic and essentially 
hydrophobic amino acids. The presence of chemically distinct segments 
within the same protein chain causes a mutual repulsion between the 
different blocks, which tend to segregate. Nevertheless, such segregation is 
constrained by the “forced cohabitation” of these blocks within the same 
molecule. As a result, they just separate into different domains, and as a 
consequence, periodic nanostructures are formed173. 
 
1.3.4 Intermolecular interaction of protein secondary 
structures 
 
The structure design offers the possibility to include almost any sequences 
into the ELR backbone that are able to form intramolecular interacting 
secondary structures, limiting factors here are, to retain the ELR 
temperature transition, and to take into account that complex folding might 
not be realized by a recombinant approach.  
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One bioinspired approach was to include natural silk sequences that are 
known to form intramolecular betasheets that self-assemble into crystalline 
regions and have unique mechanical properties174–178. These silk-based 
materials can be used to form a variety of structures like hydrogels, films, 
3D porous matrices and submicron to macroscale fibers179. Furthermore, 
silk scaffolds have been proven to be biocompatible and performed well in-
vivo180–182. In terms of the silkworm (Bombyx mori) a repetitive hydrophobic 
sequence of GAGAGS has been identified to be responsible for the strength 
of silk fibers183. These blocks are stabilized by hydrophilic compartments in 
the protein and a complex mixture of stabilizing proteins184. Fernandéz-
Colino et al. have shown that the GAGAGS sequence can be successfully 
integrated into an ELR, facilitating in-situ gelation of the material and its uses 
as an injectable system159. 
A more complex crosslinking has been realized by the use of coiled-coil 
induced oligomerization through leucine-zipper motifs, which include 
sequences that are known to develop well defined secondary structures185–
187. Leucine zippers are characterized by heptad repeating peptide-units that 
form a distorted α-helix designated as “abcdefg”, where the “a” and “d” 
positions are occupied by hydrophobic residues such as leucine, whereas 
“b”, “c”, “e”, “f”, “g” usually displays a hydrophilic nature188. The 
oligomerization of different α-helices is primarily driven by the hydrophobic 
interactions189–192, and partly by electrostatic interactions193–195 and the 
number of  heptad repeats190,196,197.  
The potential extrapolation of these domains to the creation of bioinspired 
domains has been explored in a much lower extension than it is the case for 
elastin or silk domains, which involves also a lower number of studies 
available regarding their biocompatibility. However, its human origin as well 
as the conserved nature of the sequence of these domains alleviate any 
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concerns regarding its biocompatibility. To further support this notion, in 
vivo implantation of the leucine zipper based scaffolds in a mouse model has 
been recently reported, and no foreign body reaction to the scaffold was 
detected198.  
Protein based physical cross-links in nature are ubiquitous and it can be 
assumed that was has been reported to date is merely just the tip of the 
iceberg.  
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1.4 Chemical Modifications of ELRs 
 
1.4.1 Functionalization of ELRs and Covalent Cross-linked 
ELR Hydrogels  
 
Posttranslational modification in ELRs is obtained by the reaction of the 
functional groups in the protein backbone. Which in ELRs can be included 
by active amino acids into the X position of the (VPGXG) sequence, thus 
maintaining the pH and temperature sensitivity of the ELRs199,200. These 
active amino acids facilitate on the one hand for cross-linking reactions, and 
on the other for chemical modifications. Concentration, molecular weight 
and lysine content of ELRs are key parameters for hydrogel formation. 
Below a critical concentration201, the hydrogel network is not formed due 
to the lack of inter-molecular contacts. ELRs with high molecular weight are 
more prone to establish an elevated number of inter-molecular contacts 
that promote network formation. ELRs with a high content in lysine are the 
most used to prepare hydrogel networks, because of the suitability of the 
amino group of lysine to form covalent bonds between ELRs chains. 
Furthermore, relevant features of the hydrogel, such as gelation time, 
network pore size, stiffness and degradability, can be narrowly controlled 
through the nature and the concentration of the cross-linker agent. Labile 
chemical linkages can also be formed in order to be broken under 
physiological conditions, either enzymatically or chemically202. As a 
drawback, chemical cross-linking usually requires organic solvents and 
reagents that have to be exhaustively removed for biomedical applications, 
after synthesis of the network. 
Chemical cross linking can be obtained through the following mechanisms: 
1)  radical polymerization (acrylates), 2) coupling of complementary groups  
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(click, reaction, Michael-addition203, condensation204), 3) high energy 
irradiation205, or 4) enzymatical cross-linking (transglutaminase)206–208. 
Typical functionalization motifs are fluorescent probes or bioactive 
sequences which include adhesion sites, inhibitors, antibodies and anchor, 
or signaling molecules.  
Permanent or chemical hydrogels are covalently cross-linked networks and 
may contain clusters spread within regions of the low cross-linking density 
and high water swelling. The free chain ends also cause defects in the gel 
and do not contribute to the elasticity of the networks. Both aqueous and 
organic media can be used to form ELRs networks; the cross-linking in an 
organic solvent rendering hydrogels with a more uniform structure due to 
the absence of transitions. Conversely, in water the behavior of the ELRs 
molecules is governed by the LCST105. Some organic solvents, such as tris-
succinimidyl aminotriacetate, can react with the lysine residues of different 
ELRs chains to form a network. The cross-linking confers the hydrogel with 
structural stability, being insoluble in water even upon cooling. Also 
intermolecular crosslinks between  proteins can be obtained by genipin, as 
it was shown for an ELR/fibronectin hybrid209. The chemical cross-linking 
strategy has some important advantages, for instance the covalent bonds 
avoid hydrogel network dilution and prevent components diffusing out from 
the place where the hydrogel is implanted. Click-chemistry has been of 
growing interest in the past 5 years to form ELRs networks avoiding the use 
of organic solvents210,211. It can be used to fuse ELRs with different bioactivity 
together212, or even form hybrid systems of the ELRs in an in-situ gelating 
manner. This method has further been used for the creation of non-
thrombogenic stents213. 
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1.5 ELR structures and applications 
 
Based on the design of ELRs and that nods of interactions incorporated, 
ELRs can form a variety of structures from nanoparticle to hydrogels (Figure 
8), which allow for a variety of structure related applications. 
 
Figure 8: The diversity of ELR structures and their sequential origin. 
 
Amphiphilic ELRs consist of blocks of different polarity, which have the 
ability to form micelles in solution, here the hydrophobic block is embedded 
in the core and the hydrophilic block(s) form the corona. The formation of 
stable nanoparticles requires a relatively high molecular weight of 48 
pentapeptides, and the particle size and molecular weight for a comparable 
ELR are directly related to214. The ITT of the ELRs depending on the 
characteristics of the micelles, can either lead to coalescence of micelles into 
lyotrophic gels112, to polydisperse microparticles215, or swelling and 
deswelling of the micelles, accompanied by size changes. Typical sizes of ELR 
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nanoparticles reported are usually in the range of 10 to 100124,216–220, but due 
to the temperature sensitivity and related agglomeration, also micro sized 
particles have been reported215,221. The approaches to influence ELR micelles 
are similar to those affecting the Tt of ELRs, like changing concentration112, 
the addition of surfactants222, salt concentrations124,218,220 and pH218. 
In general the shape of micelles is round, but with specific designed ELRs 
consisting of different amphiphilic blocks, micelles with a cylindrical shape 
have been obtained223. The rearrangement typically occurs over the critical 
micelle temperature (CMT) and is driven by a change in the secondary 
structure of the hydrophobic core, the cylindrical shape change further 
seems to enhance the cellular uptake of the particles214. Micelle solutions 
further have been used to generate thin coatings with nano topographic, or 
anti-fouling properties224. 
 
1.5.1 Hydrogels 
 
Due to the ELRs origin, inspired by the extracellular matrix (ECM) protein 
elastin, most research is focused on the generation of matrices. In tissue 
engineering, where the predominant matrices in the past 40 years were 
hydrogels which already made it to application in the human body151, their 
high water content, the resulting mechanical properties, and stimuli-
responsiveness are a good model for natural tissue152,153. To resemble the 
ECM physical properties (elasticity, stiffnes), the nano-topography and the 
presence of signaling molecules, protease active and adhesion sites. For the 
generation of hydrogels from linear ELRs, cross-linking points must be 
considered. They can be either of covalent or physical nature and their 
position along the ELR backbone can be fully controlled. Polypeptide-based 
block-copolypeptides for example manage to self-assemble into stable 
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hydrogels155, which can be further stabilized when flanked by protein 
segments with coiled-coil secondary structure111,156, another approach is the 
incorporation of recombinant segments of elastin, silk or collagen157–159. 
 
1.5.2 ELRs as drug carriers 
 
ELRs have several advantages over other macromolecules as drug delivery 
carriers. They can be utilized in an active (by hyperthermia induced phase 
transition), or passive (by controlling the molecular weight) approach. 
Moreover, the recombinant nature of ELRs allows for the insertion of 
specific sequences that enhance tumor targeting. 
It was shown that an anticancer drug that has been conjugated to an ELR is 
administered, and focal hyperthermia applied, the thermoresponsive 
properties and enhanced permeability and retention effects of the ELP 
facilitate drug aggregation within tumor tissues225. Further supported by 
studies by by Chilkoti et al. using ELRs for targeting  solid tumors by 
applications of hyperthermia to the tumor region, demonstrating a two- fold 
increase in ELR accumulation within a tumor upon application of 
hyperthermia, as compared to treated with the ELR construct alone226,227. 
This adjustable ELR accumulation rates may be exploited to reduce drug 
cargo doses without impairing anti-cancer efficacy. It should be noted that 
besides the control over accumulation rates, ELRs are eliminated more 
quickly and with fewer side effects from the untreated regions that have not 
been subjected to hyperthermia. 
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1.6 Cholesterol 
 
1.6.1 Cholesterols role in cell membranes 
 
One of the most abundant molecules in the membrane is cholesterol, which 
due to the hydrophobicity lays inside the membrane. Cholesterol is 
responsible for membrane integrity and cellular signaling and makes up to 
20% of the membrane's mass63. Cholesterol, among the many lipid 
constituents of mammalian cell membranes, is a key regulator of membrane 
fluidity and contributes to the formation of caveolae, and in maintaining 
caveolae microdomain64,65. Caveolae are specialized domains of the plasma 
membrane that are found in most cell types66. Nevertheless, they are more 
abundant in cells like adipocytes, endothelial cells, fibroblasts, and muscle 
cells67. Besides the influence of membrane fluidity, cholesterol is important 
for cellular structure and function, it is essential in locomotion and serves 
as a metabolic precursor for several signaling molecules, including 
oxysterols68, steroids228 and bile acids65,69,70. The intrisc property of 
cholesterol to form liquid crystal like domains (lipid rafts) in the cell 
membrane makes cholesterol an interesting group for the interaction 
cholesterol modified materials with cells. 
 
1.6.2 Cholesterol modified materials 
 
A new class of materials, has been obtained by the hydrophobic modification 
of hydrophilic polymers with cholesteryl groups, generating polymer 
amphiphiles that self-assemble into nanoparticles in aqueous solutions. The 
underlying mechanism was described in cholesterol modified pullulan as a 
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poly-core model (Figure 9), where the cholesterol groups serve as physical 
crosslinks leading to multiple cores stabilizing the nanoparticle229. 
 
Figure 9: Schematic illustration of the poly core model for cholesteryl stabilized particles. 
Reproduced from230. 
 
Other cholesterol-bearing materials that exhibit nano-aggregation into 
hydrogels, like pullulan229,231, anti-microbial peptides, or deoxycholic acid 
modified heparin232 and chitosan233, were described by the poly-core 
model229 as self-aggregated nanoparticle forming non-covalently cross-linked 
supramolecular hydrogel structures mediated by hydrophobic association of 
cholesterol moieties. Furthermore, for temperature sensitive polymers, the 
characteristic temperature to cause a structural change decreased with the 
degree of cholesteryl substituions229. It is noteworthy, that based on the 
findings of Morishima et al. this effect of self-association is more probable to 
occur in bulky hydrophobic groups such as cholesterol or deoxycholic acid, 
than in long alkyl hydrocarbon chain229,234.  
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Furthermore, cholesterol modified materials recently have been investigated 
as potential cell targeting and drug-delivery systems, using the affinity of 
cholesterol groups to cell membranes. Here the studies are ranging from 
cholesterol assisted DNA transfection235, the treatment of type II 
diabetes236, or the targeting of cancer cells237. 
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1.7 Role of Proteases 
 
To understand the process of enzymatic degradation and related demands 
on the ELR constructs, the diversity of proteases and their role in regulation 
and disease will be explained in the following. 
 
1.7.1 Peptidase Classification 
 
1.7.1.1 Classification 
 
The numerous types of proteolytic enzymes demand a system of 
nomenclature to facilitate better scientific communication that accelerates 
scientific progress. Alone the presence of a system of classification 
underlines the importance of a field of investigation. In the case of 
proteolytic enzymes, the need to distinguish between different types of 
proteases emerged already in the early 20th century and since than the field 
is rapidly expanding due to an increase in research as well as through novel 
techniques that help to discover new proteases, new catalytic domains, or 
to discover new ways of action. In mammalian cells multiple proteolytic 
systems are present that serve distinct functions. These include the 
endosomal lysosomal system (e.g., cathepsin B, D, H, L, and other 
hydrolases), mitochondrial proteases and the ubiquitin-proteasome 
pathway. The development of a classification system that is continuously 
updated, helps to draw a better picture of the interactions and connections 
of what has already been discovered, and not least importantly to give it a 
name. In the following, the terminology of proteases will be briefly 
described238. 
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1.7.1.2 Terminology 
 
One of the first approaches to differentiate proteolytic enzymes from other 
enzymes was the introduction of the term proteases in the late 19th century 
in Germany. Grassman and Dyckenhoff differentiated between peptidase 
(proteolysis of oligopeptides) and proteinases (proteolysis of bigger 
proteins)238. The term peptidase was than further specified by the finding, 
that the preference to hydrolyze small peptides was not driven by the size 
of the peptide, but by the accessibility of the N- or C-termini, where on the 
other hand some peptidase did not even require a free-termini. This led to 
the introduction of the prefixes endo- and exo- peptidases, where exo relates 
to the preferences for regions close to the protein terminus. Additionally, 
the term peptidase became a more general synonym for the class of 
proteolytic enzymes239, to account for the peptide size dependency other 
terms like oligopeptidases have also been suggested238. The further 
classification was done by moving away from the substrate as a mean for 
classification to the enzyme structure240. Here, the active sites of peptidases 
served as a mean to differentiate between peptidase classes. The active sites 
are commonly located in a surface groove of the enzyme, adjoined by 
structural domains that increase specificity, and can consist of different key 
amino acids, or even metal ions. Thus, the nature of the catalytic site let to 
peptidase specific classifications into five classes of peptidases, serine, 
aspartic, cysteine, threonine and metallo peptidases238. 
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Figure 10: Synonyms of peptidases and the differences in endo- and exopeptidases. The names in 
the box are commonly used terms for proteolytic enzymes. The differences in endo- and 
exopeptidases are, that endopeptidases preferentially act away from protein termini and 
exopeptidases act close to the C- or N-terminus (as indicated by the triangular shades)238. 
 
Due to the numerous discoveries of new peptidases, and to avoid confusion, 
a systematic classification of peptidase was needed to distinguish, or group 
the peptidases. Thus, the enzymes were classified according to the structure 
of their active site in a list better known as the EC-list of peptidases238. 
 
1.7.2 Role of Proteases in Matrix Remodeling and Related 
diseases 
 
The dynamic equilibrium of the ECM under physiological conditions is a 
consequence of the balance between the regulation of synthesis and 
degradation of ECM components. Proteolytic enzymes are ubiquitous, being 
distributed in all biological fluids and tissues241,242. Peptidases are involved in 
a variety of processes, where tissue proteins need to be removed or 
remodeled. In general, peptidases accomplish two major functions, 
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regulation of enzyme (including other peptidases) activation, or inactivation 
of specific proteins, besides their general proteolytic function. The 
degradative mechanisms remove denatured proteins and native proteins no 
longer needed by the body or cell. Both types of proteolysis are highly 
regulated and usually occur in response to specific extracellular signals, such 
as differentiation, injury, and tissue development22. An example of the tight 
interdependence and regulation of peptidases is the normal wound healing 
cascade. It begins with hemostasis and fibrin deposition, which leads to an 
inflammatory cell cascade, characterized by recruitment of neutrophils, 
macrophages and lymphocytes into the inflammatory area. At this point, 
proteolytic substances are secreted followed by attraction and proliferation 
of fibroblasts and collagen deposition, and finally remodeling by collagen 
cross-linking and scar maturation243. The removal of old or denaturated 
proteins like cellular debris, fibrous tissue, blood clots, or ECM proteins that 
have to be rearranged in the regeneration process is mainly done by 
peptidases. The peptidases involved in tissue regeneration can be subdivided 
into four classes: aspartic peptidases, serine peptidases, cysteine peptidases 
and matrix metallopeptidases (MMPs). Generally, the peptidases are 
secreted in a non-active form, which is activated by peptidase mediated 
cleavage. A scheme for the interdependence of peptidases is given in Figure 
11. 
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Figure 11: Cascade of peptidase pro-form activations by peptidase mediated cleavage244. 
 
The inactive precursor of a peptidase that is activated by proteolytic 
cleavage, is called zymogen, or proenzyme. In contrast to phosphorylation 
phenomena, no energy source is needed, and activation can also occur 
extracellularly, it is noteworthy, that this form of activation is irreversible, 
the enzyme might be deactivated by other mechanisms, but cannot return 
to its initial uncleaved form244. Besides the secretion in a non-active form, 
there are several other regulatory functions in tissue, to avoid the false 
activity of peptidases. The coordinated control of ECM degradation on the 
cell surface involves three crucial elements: secreted proteases and their 
inhibitors, surface protease receptors and integral membrane proteases245. 
The very prominent role in regulation play inhibitors of peptidases, which 
are derived from plasma, or cells in the tissues. About 10% of the proteins 
in plasma are peptidase inhibitors, which are in general class specific, besides 
α2 macroglobulin, an inhibitor capable to act across the peptidase classes. 
The balance between peptidase and their inhibitors depends on several 
factors, including production rates of proteinases and inhibitors, and their 
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secretion. Production levels of the proteinases and inhibitors within the cells 
are controlled mainly by their gene expression.  
Activation processes of proMMPs and membrane anchoring of their 
activities have been established by extensive experimental work. The 
presence of plasminogen activator (PA) inhibitors in the ECM is supposed 
to influence the extent of local PA and plasmin-mediated proteolysis. It was 
found, that the PA inhibitor is homogeneously distributed under fibroblast 
and fibrosarcoma cells246,247 and closely associated with the pericellular space 
of endothelial cells248–250, controlling the remodeling of the membrane 
locally. 
 
1.7.2 Serine Proteases 
 
Serine peptidases induce hydrolysis of peptides via a serine group; they 
include the largest number of peptidases. The main ECM degrading 
proteases include neutrophil derived elastase, cathepsin G, proteinase 3, 
plasma derived plasminogen, kallikrein, and the plasmin and plasminogen 
activators like tissue-type plasmin activator (tPA) and urokinase-type 
plasminogen activator (uPA).The role of these proteases is best studied in 
endothelial cells, fibroblasts, chondrocytes or tumor cells243. Plasmin 
activators are secreted immediately after synthesis, thus the enzymes are 
found to be extracellular251. The synthesize occurs in the liver and is 
secreted to the plasma, due to the binding capacity to cells, proximity 
related to local control of cellular response can be exerted252,253. tPA and 
uPA play a key role in the activation of plasminogens for fibrinolysis and tPA 
in particular induce clearance fibrin from the blood and blood clots254. Serine 
proteases are crucial for a cascade of zymogen conversions, in which the 
activated form of one clotting factor catalyzes the activation of the next 
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precursor (compare Figure 11 proenzymes). One of the most studied 
zymogens is fibrinogen and its role in blood clotting. Fibrinogen is a highly 
soluble molecule in the plasma, and is converted into the insoluble fibrin by 
the hydrolysis of several arginine bonds causing its precipitation in the final 
step of blood clotting, a process which is induced by the serine proteases 
thrombin. As well as being responsible for the clotting of blood, serine 
proteases are also involved in the lysis of the blood clots and the remodeling, 
mediated by uPA and tPA plasminogen activation. Although zymogen 
activation is irreversible, specific inhibitors like anti-thrombin III function as 
modulators of peptidase activity244. Plasmin can degrade most of the matrix 
components laminin, fibronectin, and possibly type V collagen)255,256, but not 
types I, II, and III collagens. Thus, serine proteases are partly complementary 
to collagenases (MMP1, 8, 13). Elastase and cathepsin G are capable of elastin 
cleavage and cleave the telopeptide region of fibrillar collagen (types I, II, III, 
IV, VI, VIII, IX, X, and XI). Moreover, they can degrade ECM components 
such as fibronectin, laminin, and aggrecan. It was further reported, that 
serine proteases play a role in the activation of latent collagenases  and other 
MMPs and thereby participate in the complete degradation of ECM257–260, as 
well as in the inactivation of peptidase inhibitors like α2 antiplasmin, α1 
antichymotrypsin, and tissue inhibitors of metalloproteinases (TIMPs)261,262.  
 
1.7.3 MMPs 
 
The second largest group of peptidases involved in tissue remodeling are 
MMPs; MMPs degrade most of the components of the ECM, like collagen, 
gelatin, aggrecan, tenascin, fibrinogen, elastin, laminin, osteonectin, or fibrin. 
MMPs possess several common characteristics: they are secreted in a latent 
form and require activation for proteolytic activity, they contain a heavy 
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metal ion, and require Ca2+ for proteolytic activity, they degrade ECM 
components, and are a target to TIMPs262,263. Most secreted-type MMPs, 
including collagenases, gelatinases, and stromelysins, are composed of three 
basic domains; a propeptide, a catalytic domain, and a hemopexin-like 
domain, with a prepended hydrophobic signal domain. The propeptide 
domain includes a free cysteine that occupies a coordination spot on the 
zinc atom, hampering the catalytic hydrolysis of peptides. The propetide 
region is a target to other peptidases, by hydrolysis/activation of the 
propetide, the active site is released from the cysteine and fully functional. 
The catalytic domain includes the metal ion (mainly zinc) complexed by a 
histidine containing sequence. C-terminal hemopexin-like domain, interacts 
with ECM components via a proline-rich hinge region, and determines the 
MMPs substrate specifity. In the process of collagen remodeling, peptidases 
like collagenases (MMP1, 8, 13) are crucial for the degradation of the 
collagen. Collagenases are enzymes that are secreted by fibroblasts, 
neutrophils, or macrophages264,265, and that clip the collagen molecule at a 
specific site. The activated collagenases specifically degrade the native triple 
helix of type I, II or III collagen, by making a single, sequence-specific266. The 
action of the collagenase on collagen further results in “unwinding” of the 
helical structure to produce a molecule that is now susceptible to 
proteolytic cleavage by other proteinases and gelatinases243,267. ECM 
molecules like Proteoglycans, laminin and fibronectin are more susceptible 
to stromelysin (MMP3; MMP10) degradation268, but stromelysins are less 
capable of degrading type IV collagen and elastin. Moreover, MMPs are 
involved in the regulation of actin microfilament system269 and in lung 
remodeling (MMP9)270. Some MMPs are anchored to the membrane of cells, 
allowing for cell-directed cleavage of ECM. These MMPs located in the cell 
membrane differ in their c-terminal anchorage region, and can be classified 
into three groups: glycophosphatidylinositol (GPI) - linked MMPs; 
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transmembrane-type 1; and type 2 MMPs. Type I transmembrane-type 
MMPs (MTx-MMPs) include MMP-14-16271,272 and MMP-24273, capable of 
degrading collagens, gelatins, aggrecans, FN, Ln, fibrin, tenascin, nidogens, 
and proteoglycans 274–277. GPI linked MMPs include MMP-17 and MMP-25, 
involved in the degradation of gelatin and fibrin/fibrinogen278,279. So far just 
one type-2 transmembrane type MMP has been discovered, MMP23, which 
is expressed in reproducible organs of males and females, but the exact 
function remains to be discovered280,281. 
 
1.7.4 Cleavable peptide bonds 
 
Current research in tissue engineering materials is challenged by a paucity 
of renewable sources, which include functional and immunologically 
compatible cells; appropriate biomaterials with desired mechanical, chemical 
and biological properties; and the inability to generate, vascularized 
tissues282. In the past ten years, the field has advanced tremendously 
catalyzed by the achievments in the related fields of biology, material science, 
chemistry and engineering. The lack of immunologically compatible cells 
might be covered by the discovery of induced pluripotent stem cells (iPSCs), 
paving the way for more sophisticated applications in personalized 
medicine283,284. 
Research has begun in detecting the proteolytic sequences in natural 
proteins, especially in ECM proteins. These groups were the first candidates 
for tissue engineering construct, by using short specific peptides as 
crosslinkers of natural or synthetic hydrogels. More recently, peptide 
libraries were designed to discover new proteolytic groups that were not 
or not yet found in natural proteins. The specificity of cleavage is mainly 
focused on the detection and or the targeted delivery of drugs in cancer, 
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but can also be used for the targeted degradation and more specific 
regeneration of tissue engineering constructs. The number of proteolytic 
groups is steadily increasing, thus is their use for degradable hydrogels. 
A simple one component synthetic polymers might be the material of choice 
in terms of mechanical stability, and emerging techniques such as spatial 
patterning285,286, two-photon polymerization287, 3D printing288–295, 
programmed self-assembly296,297 overcome the lack of defined sub micro 
structures in synthetic polymers. These techniques allow the generation of 
complex biological structures with integrated vasculature and multiple cells 
or extracellular matrix (ECM) types at high spatial resolution. The material 
stiffness in TE targets several key functions, such as stem cell differentiation, 
enabling new ways of controlling cell phenotypes using physical cues298–300. 
The limitations of synthetic polymers are mainly related to the lack of 
biochemical cues like growth factors and cytokines to be presented with 
improved bioavailability and bioactivity301,302. 
The mimicking of the extracellular matrix, with all its mechanical and 
biological complexities, also demands proteolytically cleavable 
segments303,304. To be effective mimics of extracellular matrix molecules like 
fibrin and collagen, an artificial extracellular matrix analogue would have to 
be proteolytically degradable, just like the natural extracellular matrix305,306. 
Here the kinetics of degradation depends on the application, e.g. the release 
of small and large molecules in targeted treatments demands a degradation 
rate that fosters the controlled release and diffusion of the molecules, 
whereas encapsulation for immunoisolation of cells ideally does not degrade. 
In tissue regeneration application the rate of degradation should match the 
neo tissue formation rate307. 
Further challenges involving the design of future hydrogels are related to the 
understanding of the foreign bodies and the body’s immune surveillance 
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system282,308,309. By now biomaterials are designed to be invisible for the 
immune system or to induce a weak inflammatory response to initiate the 
regeneration cascades. A better understanding of the body’s immune system 
might enable further cues triggering the immune system for more controlled 
regeneration. 
 
1.7.5 Involvement of Peptidase in tissue regeneration 
 
The general role of peptidases in protein degradation, is crucial for tissue 
regeneration. Peptidases are especially involved in vascularization, 
osteogenesis, neurogenesis and wound healing.  
 
1.7.5.1 Vascularization 
 
Vascularization is crucial for all types of tissues and blood vessels are needed 
for the supply with nutrients. Peptidases might not be the key player in 
vascularization, but they complete the complex event cascades new blood 
vessel generation. Growth factors (GFs) like aFGF, bFGF, VEGF, TGFs are 
important for the cellular signaling related to vascularization, but there is 
also a need for proteases, that degrade and penetrate the ECM, for the 
invasion of blood vessels into the tissue. It has been shown, that the 
presence of growth factors affects the peptidase expression of endothelial 
cells in vitro, raising the issue of their importancs in vascularization. The cells 
responded to bFGF with an increased synthesis of uPA and collagenases310–
312. Further, it was shown, that endothelial cells invade ECM proteins like 
fibrin and type I collagen in the presence of tPA, resulting in blood vessel-
like tubes313,314, accompanied by increased collagenases (type I and IV), PA , 
55 
Role of Proteases 
 
 
and stromelysin activity310,311,315,316. Even though the MMPs are secreted in 
their latent form, their activity is regulated by the plasmin activation, which 
itself has been activated by the coordinately secreted serine proteases like 
uPA and tPA. The interdependency of peptidases-mediated vasculatization 
in the signaling cascade is highly controlled and further self-regulated by the 
presence of several peptidase inhibitors. The main inhibitiors synthesized by 
endothelial cells are plasminogen activator inhibitor-1 (PAI-1)310,317, and 
tissue inhibitors of metalloproteinases TIMPs315, which directly target 
plasminogen activators (uPA, tPA), and MMPs (collagenases and 
stromelysin). The mechanisms of peptidase activation and inhibition are 
most likely controlled by the localization of peptidases and inhibitors. 
Peptidases are frequently cell surface associated, whereas TIMP is secreted 
to interstitial fluids and PAI-1 is secreted to the ECM. 
It has been proposed that the localization of proteases to cell surfaces may 
provide several advantages for more invasive neovascularization, including 
concentrations of proenzyme and activator enzymes. It is supposed, that the 
rate of enzyme activation is enhanced, by the protection from inactivation 
by secreted or ECM-associated inhibitors, giving regional specifity to 
enzymatic activity, directing proteolysis and angiogenesis310. 
 
1.7.5.2 Osteogenesis 
 
The regulation of matrix (re)modeling and degradation, by growth factors 
and peptidases is essential in bone development. Intramembranous and 
endochondral bone formed during embryogenesis, is subsequently 
remodeled in response to use, stress, or injury. Similar to vascularization 
events, a cascade of complex processes is involved, which include matrix 
deposition and resorption, cell recruitment and differentiation and related 
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expression of signaling molecules and proteases. Growth factors of the TGF-
b family play a pivotal role in the regulation of bone matrix synthesis and 
degradation, as well as bone morphogenic proteins (BMPs), crucial for the 
formation of new, and the remodeling of the existing bone. The complexity 
of the process is troublesome. The identification of cell types and their 
function is complicated by differentiation events, and the interpretation of 
obtained in vivo results, aggravated by simultaneously occurring processes 
like angiogenesis and hematopoiesis267. 
The peptidases for bone remodeling are mediated by osteoblasts, which are 
the major source of bone collagenase, as has been shown by biochemical 
and immunohistochemical studies. Osteotrophic hormones such as 
parathyroid hormone (PTH) stimulate osteoblasts to produce pro-
collagenase, PA, and TIMP and TGF-b318. TGF-b might stimulate the 
osteoblasts to produce type I collagen and fibronectin, and the parallel 
secretion of TIMP may prevent the collagenase mediatated degradation of 
newly synthesized matrix components267. PTH, which also stimulates PA 
accumulation in cultured osteoblasts319, may provide the means of activating 
collagenase in the resorption of bone. TGF-b and PA, may therefore also 
mediate the release of procollagenase from mineralized bone matrix and its 
conversion to an active form. Some of the TGF-b may remain latent and 
subsequently be released or incorporated in the remodeling process. The 
remodeling is induced by osteoclasts, they locally acidify the environment 
and secrete enzymes, TGF-b and PA. Thus, osteoblasts might be potentially 
stimulated by TGF-b released either from osteoclasts, or from the degraded 
bone matrix, and consequently release collagenases. The released 
collagenases can be activated by osteoclast derived PA, as a consequence 
bone resorption and synthesis a coupled in a feedback loop. 
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1.7.5.3 Neurogenesis 
 
In neurogenesis, neurite protrusion happens in a back-and-forth motion, 
making temporal contacts with ECM components. A similar process is 
observed in tumor cell invasion, where peptidases are involved, suggesting, 
that peptidases are most likely of general importance for the neurite 
outgrowth as well. This is corroborated by the fact, that approximately 50% 
of the neurons in the dorsal root ganglion secrete PA, with increased 
concentration at the growth cones320. The peptidase activity in the growth 
cone has been shown to be mediated by calcium ions321. Furthermore, the 
plasmin activated by PAs induces peptidase (MMPs, serinepeptidases) 
mediated degradation of the growth cone surrounding tissues. The 
dependence of neurite growth to ECM adhesion is supposed to be 
dependent on serine protease-like inhibitors, that are secreated by glial cells. 
The so called glia-derived nexin inactivates PA and thrombin322,323, which 
could stabilize the interaction of the growth cone with the ECM, resulting 
in an increasing neurite length. 
 
1.7.5.4 Muscle injury 
 
In muscle injury, neutrophils and their secreted proteases are involved in 
the degradation, of debris and peptides. Their key function is phagocytosis 
and degradation of proteins, debris and foreign organisms, such as bacteria. 
This happens through the activation of peptidases and other antibiotic 
molecules, as well as the generation of toxic oxygen radicals. The neutrophil 
invasion is related to muscle usage324,325, the neutrophils are supposed to be 
phagocytic326, helping to degrade cellular debris, and other muscle damage 
related proteins327. Besides excessive use and injury, inflammation or 
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immune response in tissues can also be caused by phagocytosis-associated 
events. Phagocytosis results in a respiratory burst, and release of oxygen 
metabolites, accompanied by the secretion of peptidases and cationic 
proteins327328. The liberated hydrogen peroxides are transformed into 
hypoclorous acid by myeloperoxidase (MPO) which reduces the hydroxyl 
radical concentration329, MPO activity is elevated by muscle usage324. 
Oxidant production and proteasemediation are equally crucial, proven by 
an increased susceptibility to infection in NADPH oxidase or elastase and 
cathepsin G deficient mice. It is believed that superoxide production in 
phagocytosis indirectly promotes protease function due to pH increase and 
liberation of cationic proteases from anionic proteoglycan matrix to degrade 
bacteria330,331. It was also found, that pulmonary tissue reacts to hypoxia by 
an increased collagen remodeling induced by an increased collangenolytic 
activity332. 
 
1.7.6 Disease related to peptidases 
 
Peptidases are involved in a variety of processes crucial for body function. 
Thus, their misregulation is associated with numerous diseases, making them 
attractive targets for inhibition. Peptidase overexpression and dysfunction 
are related to pathological conditions, such as cardiovascular and 
neurodegenerative diseases, arthritic diseases, and infection. Slight changes 
in expression level can cause alteration of a highly ordered and orchestrated 
event, such as  wound healing, to a pathologic condition that leads to fibrosis 
or chronic ulcers243. Moreover, matrix degrading proteases like MMPs are 
not only crucial for the remodeling of the ECM, but also, owing to their 
capacity of ECM degradation, are associated with different types of tumor 
invasion, facilitating tumor invasion and growth23. The similiarity of the 
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process of tumor invasion to that, which occurs during well-understood 
signaling cascade in vascularization, suggests that the proteolytic activities of 
endothelial cells may be related to the surrounding cells310. In fact uPA311, 
plasminogen, and plasmin333 have the capacity to bind to endothelial cells. 
Proteolytic MMP activity was found to be altered in the subventricular zone 
after focal stroke, and the related neurogenic migration was found to be 
dependent on MMPs, and MMP inhibition. It is supposed, that MMPs mediate 
neurovascular remodeling, and make MMP inhibitors a potential 
therapeutically target for the treatment of acute and chronic divergence of 
peptidase profiles, as well as in the post stroke treatment334. The imbalance 
of peptiases can also be induced by intake of the substance, as it has been 
shown corticosteroids that significantly increase MMP-3 activity, causing 
cellular apoptosis335. MMP-2 and MMP-9 are increasingly expressed in the 
acute lung injury and acute respiratory distress syndrome, as a consequence 
of the fibrotic lesions with collagen deposition that are formed336. A similar 
increase in peptidase activity is related to idiopathic pulmonary fibrosis, 
when the fibroblast activation protein activity is increasing337. Lysosomal 
enzyme (e.g cysteine peptidases) release and cell surface acidification are 
regulated events, therefore cystein peptidase dysregulation of stimulated 
macrophages is a cause that may contribute to injuries observed in cigarette 
smokers, lacking alpha-1-protease inhibitor-type emphysema338. In 
rheumatoid arthritis and osteoarthritis, lysosomal proteases as cathepsin K 
are believed to play a key role in bone resorption. The inactivation or 
deletion of the cathepsin K, which is highly expressed by human 
osteoclasts339, results in osteopetrotic phenotypes, underlying its 
importance in the process of bone resorption, and may also be responsible 
for the cartilage destruction that accompanies arthritis331,340. Also calpain 
type cysteine peptidases are involved in various pathologic conditions such 
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as muscle dystrophy338, and membrane peptidases are involved in tumour 
invasion245.  
 
 
Figure 12: Peptidases expressed by cell types and their relation to tumor cells. Reproduced from341.  
 
The numerous functions of peptidases are associated with an equal number 
of diseases, or dysfunctions, shifting peptidases in the scope for future 
therapeuctics. Especially the role of MMPs in tumor progression, growth and 
metastasis, raised the issue of MMP inhibitors as anti-cancer treatments 
 
1.7.7 Zymographic Methods of Protease Detection 
 
The importance of peptidase in disease like cancer, makes the a target for 
detection and sensing applications. Here zymographic techniques based on 
the detection of zymogens compose of a proteolytic target, whose 
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degradation by a peptidase can be detected. The first patents regarding 
zymographic techniques were focused on aminopeptidase detection from 
serum263, and a direct screening method evolved by the use of a hydrolytic 
substrate embedded in gel electrophoresis. The so called in-gel zymography 
(IGZ) was first introduced by Granelli-Piperno et al. in 1978 to study 
plasminogen activators24, and further improved by Heussen et al. by 
copolymerizing plasminogen and gelatin in the gel for the direct detection of 
plasminogen activators342. Zymography has become a standard technique for 
the detection of MMPs and other hydrolytic enzymes. Enzyme activities are 
determined based on the degradation degree of a substrate. The method 
requires conducting electrophoresis, and therefore it is troublesome in the 
procedures, and time-consuming in the detection. So far, zymographic 
techniques are able to detect a series of MMPs and other peptidases. 
Furthermore, hydrolases like: esterases25, phosphates  esterases25,343, pepsin 
A, pepsin A/C, chymosin, thermolysin, chymotrypsin344, cysteinproteases345, 
sheddases346,347, and cathepsines263,348. In the development of the method 
also the substrates have been varied from gelatin towards other proteolytic 
materials like, plasminogen, fibrin, casein, chondroitin sulfates, hyaluronan349–
352, xylans353, and zein354. Nevertheless, the majority of studies focus on 
gelatin as the substrate for the detection of MMP2 and or MMP9, due to the 
good isolation of these enzymes and their ease of detection. In in gel 
zymography, one drawback is the sample preparation in which tissue gets 
disrubted and enzymes are released, by these procedures there is a chance 
of colocalizing enzymes and inhibtors which would have an impact on the 
interpretation of the results. This drawback has been initially addressed by 
the immunostaining method specific to MMPs355, but these techniques lack 
the differentiation between the active and inactive form of the MMP, thus it 
is not feasible for MMP inhibitor studies. The combination of a zymographic 
method with tissue extracts (in-vivo zymography (IVZ)), is a zymographic 
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method without electrophoretic separation, where the proteolytic activity 
is detected by the cleavage of substrate bound fluorescent probes (gelatin, 
casein, or short peptides).  With IVZ real-time 3D proteolytic activity in a 
whole organism is quantified in small animals by the release of a fluorophor. 
In the early days of the technique, the substrates were not specific and could 
only detect broad proteolytic activities356–358. E.g. one approach used 
fluorescently labeled casein, gelatin or agarose as membranes, that can be 
applied on tissue sections, to locally access proteolytic activity. Here 
reproducibility issues occur, due to degradation of the substrate359. Specific 
FRET system, with an integrated proteolytic sequence, were used, that give 
fluorescent signal upon disintegration by proteolytic enzymes360,361. With an 
increasing number of accessible proteolytic FRET probes , more complex 
3D insights are obtained, giving new insights on the role of MMPs in the 
development of Zebrafish, with a so called “differential IVZ”361.  It could be 
shown, that gelatinases are capable of degrading tumor tissues, furthermore, 
MMP inhibitors are able to inhibit MMP activity in human thyroid cancer362. 
Nevertheless, it is difficult to clinically evaluate the benefit of MMP inhibitors 
in cancer treatments, because the in vivo activity of MMPs is inherently 
controlled by endogenous inhibitors like TIMP-1 and -2363. In conventional 
zymography the MMP-inhibitor complex is partially dissociated during the 
electrophoresis, and therefore the method does not allow the exact 
determination of the inhibitory activity of MMP inhibitors. The method is 
limited by the substrate that is used, information about the presence of 
peptidases are lacking indications about the exact cleavage site, and the type 
of peptidase detected is limited to the substrate. Gelatin zymography is only 
detecting MMP2 and MMP9, other bands that appear in the zymogram are 
mainly of unkown origin, or ignored in publications. This is mainly due to 
the presence of a variety of possible targets in native proteins like gelatin, 
collagen, casein, plasminogen, fibrinogen, etc.. This leaves space for 
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optimization of the existing techniques regarding sensitivity and in the 
numbers of potential peptidase that can be detected. When referring to the 
EC-list of peptidases there are more than 13 sub-groups of proteolytic 
enzyme classes with about 300 entries of different peptidases, all involved in 
the degradation of proteins238. In the scope of tissue engineering and 
oncology one subclass moved into the focus, which is the class of MMPs, 
which are known to be secreted by cancer cells or normal cells surrounding 
cancers. Furthermore, these class of enzymes is able to degrade 
extracellular matrix proteins like collagen282. Type IV collagenases (MMP2 
and MMP9) have been frequently reported to be accompanied with tumor 
invasion, metastasis and proliferation. 
 
Research carried out upon MMPs, increased, especially due to the relation 
of MMP activities in different types of cancer and diseases364, and on the 
other hand in tissue engineering, to introduce remodeling cues into the 
matrices. More recent methods and patents that involve zymographic 
detection are focused on the detection of certain forms of cancer (Table 1). 
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2 Hypothesis 
 
A. The DNA recombinant technique enables total control over the 
design of ELRs, further it allows for the insertion of any kind of 
peptidic sequence. It is hypothesized that the use of a spatial 
arrangement of protein sequences will allow for the enzymatic 
degradation of these ELRs. Additionally, it is hypothesized, that the 
capability of degradation is possible to be detected by a zymographic 
method using ELRs as a novel substrate. 
 
B. Using ELR as a substrate for zymographic methods enables the 
opportunity to present only a short selective region to the enzymes. 
Thus it is hypothesized, that using ELRs for zymographic techniques 
allows for the design of a new method with potential for high 
throughput applications for protease detection. 
 
C. Cholesterol modified materials have been shown to exhibit strong 
intermolecular interactions. It is hypothesized, that these interactions 
can be translated into an ELR system to generate intermolecular 
forces and to trigger self-assembly of ELRs. 
 
D. Cholesterol rich ELRs are further hypothesized to enhance the 
interaction of ELRs with certain cell types involved in lipid uptake. 
This mechanism is hypothesized to assist in the coating of living cells 
with ELR proteins. 
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3 Materials & Methods 
 
3.1 Materials 
 
3.1.1 Chemical Reagents. 
 
All reagents employed in this work are listed in Table 2. 
Table 2: Reagents employed and corresponding suppliers. 
Reactive and Abbreviation Supplier 
4-Dimethylaminopyridine (DMAP) Sigma Aldrich. 
Acetic acid Merck. 
Acetone Sigma Aldrich. 
Acrylamide/Bis-acrylamide Amresco. 
Agarose seakem. Cambrex. 
Alamar Blue Thermofisher 
Ammonium persulphate (APS). Sigma Aldrich. 
Ampicilin Apollo Scientific. 
Bromophenol blue Sigma Aldrich 
Calcium chloride  (CaCl2) Sigma Aldrich. 
Chloridric acid Merck. 
Coomassie Brillant-blue R-250 Sigma Aldrich 
Diethyl ether Scharlau. 
Dimethyl sulfoxide (DMSO) Carlo Erba 
Disodium hydrogen phosphate 
(Na2HPO4) 
Fluka 
Ethanol Merck 
Ethylenediaminetetraacetic 
acid(EDTA) 
Sigma Aldrich 
Gelatin from porcine skin Sigma Aldrich 
Glicerol. Merck 
Isopropanol Invitrogen. 
Methanol. Sigma Aldrich. 
Methacrylic anhydride Sigma Aldrich 
N,N'-Dicyclohexylcarbodiimide 
(DCC) 
Sigma Aldrich. 
N,N-Dimethylformamide (DMF). Sigma Aldrich. 
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Phenylmethylsulfonyl fluoride 
(PMSF). 
Apollo. 
Phosphate buffered saline (PBS) Gibco. 
Potassium chloride (KCl). Sigma Aldrich. 
Sodium chloride (NaCl)- Sigma Aldrich 
Sodium dodecyl sulfate (SDS) Sigma Aldrich. 
Sodium hydroxide Sigma Aldrich. 
Sodium sulfate (Na2SO4) Fluka 
Tetramethylethylenediamine 
(TEMED). 
Sigma Aldrich. 
Triton X-100 Merck 
Tris(hydroxymethyl)aminomethane 
(Tris). 
Sigma Aldrich. 
Ultrapure water Millipore 
Urea. Fluka. 
β-Mercaptoethanol. Merck 
 
3.1.2 Glass ware & other materials. 
 
During the realization of this doctoral thesis light scattering techniques have 
been employed, where glass test tubes were used. Tubes were rinsed 
distilled water followed by a wash with a mixture of soap-water (Hellmanex 
®II special for optical cleaning). To remove soap traces the tubes are 
extensively washed with water. Finally, the tubes are dry in an oven at 60 ° 
C for 6 hours. 
Other glass materials after washing and rinsing several times with distilled 
water were sterilized on an autoclave (Autester E-75). Other laboratory 
materials like tips, conical tubes, Eppendorf tubes, etc., are bought sterile or 
are sterilized when needed on an autoclave (Autotester E-75, 20 minutes 
120°C one atmosphere). 
 
3.1.3 Molecular biology materials. 
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3.1.3.1 Restriction enzymes. 
 
Table 3: Restriction enzymes used in this work and corresponding suppliers. 
Restriction enzyme Supplier 
BamHI 
New England Biolabs 
DpnI 
EarI 
EcoRI 
SapI 
XhoI 
EamI 1041 (EarI) Fermentas 
 
 
The restriction enzymes used in this work are listed below: 
BamHI, DpnI, EarI, EcoRI, SapI, XhoI (New England Biolabs). 
Eam1 104I (further refered to as Ear1) (Fermentas). 
All enzymes are used according to the manufacturer’s instructions. 
 
3.1.3.2 Other enzymes 
 
During the realization of this work the following enzymes have been 
employed: 
T4 DNA Ligase, Shrimp alkaline phosphatase (S.A.P.), Antartic alkaline 
phosphatase (New England Biolabs.), Trypsin (Corning), Trypsin (Gibco), 
Recombinant Human MMP-1 (901-MP-010), MMP-7 (907-MP-010), MMP-
8(908-MP-01), MMP-10 (910-MP-010), MMP-11 (910-MP-011), MMP- BML-
SE36012 (917-MPB-020), MMP-14 (918-MP-010), MMP-15 (916-MP-010), 
MMP-16 (1785-MP-010), MMP-17 (7796-MP-010) (all R&D Systems, UK); 
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MMP-2 (BML-SE237), MMP-9 (BML-SE360), MMP-13 (BML-SE246) (all enzo 
lifescience, Germany), MMP-19 (G04MP19C), MMP-20 (G04MP20C) (Giotti 
Pharmaceuticals). 
 
3.1.3.3 Cloning and expressing vectors 
 
The DNA fragments employed were cloned in the pDrive cloning vector 
(Qiagen), Figure 13. 
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Figure 13: Scheme of the pDrive cloning vector with mapped restriction sites. 
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For the expression of the different recombinant polimers a p7 expression 
vector has been employed (Figure 14). The p7 expression vector was 
constructed in our laboratory from Novagen’s pET-25b (+) vector, by Dr. 
A. Girotti. 
  
Figure 14: Scheme of p7expression vector based on Navagen’s  pET-25b(+) vector. 
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3.1.4 Other reagents 
 
Table 4: Other reagents used for this work. 
Reagent Supplier  
Quantm Prep Plasmid 
Miniprep Kit 
Thermo Fisher 
QIAquick Gel Extraction Kit 
Protocol 
Qiagen 
 
3.1.5 Bacterial Strain 
 
Table 5:Bacterial strains used for this work. 
E. coli strain Supplier 
XL1-Blue (Stratagene) 
BL21(DE3) Star (Invitrogen) 
BLR(DE3) (Novagen) 
 
3.1.6 Bacterial culture media 
 
The culture media used for bacteria growth and transformation are listed 
below: 
Luria-Broth (LB) (Pronadisa): Concentration 25g/l. 
Terrific Broth (TB)(Formedium): 55.85 g/l + 8ml/l Glicerol. 
LB-Agar: LB 25 g/l + 1.5 % (p/v). Agar (Fluka). 
SOC I. (Sigma Aldrich)  
 
3.1.7 Buffers 
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During the performance of the work presented on this thesis different 
buffers were employed: 
PBS (pH=7,4): 5mM Na2HPO4  pH=7,4, NaCl 140 mM 
TAE: 40 mM Tris-acetate, 1mM pH=8 EDTA 
TE (sonication buffer): 10 mM pH 8 Tris-base, 1 mM pH=8 EDTA, 
1mM PMSF. 
TBS (washing buffer) :20 mM pH 8 Tris-base, 140 mM NaCl. 
Running buffer: Tris-base 25 mM pH=8,3, glicina 192 mM y SDS 0,1% 
(w/v). 
DNA loading buffer: 30% (v/v) glycerol, 0.1% (w/v) SDS, 0.05% (w/v) 
bromophenol blue (BPB), 50mM Tris pH 8, 0.05mM EDTA  
Protein loading buffer: Tris 1MpH 6.5 312.5 mM, SDS 10%(w/v), 
Glycerol ( v/v), β-Mercaptoethanol 25%(v/v), bromophenol blue 
(BPB) 2% (v/v). 
All the solutions were prepared using ultrapure ultrapure water 
(Millipore) 
 
3.1.8 Elastin-like recombinamers 
 
All the elastin-like recombinamers (ELRs) employed in the development of 
this work have been synthesized in our laboratory (Grupo Bioforge) by 
DNA recombinant techniques. Those recombinamers listed in bold in . 
 
Table 6 were specifically designed and produced for the realization of this 
thesis. They were produced by Escherichia Coli fermentation and purified 
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taking advantage of both the smart nature and the reversible thermo-
dependent segregation showed by this kind of materials, by inverse 
transition cycling (ITC).  
The recombinamers employed, the abbreviation, molecular weight (Mw), 
and amino acid sequence are shown in . 
 
Table 6. 
 
Table 6: Composition and molecular weight of the ELbcRs and ELRs employed. 
Abbreviation Amino-acid sequence MW(Da) 
VKV MESLLP (((VPGVG)2 VPGKG 
(VPGVG)2)24 V 
 
IK (ELR-Control) MESLLP (((VPGIG)2 VPGKG 
(VPGIG)2)24 V 
51969 
IKHEX (ELR-
Ela1) 
MESLLP (((VPGIG)2 VPGKG 
(VPGIG)2)2 (VGVAPG)3)10 V 
57856 
PIT1(ELR-Ela1+FN) MESLLP ((VPGIG)2 VPGKG (VPGIG)2 
EEIQIGHIPREDVDYHLYP (VPGIG)2 
VPGKG (VPGIG)2 (VGVAPG)3)10V 
80911 
PIT2 (ELR-FN) MESLLP ((VPGIG)2 VPGKG (VPGIG)2 
EEIQIGHIPREDVDYHLYP (VPGIG)2 
VPGKG (VPGIG)2)10V 
66494 
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3.1.9 Cell lines and culture conditions 
 
Human umbilical vein endothelial cells (HUVECs, cc-2517) were purchased 
from Lonza (Lonza, Europe). Human aortic smooth muscle cells (HASMC, 
ref. CRL-1999) were purchased from the American Type Culture Collection 
(ATCC, USA). 
 
3.1.9.1 Culture Media and Buffers 
 
Dulbecco’s Modified Eagle Medium, Medium 231, and smooth muscle 
growth supplement (SGMS) were purchased from Thermo Fisher Scientific, 
fetal bovine serum (FBS), penicillin streptomycin solution(P/S), trypsin-
EDTA, DPBS, and Alamar Blue® were supplied by Invitrogen (USA), 
endothelial growth medium (EGM-2) was purchased from Lonza (Lonza, 
Europe).  
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3.2 Methods 
 
3.2.1 DNA agarose gel electrophoresis 
 
DNA agarose gel electrophoresis is used to separate and check the 
appearance and size of DNA fragments form either a plasmid or from 
enzymatic digestion with endonucleases. Different concentrations (in 1x 
TAE), are applied according to the sizes of the DNA fragments and the kind 
of gel, analytical or preparative. 
The agarose is completely dissolved in hot water (70 – 90°C). After cooling 
down to 60°C the gel is casted in a horizontal tray with the desired comb. 
0.20 volumes of 5x loading buffer are added to the samples. A fixed 
voltage, between 2 and 7 V/cm – according to each sample, is then applied. 
The electrophoresis is run having as references the color markers (Table 7). 
Last, the gel is stained for 10 to 30 minutes in a 1x GelRed solution, and the 
DNA bands are visualized by exposition to UV light in a Viber Lourmat, 
TFX-20M transilluminator.  
Table 7: Relation of linear DNA migration with the bromophenol blue (BFB). 
TAE 1x –BPB % Agarose 
2900 0.30 
1650 0.50 
1000 0.75 
500 1 
370 1.25 
200 1.75 
150 2 
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3.2.2 Plasmid purification 
 
The plasmids employed in this work were purified using “Quantum Prep 
Plasmid Mini, Midi o Maxiprep Kit” (Biorad) following the manufacturer’s 
instructions. DNA was eluted with ultrapure water. For applications were 
higher DNA concentration is required only half of the recommended elution 
volume is used and the elution water is used at 65°C. 
 
3.2.3 DNA digestion with restriction enzymes 
 
Reaction conditions (temperature, concentration, time of reaction, buffer) 
for the digestion are supplied by the enzyme manufacturer. The rate of 
digestion is followed by DNA agarose gel electrophoresis  
 
3.2.4 DNA dephosphorylation 
 
Dephosphorylation reaction conditions (temperature, time of reaction, 
buffer) are supplied by the phosphatase manufacturer. For the p7 expression 
vector two different consecutive phosphatases were used and the 
incubation time was extended to one hour. 
 
3.2.5 DNA separation and extraction from agarose gel 
 
The target DNA band is first separated and visualized in an agarose gel of 
an appropriated concentration and stained with RedGel, secondly, the band 
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is extracted from the gel with the help of a scalpel. The minimum quantity 
of agarose should be cut during band extraction. 
The purification of the fragment is carried out using the “QIAquick Gel 
Extraction Kit Protocol” (Qiagen), following the protocol indicated by the 
manufacturer. 
 
3.2.6 Ligation of genes 
 
The reaction ligation is carried out in a final volume of 10-12µL by mixing 
the insert with the vector, in a molar relation from 1:1 to 5:1, and T4 DNA 
ligase as an enzyme with its corresponding buffer following the specifications 
indicated by the supplier. The reaction is conducted for 1 hour at room 
temperature or for 24 hours at 4°C. 
 
3.2.7 Cloning on the pDrive/ p7 vector 
 
The ligation reaction is interrupted by the inactivation of the T4 DNA ligase 
by incubation for 10 minutes at 70°C. Once the ligation reaction is 
concluded, a certain quantity of it is used to transform competent cell as 
specified below. 
 
3.2.8 Transformation of competent cells 
  
3.2.8.1 Transformation of XL1 blue subcloning grade competent cells 
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This bacterial strain has an efficiency of ≥ 106 transformants per microgram 
of DNA. Plasmid DNA to be amplified by cloning is transformed in this 
bacterial strain following the protocol specified by the supplier. 
 
3.2.8.2 Transformation of XL1 blue competent cells 
 
This bacterial strain has an efficiency of ≥ 108 transformants per microgram 
of DNA. Ligation products were transformed into this bacterial strain 
following the protocol specified by the supplier. 
 
3.2.8.3 Transformation of BLR (DE3) competent cells 
 
This bacterial strain is transformed with the expression plasmid p7 following 
the method TSS reagent (“Transformation and Storage Solution”) 
A single colony, isolated and grown in an LB-agar plate, is used to inoculate 
10mL of LB medium and is grown at 37ºC with shaking (250rpm), until 
reaching an OD600=0.3-0.4. At this point the metabolism and cell growth are 
stopped by incubation on ice for 5 minutes. The cell suspension is 
centrifuged at 3000rpm (1100Gx) for 10minutes at 4ºC. The supernatant is 
discarded and the pellet is re-suspended in 1mL of cold x1TSS solution. 
About 1-10ng of the plasmid in a final volume of 1-10µL is added to the mix. 
The cellular suspension plus the plasmidic DNA is kept on ice for one hour 
followed by a heat shock, exposition at 42ºC for 2 minutes.  The heat shock 
is stopped by immersion on ice for 2 minutes. 1mL of warm LB is added and 
the suspension is incubated one hour at 37ºC with shaking (250rpm).Finally, 
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50-200µL of the transformation mix is plated in LB-agar plus the antibiotic 
plates that are incubated for 16-20 hours at 37ºC. 
 
3.2.9 Glycerol stock preparation 
 
Positive clones, which are of special interest, are stored in glycerol stocks. 
The selected colonies were grown at 37°C with shacking (250rpm.) on LB 
or LB with 0.5% of glucose (for the expression strains), until reaching an 
OD600= 0.6-0.8. At this point 0.1 volumes of 80% sterile glycerol are added 
and the cells are kept at -80°C. 
 
3.2.10 Biopolymers expression and purification 
 
Once the nucleotide sequences that encode for the whole biopolymers have 
been created, it must be expressed. To this end, the nucleotide sequence 
was transferred from the corresponding cloning vector to the specialised 
expression vector using conventional restriction enzymes. The expression 
vector p7 has been employed. p7 has been obtained in our laboratory by 
mutagenesis of pET25b (+) by Dr. Alessandra Girotti. The final 
constructions were transformed on the bacterial strain BLR (DE3) following 
the above mention protocol. 
ELRs expression starts inoculating the desired colony in liquid LB medium 
plus antibiotic at 37 ° C with orbital shaking (250 rpm.) for approximately 6 
hours. This culture is used as inoculum for a fresh TB medium (plus 
antibiotic), in a volume ratio of 1:500, not exceeding 25% of the capacity of 
the Erlenmeyer used.  
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Expression of the recombinant polypeptides was initiated by inoculating an 
isolated colony containing the corresponding recombinant vector in liquid 
LB medium with the eventual resistance antibiotic for the strain and the 
acquired resistance antibiotic with the expression vector and 1% glucose. 
The bacterial culture was incubated at 37ºC, with orbital shaking at 250 rpm, 
for approximately 11 hours, then this culture broth was used to inoculate a 
fresh medium in a 1/30 ratio, preferably a 100-fold larger volume of TB 
medium with the same antibiotic and a concentration of 0.8% (v/v) glycerol, 
0.2% (w/v) alpha-lactose and 0.05% (w/v) glucose. The mean volume in the 
Erlenmeyers did not exceed 20-25% of their capacity in order to ensure 
good oxygenation of the culture, and bacterial growth was continued under 
the same conditions until an optical density of around 0.6 at 600 nm had 
been achieved. At that point expression of the recombinant biopolymer was 
induced by adding isopropyl -beta-D-1-thiogalactopyranoside (IPTG) to a 
final concentration of 1 mM, and the resulting culture was incubated at the 
appropriate temperature for the time required for each experiment. 
Once induction was complete, further growth and metabolism of the 
bacteria were inhibited by cooling to 4ºC. The cells were subsequently 
isolated by centrifuging for 10 min at 5000g and 4ºC, and washed twice with 
100 mL/L of culture in Tris buffered saline (TBS; Tris-base 20 mM, NaCl 150 
mM pH 8), the bacteria resuspended by vigorous stirring and/or pipetting 
and the mixture centrifuged again for 10 min at 5000g and 4ºC. The 
supernatant was then decanted and the sediment resuspended in 25 mL/L 
of culture with TE solution (Tris-base 20 mM, EDTA 1 mM pH 8) by 
vigorous stirring and/or pipetting. The resulting mixture was maintained at 
4ºC and 10 Pg/mL of the protease inhibitor phenylmethylsulfonyl fluoride 
(PMSF) added.  
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The bacteria were lysed by sonication in a Sonicator 3000 apparatus 
(Misonix, New York) for 6 cycles of 3.5 minutes, each consisting of pulses 
of 2 seconds every 5 seconds at a power of around 100 W. The sample was 
maintained on ice throughout this process in order to prevent heat-induced 
denaturation and precipitation of the proteins. Finally, it was centrifuged for 
60 minutes at 15,000g and 4ºC, with the resulting supernatant containing 
the total soluble fraction and the sediment the total insoluble fraction. The 
total soluble fraction of the bacteria was acidified to pH 3.5 with 
hydrochloric acid diluted in water, maintaining the sample on ice and stirring. 
The resulting precipitate (mainly acid proteins and DNA) was then removed 
by centrifugation for 20 minutes at 15,000g and 4ºC. Depending on the 
polymer concerned, the saline concentration and pH of the supernatant 
were adjusted. 
The biopolymers were purified by taking advantage of the smart nature of 
ELRs and their inverse transition. Purification of the recombinant 
biopolymers from the soluble fraction of E. coli involves successive 
heating/precipitation and cooling/resuspension stages. Selective 
precipitation was performed by heating the sample to 70 ºC for two hours. 
The precipitate was then separated by centrifuging for 20 minutes at 15,000g 
and 40 ºC, and solubilized in 2 mL/L of ultrapure water at 4 ºC whilst stirring 
for 12 hours. Each purification stage was checked by polyacrylamide 
electrophoresis in the presence of SDS. Once the polymer was considered 
sufficiently pure, it was dialysed against ultrapure water and lyophilized. 
After the final solubilisation, the dissolved polymer was dialysed against 
ultrapure water at 4 ºC, then lyophilised and stored at -20 ºC until use. 
 
3.2.11 SDS Polyacrylamide gel electrophoresis 
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The protein polyacrylamide gel electrophoresis in the presence of sodium 
dodecyl sulfate (SDS-PAGE) – is made following the protocol for 
discontinuous systems described by Laemmli156. The direct proportional 
relation between the protein migration velocity (V) with the product of the 
effective charge (q) and the electrical potential gradient (E) , and an inversely 
proportional relation to the friction coefficient, enables separation by mass 
in molecules of similar charge densities (equation). 
      
Similar charge densities in proteins are obtained by the use of SDS. Due to 
the strong interaction of  SDS with the proteins, the proteins’ effective 
charge is strongly overcompensated by SDS with approximately one 
negative charge per each amino acid residue. This process completely 
denatures the protein by disruption of non-covalent interactions. For the 
removal of intermolecular disulfide bonds, a reducing agent (β-
mercaptoethanol) is added to the sample. For accelerated denaturation and 
reduction of proteins, the samples are kept at 90°C for 5-10 minutes.  
Samples are separated in a “MiniVE vertical electrophoresis system” from 
Hoefer (Amersham Pharmacia Biotech, Pittsburg, USA) electrophoretic 
system. The total percentage of acrylamide (%T) in the resolving gel was 
adjusted according to the molecular weight of the polypeptides of interests. 
The optimal %T for a determined size range is presented in Table 8. 
Table 8: Optimum percentage of Acrylamide/Bisacrylamide according to protein size. 
Target size range (kDa) %T in resolving gel. 
24-205 7.5% 
14-205 7.5% 
14-66 12.5% 
14-45 15% 
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The composition of a resolving and stacking for a gel X%T is detail in Table 
9. 
 
Table 9: Composition of the resolving and stacking gel in a gel 15%T 
 Resolving gel. Stacking gel. 
Acrylamide 40% X % (w/v) 4% (w/v) 
Tris -HCL pH 8.8 375 mM ------- 
Tris –HCL pH 6.8 ------- 125 mM 
SDS 10% 0.1% (w/v) 0.1% (w/v) 
APS 10 % 0.05% (w/v) 0.05% (w/v) 
TEMED 0.05% (w/v) 0.08% (w/v) 
*Both gels are prepared in ultrapure water. 
 
3.2.12 Modification of ELRs 
 
3.2.12.1 Methacrylation of ELRs 
 
ELRs were dissolved in DMF to a concentration of 10 mg/mL under nitrogen 
atmosphere, after complete dissolution of ELR, TEA was added (1 equivalent 
per lysine) and the soultion was stirred for 30 minutes. Then methacrylic 
anhydride (0.5 equivalent per lysine) was added and the mixture was stirred 
for 16h at 25°C. The product was purified by precipitation and washing in 
diethylether and acetone, followed by resolvation and dialysis in MQ water. 
The white product was obtained after lyophilization and characterized using 
NMR and MALDI-TOF. 
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3.2.12.2 Chemical functionalization of ELR VKV [1] with BCN N-
hydroxysuccinimide ester [2] 
 
BCN moieties were introduced by amidation of the free lysines (K) present 
in the ELR backbone 1, using the NHS esters of the active compound 
(1R,8S,9 S)-Bicyclo[6.1.0]non-4-yn-9-ylmethyl N-succinimidyl carbonate 
(BCN-NHS; Synaffix, Netherlands). Thus, the ELR (25 µmol; 1 eq.) was 
dissolved in DMF and, after complete dissolution, a solution of 2mL BCN-
NHS (250 µmol; 12 eq.) in DMF was added dropwise under a nitrogen 
atmosphere and the reaction mixture stirred overnight at room 
temperature. The pure product 2 was obtained as a white fibrous material 
after precipitation in diethyl ether, followed by washing with acetone, dialysis 
(12,000 MwCO – Medicell Membranes Ltd, Liverpool) and freeze-drying. 
The degree of modification was determined by NMR spectroscopy 
(referencing P1 and P2), and MALDI-TOF. 1H NMR (400MHz, D2O, δ  in 
ppm): P1 0.6–1.0 (m, CH3), P2 2.85–2.95 (t, 2H, -CH2-NH-(C=O)-0-). 
Nuclear magnetic resonance (NMR) spectra were recorded using an Agilent 
400 MHz spectrometer operating at a resonance frequency of 399.95 MHz 
for 1H. Spectra were recorded in D2O (20 mg/mL) performing 500 scans. 
The degree of conversion was estimated by 1H NMR, quantifying the isolated 
α-(C(=O)NH-alkyl) signals of the introduced functionalities.  
 
 
3.2.12.3 Covalent binding of fluorescent probe and cholesterol 
moieties 
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The active ELRs were treated with either triethyleneglycol-cholesterol azide 
(CTA; Sigma) and/or Eterneon azide (Jena Bioscience). ELRs containing 0, 1, 
3 or 5 cholesteryl groups were generated (CTA0–5).  
First, the ELR-BCN 1 (20 µmol; 1 equiv.) was dissolved in DMF and the azide 
CTA (0, 1, 3, 5 equiv.) in DMF was added dropwise under nitrogen then 
stirred overnight at room temperature. The pure product 2 was obtained 
as a white fibrous tissue after precipitation in diethyl ether, followed by 
washing in acetone, dialysis (12,000 MwCO – Medicell Membranes Ltd., 
Liverpool) and freeze.drying. The degree of modification was determined by 
NMR (referencing P1 and P3), and MALDI-TOF. 1H NMR (400 MHz, D2O, 
δ  in ppm): P1 0.6–1.0 (m, CH3), P3 5.30–5.45 (s, 1H, C-CH=C). All samples 
obtained were further modified for detection by insertion of a fluorophore 
(CTA0–5*). Thus, a solution of CTA0–5 (10 µmol; 1 equiv.) in DMF was 
treated with Eterneon azide (1 µmol; 0.1 equiv.) under nitrogen in the dark 
for 24 h and purified as product 1. Due to the unknown structure of the 
commercial compound, the insertion of the fluorophore was confirmed by 
fluorescence spectroscopy and by comparison of the 1H NMR spectra of the 
adduct and product. A newly isolated singlet at 10.1-10.3 ppm (P4) was 
observed.  
 
3.2.13 Detection of Trypsin in ELR gels 
 
Preparation of substrate gels and subsequent detection of proteolytic 
activity were conducted as previously described according to the methods 
of Heussen, et al.342 by mixing the modified ELR into a 10% polyacrylamide 
gel. Trypsin (GIBCO) was used at concentrations of 0.3 nM to 3µM in 10 
µL of loading buffer to determine the sensitivity of ELR substrates. A 
comparison of trypsins (GIBCO and Corning) was performed at 0.1 µM. 
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Samples were separated by electrophoresis on a 10% polyacrylamide gel 
containing SDS. The electrophoresis was performed at 25°C at a constant 
current of 40 mA. The gel was washed three times for 20 minutes in 2.5% 
Triton X-100, before incubation in 50 mM Tris buffer (pH 7.5) containing 5 
mM Ca2+, 150 mM NaCl. After 40h incubation at 37° C., the gels were 
stained with 0.25% Coomassie blue in 5% acetic acid and 30% methanol for 
0.5 hours and destained with 10% acetic acid and 40% methanol. Images of 
destained gels were taken with GelDoc EZ Chamber (BioRad) after 1 h of 
destaining. Proteolytic activities were detected by densitometry of clear 
zones using ImageJ (version 1.52i).  
 
3.2.14 Detection of MMP2 and 9 in ELR gels 
 
Gels with a concentration of 1 mg/ml, were prepared in 10% polyacrylamide 
gels. The gels were loaded with 50 or 500 ng of MMP 2, or 9. After 
electrophoretic separation on a 10% polyacrylamide gel containing SDS, at 
25° C with a constant current of 40 mA, the gel was washed three times for 
20 minutes in 2.5% Triton X-100, before incubation in 50 mM Tris buffer 
(pH 7.5) containing 5 mM Ca2+, 150 mM NaCl, 10 uM Zn2+. After 40h 
incubation at 37° C, the gels were stained with 0.25% Coomassie blue in 5% 
acetic acid and 30% methanol for 0.5 hours and destained with 10% acetic 
acid and 40% methanol. Images of destained gels were taken with GelDoc 
EZ Chamber (BioRad) after 1 h. Proteolytic activities were detected by 
densitometry using ImageJ (version 1.52i). 
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3.2.15 Optimization of screening parameters 
 
Acrylamide concentration for low volume gels in a 96-well plate was 
optimized by varying the acrylamide concentration in a 75µL gel containing 
0.1% of ELR-Ela+FN from 4 – 14%. The other parameters were kept 
constant. Gels were stained with CBB-solution for 30 minutes and destained 
with 10% acetic acid and 40% methanol for 2 hours, the destaining solution 
was replaced every 20 minutes. The absorbance of gels was quantified at 
590 nm using the GelDoc EZ Chamber (BioRad). With the optimized 
acrylamide concentration of 8%, gels of volumes ranging from 40 µL – 200 
µL were prepared and the resulting absorbance was examined in the same 
way. Additionally, a screening of different absorbance wavelength (620, 590, 
560, 530 nm) was performed with gels of different volumes. In the last step, 
ELR concentrations varying from 0.1 – 7 mg/mL of gel were measured in 8% 
acrylamide gels with a volume of 75 µL. Besides quantification, gels were 
imaged with GelDoc EZ Chamber (BioRad)  at an absorbance of 595 nm. 
 
3.2.16 Screening of MMPs 
 
Acrylamide gels were prepared in triplicates and preincubated with 50 mM 
Tris buffer (pH 7.5) containing 5 mM Ca2+, 150 mM NaCl, 10 uM Zn2+ for 1 
h. 10 ng of each MMP was dissolved in 100 µL of incubation buffer and added 
to each well. Gels were incubated for 4 different timepoints (0.5, 1.5, 4.5, 
12 and 48 h) at 37°C. After each timepoint gels were washed and, stained 
according to the protocol mentioned above. 
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3.2.17 Critical Micelle Concentration 
 
The critical micelle concentration (CMC) of the different ELR solutions in 
Milli-Q water was determined from surface tension measurements derived 
from a drop shape analysis using the pendant drop technique390. The changes 
in the shape of the resulting drop at the air/water interface upon increasing 
the ELR concentration previously stabilized at 5.0, 15, or 35°C, for 5 min, 
from a blank solution of Milli-Q water to 50 μM ELR, were monitored using 
the SCA 20 software of the Data Physics OCA20 instrument, which outlined 
and scaled the profile hanging from a straight precision dosing needle. Drops 
(4 μL at 0.5 μL/sec) were infused using a 500 μL Gastight® Hamilton syringe. 
The pendant drop image formed at the tip of the needle was captured and 
analyzed digitally. Five drops per condition were measured and multiple 
comparisons between groups were performed using a two-way ANOVA 
(**** p<0.0001; **p<0.001). 
 
3.2.18 Dynamic light scattering 
 
The average size distribution of the modified ELRs was determined by DLS 
using a Zetasizer Nano apparatus (Malvern Instruments, Worcestershire, 
UK), configured with a 173° scattering angle and equipped with a HeNe laser 
(633 nm) with an output power of 10 mW. Solutions (15 µM) of the ELR-
CTA modifications were dissolved in ultrapure water, and filtered (0.45μm 
PVDF syringe filter) prior to analysis. Samples were incubated for 10 minutes 
at 5, 10, 15, 20, 25, 30 or 35°C prior to measurement. Each sample was 
measured in triplicate and multiple comparisons between groups were 
performed using a one-way ANOVA (**** p<0.0001) with respect to the 
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high polydispersity of the samples (0.15-0.5). Plotted values correspond to 
mean volume intensities. 
 
3.2.19 Zeta potential 
  
The particle velocity distribution (electrophoretic-mobility) was determined 
by Laser Doppler Velocimetry and the zeta potential (ZP) was calculated for 
freshly prepared and filtered samples using a Zetasizer Nano Series 
(Malvern, UK). Default settings on the Zetasizer were used, in other words 
the dielectric constant, refractive index and viscosity were assumed to be 
the same as for water, and the Smoluchowski approximation was used. 
Determinations were carried out in a temperature range from 10 to 35°C 
by performing 10 readings. 
 
3.2.20 Circular Dichroism 
 
Circular dichroism (CD) spectra were recorded using a Jasco J-1500 
spectrometer in a stream of nitrogen in the range 190-250 nm. The 
temperature of each sample was varied from 5 to 35°C in steps of 5°C. The 
sample was equilibrated at 15°C for 10 min prior to each different 
temperature measurement and kept for 2 minutes at the target 
temperature. Sampling was carried out at points every 1 nm with a total of 
15 accumulations per measurement. Samples were dissolved in ultrapure 
water at 3.3 µM and measured in a quartz cuvette (d=0.1 cm). Data were 
smoothed using a 15pt Savitky-Golay filter. Deconvolution of the sub-
structure was performed on smoothed curves using the BeStSel web 
server391 to yield eight spectral components: helix (regular and distorted), 
irregular helix, anti-parallel (left-handed, relaxed and right-handed), parallel, 
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turns, and others. The boundaries for parallel and anti-parallel strand 
arrangements were set to 0° and 23°, respectively. 
 
3.2.21 Viscosity measurements 
 
Samples were dissolved to a concentration of 0.75 mM at a temperature of 
15°C and measured with an AR2000 (TA Instruments). Data were recorded 
using TRIOS software ( v4.1.1.33073).  
Samples were normalized between measurements by equilibration at 15°C 
for at least 5 minutes before measurement. Viscosity measurements were 
performed in triplicate at 5, 15, 25, and 35°C. Samples were conditioned 
with a pre-shear of 0.1 rad/s for 60 s, followed by a flow ramp from 1 to 
1000 s-1. Samples at 35°C were only measured up to 300 s-1 to avoid 
disruption of the sample above the LCST. 
 
 
3.2.22 Rheological determination of low-temperature 
gelation 
 
Samples were dissolved to a concentration of 0.75 mM at a temperature of 
15°C and oscillatory shear measurements were performed using constant 
stress and an AR2000 apparatus (TA Instruments). Data were recorded 
using TRIOS software (v4.1.1.33073). A cooling and heating cycle was 
performed, cooling from RT to 2°C, followed by a heating step to 50°C 
above the LCST. The evolution of the storage and loss moduli was recorded. 
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3.2.23 Contact Angle 
 
Contact angle measurements were performed using solvent films cast from 
0.75 mM aqueous solution after drying at 40°C overnight and incubation at 
the specified temperature for 5 minutes on a Peltier plate prior to CA 
measurement. For each condition, 5 drops of ultrapure water were analyzed 
using a Data Physics OCA20 system instrument. The drop profile images for 
the advancing and receding drops during micro-syringe dispensation were 
recorded using an adapted CCD video camera. The three-phase contact line 
of the liquid drop was made to advance or retreat by adding or withdrawing 
the liquid and the advancing (θa) and receding (θr) contact angles were 
measured in the stable phase of advance or recoil on both sides of the drop. 
 
 
3.2.24 Transmission electron microscopy TEM 
 
Samples were prepared by placing a drop of the solution on a carbon-coated 
copper grid and, when needed, stained with uranyl acetate solution (1.0 wt 
%), followed by water evaporation. Samples were incubated for 1, 3, 7 and 
28 days at a concentration of 125 µM at 4 or 37°C. C300Cu Carbon coated 
TEM grids were loaded with the sample by incubation for 90 s, followed by 
staining with uranyl acetate, as required. Images were taken using a Tecnai 
Thermoionic T20 microscope operated at 200kV. 
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3.2.25 Scanning electron microscopy SEM 
 
Samples were incubated for 1, 3, 7 and 28 days at a concentration of 0.25 
or 1.25 mM and 4 or 37°C. At specific time-points, samples were cryo-
fractured in liquid N2 and lyophilized. Dried samples were mounted and 
coated with a 20 nm layer of carbon using the Leica EM ACE200 vacuum 
coater. Imaging of the ELR substrates was performed using an FEI Quanta 
200 FEG instrument in low vacuum mode with a carbon coating. SEM images 
were employed to determine substrate characteristics and thickness as well 
as to check surface homogeneity. SEM captures were analyzed using the 
ImageJ software. 
 
3.2.26 Spectrophotometric cloud point determination 
 
The absorbance of the ELR solutions was recorded using a Cary Series UV-
Vis spectrophotometer (Agilent Technologies, USA). The ELR solutions 
were prepared in PBS (125 µM) and recorded using the CaryWinUV 
Thermal Application (version 4.20(468) over a temperature interval ranging 
from 5 to 40 ºC at a heating rate of 1ºC/min. 
 
3.2.27 Cell Culture 
 
HUVECs were cultured in EGM-2 supplemented with 1% P/S and HASMCs 
were cultured in Medium 231 supplemented with SGMS and 1% P/S. Cells 
were incubated at 37 °C under 5% CO2 and their medium was replaced 
every two days. 
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The relative number of metabolically active cells was evaluated using the 
Alamar Blue® assay according to the manufacturer’s guidelines. The culture 
was incubated in a 10% Alamar Blue solution for 3 h at 37 °C and under a 
5% CO2 atmosphere. Cells were cultured in triplicate with medium 
containing 375 nM, or 750 nM of the non-fluorescent substrates, for 1, 3 
and 7 days respectively. The datasets were normalized to cells of the same 
cell type and at the same time point grown on TCPS. A two-way ANOVA 
multiple Comparison was performed using the Holm-Sidak multiple 
comparison test.  ****: p< 0.0001; ***: p < = 0.001; **: p< =0.01; *: p<0.05. 
 
3.2.28 FACS and Confocal Microscopy 
 
A total of 250,000 cultured cells per condition were incubated for 24 h. 
Followed by incubation in serum-free media containing ELRCTA (375 nM) for 
18h. After incubation, cells were washed several times with cold DPBS to 
remove unbound ELRs, then trypsinized and resuspended in cold DPBS. 
Flow cytometry analysis was performed to assess the amount of ELRCTA-
positive cells. A total of 50,000 events were detected in the cytometer 
(Gallios flow cytometer, Beckman-Coulter). Quantification was performed 
using Kaluza software v1.2 (Beckman-Coulter), and for better quantification 
the fluorescent channel was presented on a logical scale with a linear region 
from -2 to 15. 
Samples used for FACS quantification were visualized using a Leica SP5 
confocal microscope (Leica Microsystems, Heidelberg) with a 63x lens.  For 
better contrast in the merged image, the red channel was displayed in 
magenta. Z-slicing depth on selected cells was set to 0.4 µm. 
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Cells prepared for FACS were cultured in 96-well plates to track ELRCTA in 
living cells. Thus, 3000 cells incubated with ELRCTA were imaged for 18 h at 
0.56 mfps. Bright-field and fluorescence microscopy were performed using 
a NIKON Eclipse Ti fluorescence microscope equipped with a digital camera 
system (Digital sight DS-2MBWc) (Nikon, Japan). 
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4 Results and Discussion 
 
4.1 CHAPTER 1: Development of a novel 
screening method for proteases based on 
proteolytically degradable ELR-acrylamide 
hydrogels 
 
 
 
 
 
 
Some of the concepts applied in this chapter are developed in the patent 
currently under revision: 
Recombinant Biopolymer for Proteases Detection,  
L. Poocza, M. Alonso Rodrigo, J.C. Rodríguez-Cabello, 
PCT/EP2019/068674 (Submitted: 04/18). 
And will be published in the article: 
A fast, sensitive and cost-effective method for protease detection using non-
fluorescent substrate 
L. Poocza, M. Alonso Rodrigo, J.C. Rodriguez‐Cabello 
in preparation.  
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Zymography has become a standard technique for the detection of MMPs 
and other hydrolytic enzymes. Enzyme activities are determined based on 
the degradation degree of a substrate. The method requires conducting 
electrophoresis, and therefore it is troublesome in the procedures, and 
time-consuming in the detection. The majority of studies use gelatin as the 
substrate for the detection of MMP2 and/or MMP9. Nonetheless, other 
bands that appear in the zymogram are mainly of unkown origin, or ignored 
in publications. This is mainly due to the presence of a variety of possible 
targets in native proteins like gelatin, collagen, casein, plasminogen, 
fibrinogen, etc.. This leaves space for optimization of the existing techniques. 
In sensitivity and in the numbers of potential peptidase that can be detected. 
When referring to the EC-list of peptidases there are more than 13 sub-
groups of proteolytic enzyme classes with about 300 entries of different 
peptidases. All involved in the degradation of protein238. In the scope of 
tissue engineering and oncology one subclass moved into the focus, which 
is the class of MMPs, which are known to be secreted by cancer cells or 
normal cells surrounding cancers. Furthermore, these class of enzymes is 
able to degrade extracellular matrix proteins like collagen282. Type IV 
collagenases (MMP2 and MMP9) have been frequently reported to be 
accompanied by tumor invasion, metastasis and proliferation. Research 
carried out upon MMPs, increased, especially due to the relation of MMP 
activities in different types of cancer and diseases364, and on the other hand 
in tissue engineering, to introduce remodeling cues into the matrices. More 
recent methods and patents that involve zymographic detection are focused 
on the detection of certain forms of cancer. 
From current zymographic methods, three prerequisites for more specific 
zymographic techniques can be derived. 1- proteolyticly cleavable, including 
solubility in water, 2- stainability with Coomassiee BB or flourescence, 3- no 
unspecific cleavage sites, meaning stability of the protein backbone against 
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proteolysis. These prerequisites are already met by specific fluorescently 
labeled peptide linkers in IVZ, but have not been translated to a protein 
substrate for IGZ purpose. 
In this study we describe a way to more specific IGZ using elastin-like 
recombinamers (ELRs) as a substrate. Elastin is an extracellular matrix 
protein, that is widely distributed in vertebrate tissues, making it per se an 
ideal candidate for studying MMPs, but the native protein is insoluble in 
water. Therefore, ELRs consisting of repetitive sequences derived from 
elastin protein precursor tropoelastin were used to bypass solubility 
issues7,13–17.  
The repeated pentapetide VPGXG (with X=V,A, I and G) of ELRs, has 
proven  biostability and slow degradation rates108,392. Furthermore, genetic 
engineering based strategies facilitate the alteration of peptide chain length, 
consensus repeat sequence, as well as the introduction of additional 
functional groups or oligopeptide units, like specific enzymatically cleavable 
groups. For the detection and bining of Coomassie, positvely charged amino 
acids are needed, which were implemented in the X position of selected 
pentapeptides in the final protein. For sufficient detection we implemented 
lysins into the protein structure, which were also used as nods for 
crosslinking to the zymography gel matrix106,109,110. Moreover, the sequences 
of the obtained proteins are uniform and completely controlled.  
The appropriate choice of peptide sequence has led to the development of 
recombinant proteins that have been processed into materials for tissue 
engineering36,104,112,113, drug-delivery systems35–38, polymer dispersants39, 
physical gelling agents40,111, or biosensors41–43. However, we believe that the 
generation of meaningful elatstin-mimetic constructs for the screening of 
peptidases has not been stated. 
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We describe herein a novel arrangement of elastin mimetic peptide building 
blocks into one protein, for the more specific detection of proteases than 
in conventional zymography substrates. The present invention comprises a 
design that is applied in a novel screening method for peptidases, without 
electrophoretic separation and denaturation of the sample. 
 
4.1.1 ELR IK-HEX gene Synthesis 
 
In an effort to obtain different molecular structures, diverse recombinant 
ELRs have been designed and produced. In this sense a set of genes with 
different proteolytic groups has been selected and designed in this work 
(Table 10). 
 
Table 10: Amino acid sequence of the different building blocks employed in this work. 
Abbreviation Sequence Mw 
(Da) 
IK24 (ELR-
Control) 
MESLLP (((VPGIG)2 VPGKG (VPGIG)2)24 V 51969 
IKHEX10 
(ELR-Ela1) 
MESLLP (((VPGIG)2 VPGKG (VPGIG)2)2 
(VGVAPG)3)10 V 
57856 
PIT110(ELR-
Ela1+FN) 
MESLLP ((VPGIG)2 VPGKG (VPGIG)2 
EEIQIGHIPREDVDYHLYP (VPGIG)2 VPGKG 
(VPGIG)2 (VGVAPG)3)10V 
80911 
PIT210 (ELR-
FN) 
MESLLP ((VPGIG)2 VPGKG (VPGIG)2 
EEIQIGHIPREDVDYHLYP (VPGIG)2 VPGKG 
(VPGIG)2)10V 
66494 
 
The biopolymers were designed according to the techniques described in 
paragraph 1.2. The pDrive cloning vector containing the genes for IK, PIT1 
and PIT2 were avaible from previous studies. The plasmid cloning vector 
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(pUC57) containing the sequences encoding the IKHEX domain was 
provided by GenScript.  
 Starting from the amino acid sequence of interest, the DNA sequence is 
translated by using the expression codons of the corresponding amino acids. 
The sequence is than reduced to a fragment ~200 bp, further restriction 
sites for the restriction enzymes EcoRI and EarI are include to the front and 
the end of the sequence, enabling the extraction of the sequence of interest 
from the vector. For IKHEX this resulted in a final sequence of 241 bp 
(sequence of interest plus restriction sites), with a total length of 204 bp, 
which was provided by GenScript embedded in the plasmid cloning vector 
pUC57. 
 
 
Figure 15: DNA sequence of the 204 base pairs (white region) and the corresponding amino acid 
sequence. 
 
 For the multiplication of the sequence, the sequence was introduced into a 
cloning vector (pDrive), which can be opened by SapI and EarI digestion. 
EarI digestion openes the vector before and after the sequence of interest, 
to remove it from the vector and SapI digestion opens the vector behind 
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the sequence of interest. The introduction of the sequence into the vector 
is obtained by ligation of the open pDrive together with the Ear1 digested 
sequence of interest using T4 ligase. For the introduction of consecutive 
sequence blocks, ligation of a SapI digested pDrive containing the 204 bp 
sequence of interest is performed together with the EarI digested sequence 
of interest. Increasing the concentration of the insert against the 
concentration of the vector leads to the introduction of multiple fragments 
into the vector. This resulted in sequences of the length (204)x+1 base pairs, 
where x is the number of inserted sequences. This process of ligation was 
repeated until the final sequence of (204)10 base pairs was obtained. This 
sequence was then removed from the cloning vector by EarI digestion and 
transferred into an expression vector. Due to the design of the expression 
vector for a better expression of the protein of interest, the sequence 
MESSLP is added before the sequence of interest, and due to the use of EarI 
digestion a V (grey shadows in Figure 15) is added to the end of the sequence 
of interest resulting in a final sequence of 2061 base pairs. 
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Figure 16:  Agarose gels of the insert IkHex of 204 basepairs. Left gel corresponds to the unimer, 
as received from the supplier after Ear1 digestion. Right gel corresponds to the decamer (204)10, 
obtained after several steps of ligation of the fragment. 
 
The sequences at each step were validated using automated dideoxy DNA 
sequencing with fluorescent ddNTP and agarose gel electrophoresis. 
Once the desired constructions were obtained and their sequences 
controlled their released inserts after enzymatic digestion with EarI and 
DpnI, which is used in order to avoid the appearance of fragments with 
similar size to the segment of interest, were subcloned in the modified pET 
25b+ vector pET 7 expression vector. These resulting vectors were used to 
transform E. coli expression strains as described in paragraph 1.2.3. 
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ELRs expression and purification 
 
The final gene constructions were transformed on the bacterial strain BLR 
(DE3) following the above mention protocol. The expression of the 
recombinamers was made as previously described The ELRs purification 
protocol was made based on the ITT (refer to paragraph 1.2.4) consisting 
on three sequentially rounds of inverse transition cycling, which rendered 
highly pure and monodisperse polymers, as corroborated by SDS-PAGE. 
 
 
Figure 17: SDS-PAGE of ELRs to determine molecular weights. M= marker, 1 = ELR-Control, 2= 
ELR-Ela, 3=ELR-FN, 4=ELR-Ela+FN 
 
The electrophoretic pattern showed an excellent level of purity for all the 
ELRs with little degradational products in ELR-ELA1 and ELR-FN, which are 
due to the proteolytically sensitive nature of these ELRs. No contaminant 
proteins form E.coli were found.  
In order to confirm the recombinamer’s molecular weight and amino acid 
composition, the samples underwent MALDI-TOF and amino acid analysis. 
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Table 11: Theoretical and experimental molecularweight of ELRs and the corresponding amino acid 
sequence, obtained by amino acid quantification. 
 ELR-Ela+FN ELR-FN ELR-Ela ELR-control 
Mw theo 80911.76 66494.83 57856.45 51969.82 
Mw 
MALDI 
80503 66177 57401 51623 
Amino 
acids 
The
o. 
Exp. The
o. 
Exp. The
o. 
Exp. The
o. 
Exp. 
Ala (A)   30 31,31 0 0 30 33,15 0 0,00 
Arg (R)   10 10,38 10 11,04 0 0,00 0 0,00 
Asn (N)   0 0,00 0 0,0 0 0,00 0 0,00 
Asp (D) 20 21,23 20 21,21 0 0,00 0 0,00 
Cys (C) 0 0,00 0 0,00 0 0,00 0 0,00 
Gln (Q)   10 
44,03 
10 
43,79 
0 0,00 0 0,00 
Glu (E) 31 31 1 1,83 1 1,04 
Gly (G) 270 270,43 210 213,54 260 262,68 240 250,86 
His (H)   20 16,86 20 16,18 0 0,00 0 0,00 
Ile (I) 110 107,51 110 106,87 80 80,25 96 94,52 
Leu (L)   12 11,85 12 11,98 2 2,91 2 2,12 
Lys (K)   20 17,60 20 16,99 20 15,75 24 19,46 
Met (M)    1 0,75 1 0,98 1 0,06 1 0,88 
Phe (F) 0 0,00 0 0,00 0 0,00 0 0,00 
Pro (P) 151 151,78 121 131,11 131 131,51 121 121,78 
Ser (S)    1 0,70 1 0,84 1 0,98 1 0,76 
Thr (T) 0 0,00 0 0,00 0 0,00 0 0,00 
Trp (W)    0 0,00 0 0,00 0 0,00 0 0,00 
Tyr (Y)   20 21,00 20 20,80 0 0,00 0 0,00 
Val (V) 171 172,19 111 113,30 161 160,57 121 120,82 
         
 
Succesful expression of ELRs was performed by pre-expressional 
sequencation of the plasmid and NMR of the expressed proteins, moreover, 
the molecular weight of the expressed protein was correlated to theoretical 
mass by mass spectoscropy and SDS-PAGE (Figure 17).  
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4.1.2 Methacrylation of ELRs 
 
ELRs have been succesfully modified with methacrylamide groups by 
modification of 40-55% of lysines present in the protein, as characterized by 
MALDI-TOF and NMR, results are shown in Table 12. 
Table 12: Results of characterization of ELR modification with methacrylate groups (MA) by NMR 
and MALDI-TOF. Spectra are shown below. 
 %age of lysines 
modified (NMR) 
%age of lysines modified 
(MALDI-TOF) 
ELR-Control 54,5 42,5 
ELR-Ela 46,0 54,1 
ELR-FN 46,0 36,6 
ELR-Ela+FN 45,5 42,5 
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Figure 18: Mass spectra obtained by MALDI-TOF. The left column presents the pure ELRs and the 
right column shows mass after modification with methacrylic anhydride. 
119 
CHAPTER 1: Development of a novel screening method for proteases 
based on proteolytically degradable ELR-acrylamide hydrogels 
 
 
 
Figure 19: NMR spectra of modified and unmodified ELRs used in this study. Methacrylate signals 
are isolated singuletts at 5.25 and 5.60 ppm. 
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4.1.3 WORKING PRINCIPLE OF THE METHOD 
 
The present method uses the advantage of the spatial design of the ELR for 
the detection of proteases in a zymography-like manner. As a prerequisite, 
the ELR should consist of at least three domains, a degradable group 
(peptidase target), a mechanism of detection, and a stable cross-link to the 
acrylamide matrix. For better integrity with the matrix an additional block, 
which is not a target to most of the peptidases was implemented, as a spacer, 
to augment the molecular weight and to minimize sterical hindrance 
between cross-links and degradable groups. The process of detection is 
displayed in Figure 20A, in the first step, cross-linking motifs, in this study 
methacrylate groups, are added to a sufficient number of free lysins in the 
stainable region, and cross-linked to the substrate (acrylamide gel). The 
modification of lysines impairs stainability with coomassie BB as indicated by 
the grey boxes (Figure 20A), this is crucial since crosslinks will remain in the 
matrix gel and should not give a false positive signal, on the other hand a 
sufficient number of lysines has to remain unmodified for detection. In the 
next step the gel is incubated with an enzyme selective to the proteolytic 
group and stained after washing-off the degraded parts. This approach allows 
for calibration and quantification of protease activity. 
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Figure 20: Design of recombinant protein for protease detection and mechanism of zymographic 
detection. The first step is the genetic design of the ELR consisting of non-staining, stainable and 
functional, and degradable region. The next step is the introduction of cross-linking features on 
free- lysins, which allow for cross-linking to the substrate and disable Coomassie BB detection of 
modified lysins. The ELR-substrate complex is than incubated with proteolytic enzymes and cleaved 
parts are washed off and the remaining gel is stained with Coomassie BB, and the efficiency of 
cleavage towards the presented group is monitored. 
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For the screening of MMPs in this study, four ELRs (Figure 20B) have been 
designed only varying in the proteolytic domain, with a non-staining region 
of the sequence VPGIG which is not a known-target to proteases392, the 
staining region bears penta peptides of the structure VPGKG with lysines of 
positive charge for stainability with Coomassie BB, or to be modified with 
methacrylic anhydride, and a degradable domain bearing sequence as 
substrate to proteases. For this study we selected two degradable groups, 
one is known to be sensitive to elastolytic proteases (ELR-Ela) and the other 
is a fibronectin derived sequence (ELR-FN) which is sensitive towards a 
broader range of proteases capable to degrade ECM, additionally a negative 
control (ELR-control) and a positive control (ELR-Ela+FN) are part of the 
study. The specificity of the substrate ELRs, with just one cleavable group, 
allows for the preparation of an in-well zymography (IWZ) without the need 
for electrophoretic separation and denaturation of the proteases. 
 
4.1.4 ELR in gel zymography 
 
The sensitivity of ELR degradation in IGZ was controlled using a 
concentration screening. Due to the amounts of protease needed for IGZ 
and corresponding costs of recombinant derived MMPs, the initial screening 
for feasibility was performed with an unspecific serine protease trypsin 
(Figure 21). The incubated gels revealed a clear band at 24kDa 
corresponding to the degradation with trypsin. The lower sensitivity limit of 
this method for trypsin was between 0.3 -3 nM.  
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Figure 21: ELR-Zymogramms: On the left developed gels after development and on the right, 
densitometry data obtained from the degradation of ELR-Ela+FN with different concentrations of 
trypsin (GIBCO) ranging from 0.3 nM to 3µM. 
 
In an additional step all four ELR-gels were compared with two different 
types of trypsins at a concentration of 0.1µM. The intensity in Corning® 
trypsin was approximately doubled compared to GIBCO® trypsin. In both 
trypsins ELR-Ela was slightly more degraded than ELR-FN, whereas ELR-
Ela+FN had the highest intensity. Gelatin zymogramm with trypsin showed 
strong degradation with a broad diffusion isolated bands could not be 
detected. The elastase sensitive group was more sensitive to the 
degradation with trypsin than the FN derived sequence. The results show 
that differences in peptidase concentrations can be measured with ELRs as 
the substrate and serine proteases which are more unselective upon 
degradation and thus cannot be detected with classic gelatin zymography, 
can be visualized.  
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Figure 22: Comparison of ELR zymograms with two different types of trypsin and their 
densitometry profiles (right) (TryI correspond to Corning® and TryII to GIBCO® Trypsin). 
 
For the feasibility studies with MMPs, ELR-Ela+FN was compared to ELR-
Control with MMP2 and 9, the standard substrates of gelatin zymography. 
The results revealed detectable degradations of both MMPs for ELR-IGZ. 
The sensitivity towards MMP9 was almost tenfold with ELR-Ela+FN as the 
substrate. The negative control without any proteolytic region was not 
degraded by the selected enzymes under the selected conditions. The 
complex set-up of zymography including gel preparation, loading, 
electrophoretic separation, renaturation, degradation, staining and 
destaining leads to a strong variation between different gels which does not 
allow for statistical correlation of separate gels. 
 
125 
CHAPTER 1: Development of a novel screening method for proteases 
based on proteolytically degradable ELR-acrylamide hydrogels 
 
 
 
Figure 23: ELR zymogramms of the degradation of ELR-Control and ELR-Ela+FN with different 
concentrations of MMP 2 and 9. 
 
To avoid the drawbacks of electrophoretic separation and the 
denaturalization of the sample by detergents like SDS, we developed the 
ELRs in a way, that the specificity is not determined by the molecular weight 
of the sample, but by the degradable group of the substrate. This is in analogy 
with familiar methods that use fluorescent peptide-linkers for detection. The 
absence of fluorophores in this method might be less sensitive, but is more 
economical. Additionally, the cleaved group is presented in a more native 
protein surrounding, which is especially of interest when investigating exo-
peptidases. For the screening of MMPs in a 96-well plate set-up, acrylamide 
concentration, ELR concentration, gel volume and destaining protocol have 
been optimized in the following. 
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4.1.5 ELR in-well zymography (IWZ)  
 
 
Figure 24: Schematic description of the hypothesis for the novel in-well zymography (IWZ) method. 
 
Several concentrations of acrylamide gel with 0.1% ELR-Ela+FN and 75 µL 
gel volume per well have been prepared, stained and destained (no 
degradation) and measured for absorbance. The results are displayed in 
Figure 25. Below 8% of acrylamide the gels became instable and could no 
longer be measured. Gels above 8% were stable and had a comparable 
maximum absorbance of 1.0. For better diffusability the lowest stable 
concentration of 8% was chosen for the following experiments. After setting 
the acrylamide concentration to 8%, the gel volume per well was varied from 
200-40 µL. The correlation of absorbance and volume is linear which is in 
correlation with the amount of ELR present. The 200 µL sample is slightly 
above the linear correlation due to limited diffusion in the step of destaining, 
and samples below 75µL were instable. This trend becomes more evident 
when looking at the absorbance at a different wavelength of all samples, 
which is divided into three populations, 40-50µL, 75-150µL and 200µL, with 
a maximum in all volumes at 590 nm. For further experiments gel volume of 
75µL was chosen with an absorbance around 1.0 which reduces slightly the 
sensitivity, due to the smaller window between 1.0-0.0, but augments the 
reproducibility due to reduced destaining times at low volumes. In the final 
step, the 8% and 75 µL acrylamide gels were subjected to varying amounts 
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of ELR to define the concentration intensity correlation. The linearity at 590 
nm had an R² of 0.9925, which allow for the quantification of protease 
activity (supporting information). For further experiments concentration of 
0.1% was selected, which had an absorbance at 590 nm around 1.0 and which 
are most commonly used in other zymographic methods342,349–352. 
 
Figure 25: Optimization of parameters for the screening method. A: Optimization of Acrylamide 
concentration. B: Optimization of gel volume of 0.1% ELR-Ela+FN 8% acrylamide gels. C: 
Optimization of thewavelength of absorbance with different gel volumes. D: Absorbance image 
collected from wells of different ELR-Ela+FN concentrations,  increasing from left to right, first 
well contains no ELR. E: plot of ELR concentration over absorbance at 4 different absorbance 
wavelength. 
 
The optimized settings of 0.1% ELR concentration, 8% acrylamide and 75 µL 
were used to apply a screening of MMPs 1-20 with the four different ELRs, 
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the results are shown in Figure 5. Missing MMPs 4, 5 and 6 have not been 
investigated or described in the literature, and are not commercially 
available. Additionally, MMP-18 and MMP-19 seem to be identical393 which 
reduces the number of MMPs to 16.  
 
Table 13: Linearity of ELR-Calibration curve at different wavelengths of absorbance. 
R² Absorbance (nm) 
0.9669 530 
0.9871 560 
0.9925 590 
0.9835 620 
 
The screening was set up to be measured in a 96-well plate in triplicates. 
The degradacion of sample was tracked over time and per time point a 
separate 96 well plate was measured. The arrangement of MMPs in the well 
is displayed in Figure 26, showing a clear difference in 590 nm absorption 
between 0 and 40 h. 
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Figure 26: Comparison of ELR-Control and ELR-Ela+FN 40h of incubation after staining and 
destaining. 
 
The results of the MMP screening after normalization to the non-degraded 
control are displayed in Figure 27 and Figure 28. 
The sensitivity of the method, even though the complexity compared to IGZ 
was reduced by removing electrophoretic separation and denaturation of 
the sample, was limited to difference greater than 10% of the normalized 
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un-degraded control (compare for example to the degradation of ELR-Ela 
by MMP7).  
 
 
Figure 27:: Screening of MMPs 1-11 with four different ELRs collected over time.  
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In general, the control sample is not degraded by any of these MMPs meaning 
that the detected degradation corresponds to the inserted proteolytic 
fragments. On the other hand, in the case of degradation, degradation is 
most prominent in the sample containing both degradable groups (“positive 
control”). The difference in degradation could be detected and the amount 
of MMP needed for quantification was reduced from 50-500 ng in IGZ to 10 
ng per sample. 
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Figure 28: Screening of MMPs 12-20 with four different ELRs collected over time. 
 
The results can be divided into four different groups, no degradation (MMPs 
2, 3, 10, 14, 16, 19 and 20), FN mediated (MMP1, 13, 16), ELA mediated 
(MMP7), and unspecific for ELA and FN mediated degradation (MMP 8,9, 12, 
17). Overall the obtained cleavage pattern for MMPs corresponds to the 
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degradation targets of MMPs described in the literature. ELR-Ela was more 
specific and only cleaved by MMPs 7, 8,9, 12, and 17. MMP7, or matrylysin 
which is known to cleave FN, collagen and elastin, was the only example 
where the degradation is predominantly driven by the elastolytic sequence 
of the ELR. MMP7 and MMP12 have been described to be upregulated in 
actinic damage394, which explains their capacity to degrade  ELR-Ela. 
Moreover, MMP12 also known as neutrophil elastase is able to degrade 
fibronectin as well as elastin at about 40 known cleavage sites, with a 
prevalence of domains rich in Ala/Gly, which is in line with the selected 
sequence395,396. MMP-8 and 9 are not specifically known to degrade elastin, 
or the sequence of ELR-Ela, but for both, a broad range of targets has been 
described in literature397–402. Fewer studies exist about the prevalence of 
MMP17, but it was found a structural effect on elastin lamellae in MMP17 
deficient mice403,404. In terms of FN degrading MMPs there are numerous 
MMPs studies due to the importance and performance of FN in tissue 
engineering and remodeling. MMP1, 8, and 13 are also called collagenases, 
and have been described to degrade collagens and fibronectin405, the fact 
that MMP2 is not degrading the fibronectin sequence, might be explained by 
the fact, that MMP2 is a more specific collagenase, that only cleaves collagen 
type 4393. MMP3 has been described to cleave FN, where the selected 
fragment of ELR-FN is not a target of selected MMP3. MMP-9 also known 
as gelatinolase is one of the most studied MMPs due to its performance in 
the cleavage of ECM396,406. MMP10 is involved in macrophage locomotion 
through fibronectin matrices407, MMP-11 is crucial in regulating fibronectin 
levels in zebrafish408, andMMP16 is an inefficient type 1 collagenase but has 
been shown to cleave fibronectin393,409.
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Some of the concepts applied in this chapter are developed in the article:  
Introduction of thermoreversible UCST gelation by hydrophobically hijacking 
LCST-related secondary structural motifs in a model elastin-like recombinamer  
Leander Poocza; Sergio Acosta; Matilde Alonso Rodrigo; José Carlos Rodríguez 
Cabello. 
  
In preparation 
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Interest in self-assembled biomaterials has increased considerably in the last 
few decades as a result of their complex spatial arrangement and the 
subsequent emergence of different functionalities. The direct implications of 
structure on self-assembly in amphiphilic block-polymers and proteins, and 
the possibility of generating hydrophobic26,27 and hydrophilic28,29 interactions, 
has enabled some degree of control over hierarchical structures, such as 
spherical or cylindrical micelles, vesicles, bimolecular membranes, and 
hydrogels30–33. Additionally, properties such as stimuli-responsiveness 
towards changes in temperature27,34 or pH35 have resulted in the applicability 
of these materials in tissue engineering36, drug-delivery systems35–38, polymer 
dispersants39, physical gelling agents40, or biosensors41–43. Thermo-
responsiveness is the most investigated and best controlled feature for 
block-copolymers27,34 and, as such, has gained increased interest in cutting-
edge recombinant protein design, especially in light of the findings by Urry 
regarding the LCST of elastin-mimetic peptides44–47. Furthermore, elastin-
like recombinamers/polypeptides (ELR/ELPs), which are block-copolymer 
analogs with domains of differing hydrophilicity, have been explored as 
models for understanding the folding, self-assembly, and function of natural 
proteins46,47. The variety of protein-based features that can be added to ELRs 
makes them an ideal model for relating properties to structure. The majority 
of the ELRs described in the literature are based on the pentapeptide repeat 
sequence VPGXG, with blocks of different hydrophilicity being generated by 
incorporating either polar or apolar amino acids in the X position48–50. The 
presence of equidistant prolines in the sequence predetermines the 
structure of the ELR and leads to a reversible phase transition characterized 
by a critical transition temperature (Tt) that depends on the polarity of the 
amino acid residue48–50. Below the Tt, the free polymer chains display a fully 
hydrated disordered structure that is not defined and is dominated by 
random coils, thus being best described as an intrinsically disordered protein 
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(IDP)410. The contribution of proline and glycine to the solvation of ELRs 
governs their highly disordered nature. Thus, glycine adds an extremely high 
degree of chain mobility, which allows for conformational changes that are 
predetermined by the heterocyclic proline411. In contrast, protein chain 
folding induced by hydrophobic interactions occurs above the Tt, thus 
leading to conformational changes dominated by type II β-turns44,50. Although 
upper critical solution temperature (UCST)-type phase-separation behavior 
in water51–54 is expected to contribute to the creation of intrinsically 
ordered polymeric materials55–59, fewer examples of polymers that exhibit 
UCST-type phase separation have been reported412–414. Thus, although 
proteins such as abductin and resilin, which exhibit a UCST and LCST60,61, 
are known, to the best of our knowledge a UCST upon chemical 
modification of recombinant proteins, especially ELRs, has not been 
reported to date. UCST-type polymers self-assemble upon cooling via 
electrostatic interactions and the formation of hydrogen bonds between 
zwitterionic groups such as sulfobetaine415, glycinamide416, ureido 
moieties417, or polymeric ionic liquids418,419. 
Herein we augment the hydrophobic interaction of proteins by adding 
cholesteryl side-chains, which are known to foster intermolecular 
interactions in polymers229,231 to increase the order in the IDP and 
investigate how protein secondary structure is affected. For a better 
understanding of the determinants of hydrophobically induced gelation, the 
resulting cholesteryl-modified ELRs (CTAs) were further characterized in 
terms of their critical micelle concentration, contact angle, dynamic light 
scattering, circular dichroism, SEM and TEM imaging. It was found that the 
resulting CTAs (CTAx (x= number of cholesteryl groups)) establish a novel 
and peculiar group of materials comprising of two sharp Tts with cool 
gelation at temperatures below UCST. Thus, a new feature, which might 
have future implications in biomedical applications such as smart surfaces, 
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selective bioseparation, and strategic protein design, could be added to 
protein-based materials. 
 
4.2.1 Chemical Modification of ELRs 
 
Table 14: Overview of NMR-signals and the related conversion of functional groups. 
 P1 
(normalized) 
0.6-1.0 
P2 (2H) 
2.85-2.95 
#BCN 
 
VKV 1335 - - 
VKV-BCN 
(CTA0) 
1335 21.01 10.5 
 P1 
0.6–1.0 ppm 
P3 (1H) 
5.30-5.45 ppm 
#CTA 
CTA1 1335 1.19 1.19 
CTA5 1335 4.03 4.03 
 
We have demonstrated the successful modification of ELRs with the 
structure (MESLLP VG VPGVG [VPGKG(VPGVG)5]23 VPGKG VPGVG 
VPGVG VPGVG VPGV) (1; subsequently referred to as VKV) with 
cholesteryl groups in a two-step synthesis via BCN-mediated coupling of a 
cholesteryl-triethyleneglycol azide (CTA). In the first step, the BCN linker 
is introduced by way of a succinimide-induced amide coupling at 10/24 of 
the free lysines in the ELR, thereby resulting in 2 (subsequently referred to 
as CTA0). Due to solubility issues, the maximum number of cholesteryl 
groups that could be grafted was limited to 5 groups per ELR molecule. To 
characterize the influence of cholesteryl groups on the protein dynamics in 
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solution, two modifications containing 1 (CTA1) or 5 (CTA5) cholesteryl 
groups, respectively, were synthesized. 
 
 
Figure 29: 1H- NMR Spectra of CTA0. 
 
Figure 30: 1H- NMR Spectra of CTA1. 
 
For quantification of the degree of modification the products were 
characterized by 1H-NMR and MALDI-TOF. For NMR analysis,  signals were 
normalized to corresponding terminal alkyl protons in the region of 0.6-1.0, 
which for this protein included 1335 protons, the final results can be seen 
in Table 14 and the spectras are displayed in Figure 29 - Figure 31.  
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Figure 31: 1H- NMR Spectra of CTA5. 
 
 
Figure 32: Results of MALDI-TOF for VKV,CTA0, CTA1 and CTA5. 
 
For MALDI-TOF quantification, the mass differences of the principal signals 
(M1+) were determined and divided by the molecular weight of the added 
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component. For CTA0 the reference signal was VKV, and for the 
determination of cholesteryl modifications, CTA0 served as the reference 
(Figure 32). 
Due to the LCST, ELRs dissolve better in ice cold water. Interestingly, at 
low temperature, modified CTA1 and-5 tend to form gels at a concentration 
as high as 5% which motivated the detailed characterization of ELR behavior 
in solution at both, low and high temperatures. 
 
Figure 33: Reaction of  (VKV) with BCN succinimide results in  (CTA0), and after copper-free 
addition of cholesteryl-TEG-azide CTA1 or CTA5 are obtained respectively. 
 
 
 
4.2.2 Characterization in solution 
 
N
N
N
CTA
O
O
N
N
N
CTA
N
N
N
H2
C
C
H2
O
C
H2
H2
C
N
H
C
O
O
H
H H
3
H
H
O
C
O
O
N
O
O
O
O
CTA
H
H H
H
NHCHC
CH2
O
O
CH2
CH2
CH2
NH2
ELR
R
NHCHC
CH2
O
O
CH2
CH2
CH2
HN
ELR
R
NHCHC
CH2
O
O
CH2
CH2
CH2
HN
ELR
R
Protein Sequence ELR:
[(VPGVG)2VPGKG (VPGVG)2]24
ELELEL
143 
4.2 CHAPTER 2: Chemical Modification of ELRs with Cholesterol and 
Structural Mechanistics of Cholesteryl Group Mediated UCST Gelation 
 
 
The effects of modification on structural dynamics were characterized in 
solution by DLS, pendant drop and CD to gather information concerning 
the critical micelle concentration (CMC), micelle size, surface charge and 
secondary structure and relate them to changes in temperature. The CMC 
was determined using surface tension measurements at different 
temperatures390 below the gelation temperature, above the LCST and in-
between (dissolved state). The critical micelle concentration of CTA0 and 
CTA1 was found to be around 2-4 µM for all temperatures, decreasing 
slightly at higher temperatures, which is in accordance with the 
temperature-dependence of the surface tension of water. CTA1 exhibits 
slightly higher CMCs at all temperatures, which are more pronounced at 
5°C. CTA5 exhibits a fourfold higher CMC at 5°C (around 12 µM) and 35°C 
(around 6 µM), and the lowest CMC at 15°C (4.5 µM) is still higher than 
that for the control (Figure 34). Self-association of amphiphilic polymers is 
mainly driven by a decrease in free energy of the system due to the removal 
of hydrophobic fragments from the polar solution and their incorporation 
into the core of micelles420. Low CMCs represent more stable micelles 
formed even at very low concentrations, whereas the increase in CMCs at 
5°C is in correlation with the number of hydrophobic moieties, thus 
indicating destabilization of the micelle towards dissociation into unimers411, 
or coagulation of micelles421, in other words exposure of cholesteryl groups 
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to the solution, thus allowing intermolecular interactions to destabilize or 
hamper micelle formation.  
 
 
Figure 34: Determination of CMC by surface tension measurements revealing a different behavior 
for CTA5 which is most prominent at low temperatrues. A) at 5°C, B) at 15°C, C) at 35°C and D) 
the resulting CMCs. Error bars represent SD. 
 
DLS and zeta potential (ZP) measurements were performed to understand 
the influence of cholesteryl modification on the nanostructure of ELRs on 
the basis of their hydrodynamic diameters (dH) and surface potential. 
Although DLS measurements were performed at 15 µM, which is above the 
CMC for all conditions, it is noteworthy that the nanostructures found are 
unstable in solution for long-term incubation due to the formation of large 
aggregates, especially beyond their transition temperatures. In the pure 
VKV, and to a lesser extent in CTA0, very small particles, ranging from uni- 
to decamers (Figure 35) are observed below the LCST as a result of the 
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hydrophilic nature of the ELR at this temperature, with a mean dH of 20 or 
60 nm respectively (Figure 36). 
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Figure 35: Intensity distributions of ELRs at different temperatures. 
 
Above the LCST, hydrophobic blocks start to interact with each other via 
intra- and intermolecular interactions, thus meaning that particles fuse 
together and larger micellar aggregates are formed in the early stages of 
agglomeration (180, or 150 nm respectively), which is accompanied by huge 
deviations in the transition region (20-30 °C). Likewise, the addition of one 
cholesteryl group (CTA1) increases the size of the aggregates below the 
LCST, although the difference with respect to CTA0 is not significant, thus 
resulting in a smaller dH above 30°C (120 nm). In contrast, the introduction 
of five cholesteryl groups (CTA5) completely changes the behavior of the 
recombinamer. Thus, below the LCST, CTA5 self-assembles into 
nanoparticles with a size of 110 nm, which are less thermosensitive, and with 
a slight decrease in dH with temperature in the range of 100 ± 10 nm (Figure 
36A). This effect is triggered by the cholesteryl groups, which form 
hydrophobic intra- and intermolecular interactions that are strong enough 
to prevent the formation of larger agglomerates in the initial stages. The 
introduction of hydrophobic groups (BCN < Cholesteryl) into the 
unmodified ELR leads to a leveling out of the relatively sharp increase in 
particle size observed with temperature, which mainly occurs as a result of 
the solvophobic compartments in the polypeptide backbone acting as 
anchors for intermolecular attraction. Nanoparticles of similar stability have 
also been observed in cholesteryl modified pullulan and have been described 
as poly-core stabilized particles229. However, none of the micelles are stable 
beyond the transition temperatures for long-term incubation as larger 
aggregates are formed as a result of interactions between the 
nanostructures. This may be a consequence of the lack of a strong 
electrostatic repulsion between the nanoparticles. The Zeta potential (ZP)  
values were in the unstable ZP range (+30/-30 mV) in all cases422. The ZP in 
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the temperature regime studied remains essentially constant for all 
modifications, with a small increase in charge at higher temperatures. VKV 
and CTA0 have similar values of around +14 mV, meaning that the 
introduction of 12 BCN groups has no significant effect on surface 
potential.The introduction of a single cholesteryl group decreases the ZP to 
+5 and the addition of five cholesteryl groups results in a negative ZP of -20 
mV (Figure 36B). Although the influence of cholesterol side groups on the 
ZP is not yet well understood, it has been shown that cholesterol is able to 
drastically decrease the net charge of liposomes423, lipid bilayers424 
phospholipid membranes424, low density lipoproteins (LDLP)425 and PLGA 
particles424. It is believed that the repulsive surface potential and repulsive 
electrostatic force (or energy barrier) in membranes increase with the 
incorporation of cholesterol, which results in a decrease in the binding 
interaction between vesicular surfaces and polar solvent426. 
 
Figure 36: Dynamic light scattering measurements for CTAx at a concentration of 15 µM and 
different temperatures. The addition of cholesteryl groups leads to less thermosensitive particles 
which are more negatively charged. A) hydrodynamic radii, B) Zeta potential. Error bars represent 
SD. 
Another explanation derived from the Flory-Huggins theory assumes that 
excluded volume effects are responsible for the increase in surface charge 
upon addition of neutral molecules422, similar effects have been observed in 
PLGA most probably originating from the formation of a Helmholtz layer 
around the surface of particles bearing oriented carbony,l or amide dipoles, 
and the resulting electrostatic repulsion of the stabilizing double layer of 
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counterions (OH-, Cl-, etc427,428. The ZP value obtained for CTA5 implies a 
similar behavior for cholesteryl groups in polypeptide-based micelles. 
 
 
Figure 37: CD raw data before BeStSel fitting. 
In general, some controversy still remains regarding the secondary structure 
of ELRs and, as in most IDPs, some structural features cannot be resolved. 
β-turns are the most widely studied structural feature of ELRs found in the 
literature as, in an ideal arrangement, they can form concatenated ordered 
β-helices that could explain the elastic properties of such materials and their 
thermomechanical behaviour44,46,112,157,429. Despite this, a quantitative 
estimation of protein secondary structures in IDPs remains challenging due 
to the huge morphological and spectral diversity of structures and their 
overlap in the CD spectra. As crystal-based X-ray structure determination 
and solution NMR spectroscopy cannot be used due to the sheer size of the 
ELR, a deconvolution of recorded CD spectra Figure 37) was performed to 
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extract more information about substructures and to resolve the effect of 
the temperature transitions.  
 
The BeStSel algorithm was selected as an approximation of the β-turn-rich 
ELRs44–47 as this algorithm has proven to be especially useful for resolving β-
sheet-rich proteins, as well as the twisting angles between β-strands. Indeed, 
it improves secondary structure prediction in general, and specifically for β-
structure-rich proteins and amyloid fibrils. Eight substructures, namely 
regular and distorted helices, turns, parallel and anti-parallel (left-, right-twisted 
or relaxed) structures and non-specified structures, were extracted391,430,431. 
Regular helices and left-twisted anti-parallel structures were not observed in 
any of the modifications and were thus excluded. The five sub-structures 
extracted are shown in Figure 39. Above the LCST of control samples VKV 
and CTA0, the formation of parallel and anti-parallel (relaxed) structures 
were observed, with this being directly related to the temperature transition 
of the ELR (LCST) as they form at the same temperature as the cloud point 
(supporting information Figure S4).  
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Figure 38: Cloud point determination of modified ELRs. Left heating, right cooling 
 
Moreover, the content of secondary structures like anti-parallel (right 
twisted) and distorted helical features decreases above the LCST. Over the 
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whole temperature range, turn and helical structures remain essentially 
constant in VKV, whereas a decrease in the onset of the LCST is found in 
the modified samples, with this being best resolved in CTA5. The amount 
of anti-parallel (right twisted) structures increased with decreasing 
temperature in all samples, and, for CTA5, below 10°C it dropped from 23% 
(10°C) to 16% (5°C), a similar value to that observed for VKV and CTA0 
(above the LCST; 25-35°C). Interestingly, CTA5 revealed similar a structural 
distribution of parallel, anti-parallel (relaxed), anti-parallel (right twisted) and 
distorted helical structures at 5°C as above the LCST, thus suggesting the 
presence of a UCST (The corresponding experimental and BeStSel fitten 
data points are presented in Table 18.  
 
In general, temperature changes alter polymer-water interactions, which 
become unfavorable below the UCST and above the LCST, thereby 
minimizing exposure of the macromolecule to water412. In polymers 
presenting a UCST, this transition is enthalpy driven, related to partial 
hydration upon heating 229 and the LCST is determined by the entropy of 
water (hydrophobic effect)432. As such, we predict a less-soluble material 
with a stronger tendency to form globules with a hydrophobic core. This 
explains the relatively constant hydrodynamic diameter of CTA5, supported 
by the hydrophobicity of cholesterol, which might lead to stabilized particles 
that are less affected by temperature changes. The structural analogy of 
LCST and UCST states in CTA5 further supports the hypothesis that the 
underlying ELR backbone determines structural flexibility driven by changes 
in the hydrophobicity either by entropy-driven exposure of the hydrophobic 
domains of the ELR (above the LCST), or by enthalpic intermolecular 
interactions between cholesteryl groups (below the UCST). 
 
151 
4.2 CHAPTER 2: Chemical Modification of ELRs with Cholesterol and 
Structural Mechanistics of Cholesteryl Group Mediated UCST Gelation 
 
 
 
Figure 39: Results from circular dichroism, deconvoluted using the BeStSel algorithm, showing the 
relative distribution of distorted helix (●), relaxed (▲) or right-twisted (▼) anti-parallel beta-
sheets, parallel beta sheets (♦) or turns (○).  For VKV and CTA0 ♦ and ▲ appear at temperatures 
between 20 – 25°C which is in correlation with observed LCST transitions, surprisingly the same 
is as well observed in CTA5 at temperatrues below 10°C. 
 
Herein, and to the best of our knowledge, we show for the first time that a 
UCST can be induced by side-chain modifications that foster a similar 
secondary structure distribution below the UCST as observed above the 
intrinsic LCST. Keeping in mind the theory of IDP, an order can be induced 
in all cholesteryl bearing protein samples by moving below the UCST or 
above the LCST (Figure 40). Surprisingly, in CTA1 a higher order, 
characterized by a higher degree of parallel and anti-parallel (relaxed) 
structures, is obtained above the LCST than observed in CTA5. This 
reduced reorganization might be explained by the presence of less dynamic 
particles, which are held together intramolecularly by more than one 
cholesteryl group, thereby impairing fast reorganization at high 
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temperatures, which is in accordance with the less dynamic particle sizes 
obtained by DLS. In contrast, below the UCST, parallel and anti-parallel 
(relaxed) structures only occur to a detectable extent in CTA5, thus 
resulting in a U-shaped temperature versus secondary structure profile 
(Figure 39). However, the algorithm has been applied to differentiate 
recombinant elastin-based polypeptides, and zwitterionic recombinant 
polypeptides recently433, but structural differences upon changes in charge 
were not stated. 
 
 
Figure 40: The accumulated percentage of secondary structures by CD defines the total order of 
proteins in solution. The missing percentage corresponds to random, or structural components 
unrecognized by the used algorithm. 
 
4.2.3 Characterization of gelation 
 
To characterize the cool gelation, solutions of higher concentration (0.75 
mM) were prepared and investigated using flow and oscillatory rheology 
techniques. Oscillatory measurements were performed using a heating and 
cooling cycle (25 – 2 – 50°C) and showed a complete reversibility of 
gelation. In general, no gelation was observed in the absence of cholesteryl 
side groups and the strength of the gel, as expressed by the storage modulus, 
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increased with the number of side groups (31 Pa for CTA1 and 60 Pa CTA5; 
Figure 43A). Moreover, no increase in storage modulus was observed above 
the LCST, where coacervation of the ELR takes place. To determine the 
viscosity, flow experiments were performed with shear rates from 10 to 
1000 s-1 at different temperatures. The viscosity and stress decreased with 
temperature or shear rate (viscosity vs. shear rate, supporting information 
Figures S7 and S8) in all samples. 
 
Table 15: Comparison of viscosities obtained from flow measurements at a shear rate of 60 s-
1(Exp.) using parameters derived from the Bingham and Herschel-Bulkley models. 
Sample Exp.: Bingham Herschel–Bulkley 
 T 
(°C) 
η(Pa s) σ0 (Pa) A (Pa s) σ0 (Pa) n 
CTA0 5 0.0204±0.0009 0.798±0.007 0.0096±0.0001 0.798±0.007 -0.464 
 15 0.0203±0.0005 0.786±0.012 0.0071±0.0002 0.786±0.012 -0.586 
 25 0.0173±0.0003 0.769±0.014 0.0055±0.0002 0.769±0.014 -0.695 
 35 0.0098±0.0006 0.259±0.003 0.0096±0.0002 0.259±0.003 -0.755 
CTA1 5 0.0213±0.0008 0.840±0.017 0.0071±0.0003 0.840±0.017 -0.594 
 15 0.0203±0.0005 0.769±0.014 0.0079±0.0002 0.769±0.014 -0.548 
 25 0.0177±0.0004 0.856±0.010 0.0041±0.0002 0.856±0.010 -0.824 
 35 0.0093±0.0008 0.248±0.004 0.0043±0.0002 0.248±0.004 -0.798 
CTA5 5 0.1880±0.0165 12.935±0.391 0.0326±0.0067 12.935±0.396 +0.052 
 15 0.0599±0.0008 3.124±0.035 0.0104±0.0006 3.124±0.035 -0.432 
 25 0.0414±0.0005 2.160±0.019 0.0056±0.0003 2.160±0.019 -0.690 
 35 0.0236±0.0014 1.323±0.010 0.0038±0.0005 1.323±0.010 -0.850 
 
With respect to the function-valued nature of rheologically complex 
material properties, fitting to the Herschel–Bulkley and Bingham models 
gave low-dimensional representations, thus allowing for a better 
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comparison. Thus, the yield stress (σ0) and plastic viscosity (A) were 
obtained by fitting to the Bingham model: 
𝜎𝜎 = 𝜎𝜎0 + 𝐴𝐴𝐴𝐴 
The three-parameter Herschel-Bulkley model is typically written as: 
𝜎𝜎 = 𝜎𝜎0 + 𝐾𝐾𝐴𝐴𝑛𝑛 
where σ0 is the yield stress of the material, K is the consistency factor, and 
n is the flow behavior index. Essentially, the behavior of the material is 
governed by these three Herschel–Bulkley parameters. The results are 
displayed in Table 15. 
 
 
Figure 41: Stress over shear rate raw data with Herschel Bulkley Fit (thin line). 
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Figure 42: Stress over shear rate raw data with Bingham Fit (thin line). 
 
Figure 43: Rheological characterization of samples under gelling conditions (0.75 mM). A) 
Oscillatory measurement, the evolution of G’ with temperature. B) Flow measurement, values 
displayed for a shear rate of 60s-1 (complete dataset available as supporting information). 
 
At a shear rate of 60 s-1, CTA0 and CTA1 behave quite similarly, with CTA1 
having a slightly higher viscosity at 5°C. As the temperature decreases below 
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10°C, into the gelation window of CTA5, the viscosity rises dramatically, 
yielding values more than one order of magnitude higher than for CTA0. A 
similar trend, albeit with smaller values, was obtained for the plastic viscosity 
derived from the Bingham model. The yield stresses were essentially 
constant) for CTA0 and CTA1 in the temperature range 5-25°C, with a 
small variation from 0.769 – 0.856 ± 0.037 Pa. A more significant decrease 
by approximately 66% was observed at 35°C, with no difference between 
the two models. CTA5 had significantly higher yield stress (fivefold higher) 
of 13 Pa at 5°C, decreasing with temperature to 2-3 Pa at 15-25°C (still 3-4 
fold higher than for CTA0), and to 1.3 Pa at 35°C. Higher yield stresses and 
viscosity upon changes in secondary structure have been reported 
previously in solutions of carrageen, a polysaccharide that exhibit 
comparable high yield stresses and n-indices at its UCST416, upon reducing 
the temperature, which is also driven by an increase in order (random coil 
to helix)434.  
 
Figure 44: Contact-angle measurements for solvent-cast CTA samples at different temperatures. 
Representative images of drops correspond to contact angles for the corresponding dashed lines. 
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To support the hypothesis of outward-facing cholesteryl groups, contact-
angle measurements were performed on solvent-cast films at varying 
temperatures to investigate the temperature dependence of the surface 
hydrophobicity. 
In CTA0, the hydrophobicity of the substrate only changed (from 72° to 
around 95°) when heating above 25°C. The cholesteryl-containing samples 
had three states of hydrophobicity, with the first at around 72° at 15°C 
(comparable to CTA0 below 25°C), the second at around 95-100° at 25 and 
35°C (comparable to CTA0 above 25°C), and the third at around 120° 
below the supposed UCST at 5°C. In cholesteryl-containing samples at low 
temperatures, the hydrophobicity increases in such a way that non-
condensing films with hydrophobicities of 120° and higher were obtained. 
Although the transition temperature of hydrophobicity measurements 
between 25 and 35, are slightly higher than the measured cloud point values, 
temperature transition seems to be the key driver, considering the results 
of the CD. We believe, that these films support the formation of gels at the 
same temperature driven by hydrophobic interactions, which become more 
accessible due to the structural change. A closer look at other UCST-type 
polymers with low-temperature gelation properties shows that they all 
exhibit a betaine-like zwitterionic-phenotype415–419. The combination of the 
negative surface potential of the CTA samples together with the positively 
charged lysine residues means that these systems can be considered to be a 
pseudo-zwitterionic phenotype, which would be in agreement with the 
formation of other UCST gels. Furthermore, we believe that low 
temperature gelation/aggregation is fostered by structural changes that 
increase hydrophobic (cholesterol-cholesterol) interactions, thus meaning 
that an increase in temperature would deteriorate the physical stability and 
disrupt the gel. Additionally, CA and ZP experiments also suggest a lower 
electrostatic repulsive and higher hydrophobic attractive surface potential 
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between the micelles. Other cholesterol-bearing materials that exhibit 
nano-aggregation into hydrogels, like pullulan229,231 and antimicrobial 
peptides, or deoxycholic acid modified heparin232 and chitosan233, were 
described by the poly-core model229 as self-aggregated nanoparticle forming 
non-covalently cross-linked supramolecular hydrogel structures mediated 
by hydrophobic association of cholesterol moieties. Furthermore, the 
characteristic temperature to cause a structural change decreased with the 
degree of cholesteryl substituions229. It is noteworthy, that based on the 
findings of Morishima et al. this effect of self-association is more probable to 
occur in bulky hydrophobic groups such as cholesterol or deoxycholic acid, 
than in long alkyl hydrocarbon chain229,234. Due to the structural analogy of 
materials, the model is suitable to illustrate the structure of the self-
aggregation of nanoparticle into the observed CTA hydrogels at low 
temperatures.  
 
4.2.4 Evolution of macrostructures below the UCST 
 
From the obtained results a phase behavior of CTA5 with two transitions 
around 10 and 20°C with an intermediate region of solubility can be derived. 
Here solubility is mainly characterized by the absence of parallel and anti-
parallel (relaxed) secondary structure (Figure 45), The LCST of ELRs is 
accompanied by structural changes resulting in an increase of these 
substructures, which seems to be as well the drivers of UCST-type gelation. 
Since gelation and ordered secondary structures are indicators for 
hierarchical self-assembly,the long-term effect of cholesteryl ELR was 
monitored, samples were incubated for 1, 3, 7 and 28 days below the UCST 
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or above the LCST and then imaged by TEM (125 µM) and SEM (0.25 and 
1.25 mM).  
 
 
Figure 45: Phasediagram for CTA5,derived from CD data, Absorbance and rheology. Changes in 
the secondary structure are in correlation with observed solubility in water. For absorbance CTA0 
curve was plotted due to the absence of cloudpoint in CTA5 even though secondary structural 
changes of CTA0 and CTA5 above 20°C are in accordance. 
 
The evolution of nano-/microstructures over time in low concentration 
samples below the UCST is shown in Figure 9. In CTA1 and 5, the formation 
of linear nanofibers with diameters ranging from 70 to 100 nm, which seem 
to originate from spherical micelles, was observed. These nanofibers vary in 
length from 200 (two spheres) up to several micrometers, with a tendency 
to form branched structures containing oriented nanofibers (9; D28). In 
CTA0, self-assembly into linear structures was not observed after 3 days 
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two populations of particles, with diameters of 7-10 and 60 nm, respectively, 
were observed (in accordance with populations obtained by DLS, Figure S6). 
Over time (from D7 onwards), these phases separated into domains rich in 
either type of particles. The 60 nm and 70-100 nm micelles correlate with 
the size obtained by DLS for CTA0 and CTA5, respectively. The increased 
size of cholesterol-bearing ELRs and their stability with temperature has also 
been demonstrated in cholesteryl-stabilized pullulan colloids, which 
aggregate above a critical concentration as a result of hydrophobic 
interactions435.  
 
 
Figure 46: TEM images of CTA samples (125 µM) incubated at 4°C for 24 h, 3, 7 or 28 days. 
 
When increasing the concentration to 0.25 mM, the formation of bundled 
linear structures was observed by SEM, with these structures evolving into 
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small platelets (approx. 5 µm²) after 24 h. In CTA5, these domains organized 
over time into bigger planar structures (D3-D7), thus resulting in a 
honeycomb-like arrangement (D28; Figure 47). The presence of 60-100 nm 
micelles at the periphery of these planes and bundles indicate their origin as 
a consequence of micellar coagulation. In all samples, a fivefold increase in 
concentration led to porous structures from day 1 onwards. To distinguish 
between samples, a pore area quantification of an area of 3000 µm² was 
performed. This study revealed that the pore area tends towards smaller 
pores over time, with complete depletion of pores bigger than 2.5 µm² in 
CTA1 and -5 after 7 days (Figure 48).  
 
Figure 47: SEM images of CTA samples (0.25 mM) incubated at 4°C for 24 h, 72 h, 7 days or 28 
days. Scale bar: 5 µm. 
 
Cholesteryl-containing block-copolymers based on amphiphilic 
glycopolymers with galactose and cholesterol grafts has been shown to form 
similar self-assembled structures and to form nanofibers similar to those 
observed in CTA1 and CTA5 after cold incubation for 7 days (Figure 46)436. 
Reversible sol-gel formation upon cooling in organic solvents was also 
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observed for some cholesteryl modified chiral molecules, with van der 
Waals forces and π-π stacking as the main drivers of gelation437, which is 
attributed to the chiral protein backbone of CTAs and a preference for 
secondary structures below the UCST. Additionally, some proteins such as 
abductin and resilin, and their corresponding protein-like polypeptides, have 
been reported to exhibit both a UCST and an LCST60,61. When comparing 
TEM images of a tyrosine-rich resilin-like polypetide below the UCST (4°C 
10mg/mL) with CTA1 and -5 (Figure 46), a similar interconnected gel-
particle network is formed, possibly driven by π-π stacking of tyrosines60,438. 
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Figure 48: Top: SEM images of CTA samples (1.25 mM)d at 4°C for 24 h, 72 h, 7 days or 28 days. 
Scale bar: 10 µm. Bottom: Pore-size analysis of an area of 3000 µm². 
 
Evolution of macrostructures above the LCST 
 
The structures observed above the LCST, at 37°C, are characterized by 
agglomeration, coagulation and precipitation from solution induced by the 
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hydrophobic effect in all samples, with no clear differences over time (see 
Figure 49)439.  
 
Figure 49: TEM images of CTA samples (125 µM)incubated at 37°C for 24 h, 3, 7 or 28 days. 
 
Increasing the concentration to 0.25mM results in more organized 
structures similar to those obtained below the UCST in the first 7 days of 
incubation (Figure 50 A-C; E-G; I-K). After 28 days, CTA0 tends to form 
domains with a microphase separation, similar to the separation observed 
at low concentrations in TEM (Figure 50 D), whereas in CTA1 and CTA5 
the structures form a more laminar phenotype (Figure 50 H and L). An 
increase in concentration at 37°C leads to the development of pore-like 
honeycomb structures over time similar to those observed at 4°C and, once 
again, these comprise small micelles and fibers with diameters of approx. 90 
nm. Interestingly, in the cholesteryl-rich sample CTA5, these pores develop 
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into grooves over time, thus resulting in well-defined parallel polymer 
platelets with a larger and less quantifiable pore area (Figure 51 I-L). 
However, for CTA0 and CTA1 the pore areas develop towards smaller 
pores over time, with complete depletion of pores larger than 10 µm², 
comparable to the observations below the UCST. 
 
Figure 50: SEM images of CTA samples (0.25 mM) incubated at 37°C for 24 h, 72 h, 7 days or 28 
days. Scale bar: 5 µm. 
 
CTA5 has a special distribution of hydrophobic and hydrophilic groups, 
which results in two competing structures (laminar vs. pores). The 
formation of laminar structures might correlate to the favored formation of 
orientated nanofibers, whereas branches, which would give rise to pores, 
are thermodynamically unfavored. At 4°C, two effects might be responsible 
for the preference of pores: 1) structural exposure of cholesteryl groups 
leads to stronger intermolecular interactions, thereby augmenting branching 
towards more and smaller pores, 2) low thermal energy in the systems, 
which decreases the speed of reorganization towards the 
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thermodynamically favored parallel grooves, considering the fact that such 
grooves are formed after 28 days of hot incubation. 
 
 
Figure 51: Top: SEM images of CTA samples (1.25 mM) incubated at 37°C for 24 h, 72 h, 7 days or 
28 days, Scale bar: 10 µm. Bottom: Pore-size analysis of an area of 3000 µm².  
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Some of the concepts applied in this chapter are developed in the article:  
Hydrophobic cholesteryl moieties trigger substrate cell-membrane interaction of 
elastin-mimetic protein coatings in vitro  
Leander Poocza; Sergio Acosta; Matilde Alonso; José Carlos Rodríguez Cabello. 
Published in ACS Omega: ACS OMEGA, 2019, 4, 6, 10818-27  
DOI: 10.1021/acsomega.9b00548  
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Modification of the cellular surface with natural or synthetic polymers allows 
for new opportunities in tissue regeneration and biomedical engineering. As 
such, control of the cellular microenvironment has become an important 
tool for controlling cell growth, cell-cell interactions, cytokine expression, 
stem cell differentiation and extracellular assembly. Here, the patterning and 
chemical modification of surfaces440–442, the expansion into 3D by using 
biomimetic or natural hydrogels443–445, or Layer-by-Layer (LbL) assemblies 
onto the cells are the focus of current research90,91,446–448. Generally, 
substrates are bound to the cell membrane via covalent conjugation, 
hydrogen bonding and electrostatic, dipole-dipole, or hydrophobic 
interactions. When mimicking the natural interaction of materials with cells, 
three key events need to be considered: (1) the composition of the material, 
(2) cell-membrane interactions, and (3) the composition of the cell 
membrane itself.  
The membrane bilayer is a physical barrier that defines the frontier of the 
cells and segregates the interior into distinct compartments with specialized 
functions. The amphiphilic nature of the membrane leads to a negatively 
charged outer surface and a hydrophobic core inside the membrane, which 
serves as an anchor for membrane and transmembrane proteins. 
Consequently, cells have the ability to bind substrates via integrin binding, 
electrostatic interactions, hydrogen bonds, or hydrophobic interactions. 
Moreover, the membrane contains a variety of compounds and proteins that 
are crucial for cellular function. One of the most abundant molecules in the 
membrane is cholesterol, which is found inside the membrane due to its 
hydrophobicity. Cholesterol is responsible for membrane integrity and cell 
signaling and accounts for up to 20% of the membrane's mass63. Cholesterol, 
among the many lipid constituents of mammalian cell membranes, is a key 
regulator of membrane fluidity and contributes to the formation of caveolae, 
and in maintaining caveolae microdomain64,65. Caveolae are specialized 
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domains of the plasma membrane that are found in most cell types66. 
However, they are more abundant in cells like adipocytes, endothelial cells, 
fibroblasts, and muscle cells67. In addition to the influence of membrane 
fluidity, cholesterol is important for cell structure and function, it is essential 
in locomotion and serves as a metabolic precursor for several signaling 
molecules, including oxysterols68, steroids228 and bile acids65,69,70. 
The majority of substrates or hydrogels focus on integrin binding sites, in 
particular the RGD binding site, to generate cell binding, or infiltration. 
Synthetic materials with covalently bound RGD residues nevertheless 
struggle to meet the results of native ECM protein materials71. Other 
research for the fabrication of 3D-tissue constructs has focused on cell sheet 
engineering62, magnetic liposomes72, cell beads73, and cells containing gel 
layers74–76. In particular, the creation of cell type specific and target tissue 
specific nano- and microdomains using biological interactions, such as 
avidin–biotin77–80, antibody–antigen81,82, lectin–polysaccharides83,84, or ECM 
proteins like fibronectin, collagen and/or gelatin74,75,85–89, has shown 
promising results in “hierarchical-cell manipulation” in vitro85,88,90,91.  
In this approach, a cell coating based on hydrophobic interactions with the 
cell membrane is presented. To reduce the batch-to-batch and other host-
specific variations of organism-derived proteins, an ECM analog elastin-like 
recombinamer (ELR) is used as a model protein for the tissue-inductive 
coating. The main objective is the creation of a well-distributed initial layer 
of protein on the cells. As such, the potential of hydrophobic groups as intra-
membranous anchors for cellular coatings is determined. Cholesteryl side 
groups were selected as hydrophobic anchors to mimic the intra-
membranous situation and to facilitate the mobility and distribution of the 
proteins in the membrane. For better interaction of the cholesterol material 
with the membrane, caveolin-rich cell types like human umbilical vein 
endothelium-derived cells (HUVEC) and human aortic smooth muscle cells 
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(HASMC), which are involved in lipid uptake from sanguine fluid and in 
processes such as stenosis, were selected67. 
 
4.3.1 ELR Modification 
 
Modification of the ELR with the BCN linker, fluorophore and CTA groups 
was successfully performed by a two-step synthesis (Scheme 1). The number 
of incorporations was followed by NMR spectroscopy integrating P3 for the 
determination of cholesteryl incorporations, or P4 for the degree of 
Eterneon incoproations, results are displayed in Table 14. The efficiency of 
fluorescence was further visualized by UV irradiation of the sample. 
 
Scheme 1: Synthetic route of cholesteryl modification of ELR at free lysine’s through BCN mediated 
cycloaddition . 
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Figure 52: Signals of Eterneon and Cholesterol in NMR spectras of CTAx*. Signals were normalized 
to P1 (for complete Spectra refer to Figure 29 to Figure 31). 
The results revealed 10.5 BCN groups for CTA0 with an addition of 1.19 
and 0.95 cholesteryl groups for CTA1 and CTA1*, 3.03 and 3.33 cholesteryl 
groups for CTA3 and CTA3* and 4.03 and 6.09 cholesteryl groups for 
CTA5. Besides the NMR analysis, samples were characterized by MALDI-
TOFF (Figure 53), and the results yielding comparable values are displayed 
in Table 17. 
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Table 16: Overview of NMR signals and the related conversion of functional groups.P1 serves as 
internal reference, representing –CH3 and -CH2- protons of amino acid residues (G, E, L, K, M, P, 
S, V); P2 represents H2C-O(C=O)O- of the BCN linker; P3 represents C=C-H proton of the 
cholesteryl residue; P4 is an isolated signal from the ETERNEON fluorophore (structure not 
known).Complete spectra are provided as Supplementary Information. 
 P1 
(normalized) 
0.6–1.0 
P2 
2.85–2.95 
#BCN 
 
 
VKV 1335 - - 
VKV-
BCN 
(CTA0) 
1335 21.01 10.5 
 P1 
0.6–1.0 ppm 
P3 
5.30–5.45 
ppm 
#CTA P4 
10.1-10.3 
CTA0* 1335 - 0 0.91 
CTA1 1335 1.19 1.19 - 
CTA1* 1335 0.95 0.95 1.59 
CTA3 1335 3.03 3.03 - 
CTA3* 1335 3.33 3.33 1.54 
CTA5 1335 4.03 4.03 - 
CTA5* 1335 6.09 6.09 1.10 
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Figure 53: MALDI-TOF Spectra of modified ELRs. 
 
The mass analysis revealed slightly higher values for all modifications, where 
ELRCTA0 with 13.14 groups compared to 10.5 groups (NMR) showed the 
biggest variance. All other values were in good agreement with NMR data. 
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Table 17: Degree of modification, calculated from the mass analysis. 
 Mw (MALDI-TOF) Calculated 
BCN/CTA groups 
VKV 60977  
CTA0 63505 BCN: 13,146 
CTA1 64446 CTA: 1,49 
CTA3 66019 CTA: 3,98 
CTA5 67096 CTA: 5,69 
 
4.3.2 Characterization in solution 
 
The hydrodynamic radii of ELRCTA in PBS was determined by DLS. However, 
as the multi-modality of the sample above the LCST did not allow for size-
average comparison, the volume intensities were plotted (Figure 54). 
Moreover, volume intensities allow for small particle detection in a complex 
precipitating sample. All samples have a similar size at 4°C, ranging between 
3 and 7 nm, which corresponds to 2-10 ELR molecules according to the 
size-mass calibration. An additional population of 2 nm particles, which might 
correspond to unimers is observed in ELRCTA5. Above the LCST, ELRCTA0 
agglomerates into larger structures and precipitates from solution, starting 
with 30 nm particles and larger micrometer-sized populations in the initial 
stage of precipitation. Upon cholesteryl addition, a significant shift towards 
smaller particles is observed above the LCST in the volume intensities, as 
well confirmed by a left shift of the correlation function (Figure 55). The 
addition of more CTA groups leads to a reduction in the number of larger 
particles, which is most prominent in ELRCTA5, similar to conditions below 
the LCST. 
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Figure 54: Volume Intensities of cholesteryl ELRs in PBS at different temperatures. Graphs show 
an overlay of three individual measurements. Black arrows mark the size shift of distribution. 
 
 
Figure 55: Correlation function of ELRCTA0, 1, and 5 at 4 and 37°C. Most prominent is the left shift of 
ELRCTA1 and ELRCTA5 at 37°C indicating the presence of smaller aggregates/particles (ELRCTA3 was 
removed for better visibility). 
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The cloud point of the samples was determined as the derivative of the 
absorbance versus temperature profile of ELRCTA. A significant increase in 
turbidity and related absorbance was only observed in CTA0, which was 
already drastically reduced in CTA1, with a transition temperature (Tt) of 
23.9 and 26.0ºC and a maximum absorbance of 1.6 and 0.3, respectively. No 
changes in absorbance were observed for ELRCTA3 and ELRCTA5 in the 
temperature range 5–40ºC (Figure 56), which is in accordance with the 
decrease in the number of larger agglomerates observed by DLS. 
 
 
Figure 56: Cloudpoint determination of ELRs. The cholesteryl-modified ELRs show markedly 
reduced to no absorbance above the LCST of ELRCTA0. 
 
4.3.3 Cytotoxicity of ELR particles  
 
The different substrates were tested for their effect on cell proliferation 
over 7 days using the AlamarBlue® assay at concentrations of 375 and 750 
nM. The values were normalized to non-conditioned cells grown on TCPS 
for better visibility. HUVECs showed no significant differences in 
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proliferation under all conditions (Figure 57 A), whereas for HASMCs, 
treatment with cholesteryl ELRs (ELRCTA) at 750 nM led to a decreased 
proliferation for ELRCTA0 and ELRCTA1 at day 1 and at day 3 and 7 for all 
conditioned samples, becoming more significant with time (Figure 57 B). 
Moreover, the cytostatic effect is more pronounced in ELRCTA0 and ELRCTA1 
on day 1 and day 7. The lower concentration (375 nM) had no negative 
effect on proliferation. 
 
Figure 57: Metabolic activity of cells incubated with ELRs and ELR-CTA at 375 and 750 nM. A) HUVEC 
cells; and B) HASMC. P values refer to cells cultured on TCPS (* P<0.05;** P<0.01;*** P<0.001). 
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All subsequent incubation studies were performed at concentrations of 375 
nM as the proliferation of both cell lines was unaffected at this 
concentration. 
 
4.3.4 ELR – cell Interactions 
 
The cell-ELR interaction was quantified by FACS, therefore the resulting 
events were first analysed by plotting forward and sideward scatter 
intensities (FS INT vs. SS INT) which gives information about size and 
complexity of the detected events going from small samples like cellular 
debris (low values of FS and SS) towards di- to oligomerized cells (high FS 
and SS). To select only single cells the results were gated as characterized 
by the pentagons in Figure 58 and Figure 59, respectively. As can be seen by 
the amounts of gated cells, approximately 60% of HASMC were gated, 
whereas 93% of HUVEC cells were gated. Considering the fact that 60% of 
50.000 events that were collected reflects 30.000events, together with the 
comparability of differences in cellular debris and more complex events 
throughout the whole sequence of ELRCTAx with HASMC cells, this drop in 
selected cells can be neglected for this study and is just an expression of a 
cell aliquot of intermediate quality. 
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Figure 58: Flow Cytometry forward vs side scatter and gated single HASMC cell population (A) 
used for quantification of fluorescence. 
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Figure 59: Flow Cytometry forward vs side scatter and gated single HUVEC cell population (A) 
used for quantification of fluorescence. 
 
 
Figure 60: Forward scatter intensity (FS INT) vs. fluorescence (FL3 INT) of HASMC cells treated 
with CTA samples. 
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In the consecutive step the gated cells were plotted by FS INT vs 
fluorescence (FL3 INT) with the number of fluorescent events increasing 
from ELRCTA0 to ELRCTA5, as indicated by a right shift in the dot plots from 
10% to 80% (HUVEC), or from 20% to 85% (HASMC), fluorescent cells 
(Figure 60 and Figure 61 A-E). HASMC cells interact with the material to a 
higher extent at low cholesteryl contents, increasing from 20% to 60% from 
ELRCTA0 to ELRCTA3, whereas the coating efficiency of these ELRs remains 
below 30% with HUVEC cells (Figure 61F). 
 
 
Figure 61: Forward scatter intensity (FS INT) vs. fluorescence (FL3 INT) of HUVEC cells treated 
with ELRCTA samples, obtained by flow cytometry. A) untreated HUVEC cells; B) HUVEC cells 
treated with ELRCTA0*, C) HUVEC cells treated with ELRCTA1*, D) HUVEC cells treated with 
ELRCTA3*, E) HUVEC cells treated with ELRCTA5*, F) Fluorescence fraction of HUVEC and HASMC 
cells. See the supporting information for HASMC dot plots. P values refer to cells treated with 
ELRCTA0* (* P<0.05;** P<0.01) 
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Figure 62: Confocal images of HUVEC (A) and HASMCs (B) after incubation with CTAx samples. 
From left to right: texas red (displayed color was changed to magenta for better visibility of small 
particles), phase, and merge. Top to bottom: ELRCTA0*, ELRCTA1*, ELRCTA3* and ELRCTA5*. The scale 
bars represent 7.5 µm. 
 
Confocal images of trypsinized cells after incubation revealed a change in 
ELR distribution on the cell membrane that is dependent on the cholesteryl 
content, ranging from more agglomerated micron-sized particles towards 
finely dispersed sub-micron dots, with this being found for both cell lines 
(Figure 62). Additionally, a Z-scan was performed for the sample with 
dispersed fluorescence to determine the fluorescence distribution. The 
localized presence of ELRCTA in the cell center (first five layers), followed by 
the depletion of fluorescence in the center (subsequent layers), indicates 
binding of ELR to the membrane (Figure 63). Live cell imaging further 
revealed an increased aggregation of bound ELRs in HASMC (CTA0 and 
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CTA1) and increased dispersion of ELR in both HUVEC and HASMC 
(CTA5) (results are shown in the right part of Figure 73). 
 
 
Figure 63: Z-slicing of HUVEC cell with ELRCTA5*. Slices are from top to bottom starting from the 
top left (z04) to the bottom right image (z19). ELR fluorescence in the top image covers most of 
the cell surface, whereas in the lower slices the ELR is more concentrated at the perimeter of the 
cell, thus indicating that the ELR is not incorporated into the cells.  The scale bars represent 7.5 
µm, slicing depth is 0.4 µm. 
 
Several studies concerning polymer–membrane interactions and 
internalization have been published in recent years75,449. Indeed, it is well 
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documented that biophysical properties such as net charge, hydrophobicity, 
and protein-driven cell–ligand (integrin binding) interactions influence the 
interaction of polymers, proteins or peptides with model membranes and 
biological cells450. Most polymer modifications have focussed on the 
introduction of a positive charge to foster electrostatic interactions with the 
membrane (polycations)75, or on the insertion of integrin-binding domains 
(like RGD)449. Since integrin-binding amino acid sequences frequently 
contain charged residues, both these approaches increase the net-charge 
and hydrophilicity of the material. The basis for this study was an 
antagonistic approach that makes use of a set of carefully designed ELRs of 
varying hydrophobicities to trigger membrane–substrate interactions. For 
the introduction of hydrophobic moieties, a strategy of post-expressional 
modification with cholesteryl groups was used to keep other peptide 
properties, such as peptide charge and charge distribution, unchanged. 
Cholesteryl groups were selected as cell-anchor moieties due to the 
abundance and importance of cholesterol in cell structure, function, and 
locomotion; furthermore, the ability of membranes to stabilize cholesteryl 
groups is thought to assist the coordination of hydrophobic ELRs to the 
membrane. The main objective was to generate a defined cellular coating of 
a recombinant protein that allows for total sequence control and less host 
or batch-to-batch variation as a substitute for existing coatings such as 
alginate74, polyelectrolytes75, collagens and fibronectin87–89. 
An in vitro cell binding assay was used to quantify cell–membrane 
interactions. Thus, HUVEC and HASMC were incubated with molecular 
probes of varying cholesteryl concentrations (Figure 1). At 37ºC, ELRCTA0 
and ELRCTA are above their LCST of 23.9 and 26°C, respectively, therefore 
precipitation and hydrophobic ELR-ELR interactions are more favored and 
agglomeration occurs. 
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This agglomeration can be prevented upon the introduction of cholesteryl 
side chains, which hamper aggregation and lead to the disappearance of the 
LCST transition. Although more hydrophobic, agglomeration of ELRCTA was 
not observed. For a better understanding of LCST disappearance in ELRCTA 
samples, CD spectra were recorded at 37°C, which showed a slight 
decrease of random coil signal at 197 nm upon cholesteryl addition, 
indicating an increased order towards beta-turn451 and alpha helical 
structures452, which is consistent with studies on cholesteryl modified 
polylysine453. Nevertheless, besides slightly augmented order, overall spectra 
were quite similar (Figure 64) and give no explanation on diminished 
precipitation. Consequently, we assume that the shift in particle size towards 
uni- and oligomers are due to a destabilization of micelles in ionic solutions 
such as PBS, which, given their size, are non-absorbent even above the LCST.  
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Figure 64: CD spectra of modified ELRs at 37°C. Upon the addition of the BCN linker, a negative 
shoulder at 220 nm is slightly increased. This change is reversed by the addition of 1-5 CTA groups, 
accompanied by a reduction of the negative peak at 197 nm. 
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Furthermore, the probes with higher amounts of cholesterol showed a 
significant increase in ELR binding to the cell membrane as hydrophobic 
interactions with the membrane lead to a better distribution of the material 
in the membrane. It is believed that the abundance of cholesterol in the cell 
membrane and its hydrophobic nature further foster the cell–ELRCTA 
interaction. The hypothesized mechanism of cellular ELR association relates 
to the cholesterol content (Figure 73). Thus, in the absence of cholesteryl 
groups, the ELR agglomerates over time to form micron-sized particles as a 
result of hydrophobic and electrostatic interactions, whereas increasing 
numbers of cholesteryl groups lead to a weakening of the ELRCTA–ELRCTA 
interaction and to an increased ELR-Membrane interaction under 
physiological conditions, thus resulting in distribution of the ELR in the cell 
membrane.  
 
𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼(𝐸𝐸𝐸𝐸𝐸𝐸 − 𝐸𝐸𝐸𝐸𝐸𝐸) > 𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼(𝐸𝐸𝐸𝐸𝐸𝐸 −𝑀𝑀𝐼𝐼𝑀𝑀𝑀𝑀𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼) 
𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼(𝐸𝐸𝐸𝐸𝐸𝐸𝐶𝐶𝐶𝐶𝐶𝐶 − 𝐸𝐸𝐸𝐸𝐸𝐸𝐶𝐶𝐶𝐶𝐶𝐶) < 𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼(𝐸𝐸𝐸𝐸𝐸𝐸𝐶𝐶𝐶𝐶𝐶𝐶 − 𝑀𝑀𝐼𝐼𝑀𝑀𝑀𝑀𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼) 
 
Cells were followed for 18 h in culture to analyze the behavior of cell 
substrate interaction. The results for better visibility one image per 3h is 
presented. 
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Figure 65: Life cell imaging of HASMC cells incubated with 375 nM ELRCTA0* over a period of 18h, 
circle and arrow highlight movement and fusion of ELR agglomerates into bigger agglomerates. 
 
Figure 66: Life cell imaging of HASMC cells incubated with 375 nM ELRCTA1* over a period of 18h. 
 
HASMCs incubated with ELRCTA0 and ELRCTA1 revealed a similar behavior, 
the ELRs are above there LCST are in a collapsed state and agglomerates 
are moved around by cellular movement. Interestingly, upon contact of ELR 
particles with them self, they fuse together and over time bigger 
agglomerates are obtained, which are still attached to the cells (Figure 65 
and Figure 66). 
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Figure 67: Life cell imaging of HASMC cells incubated with 375 nM ELRCTA3* over a period of 18h. 
 
Figure 68: Life cell imaging of HASMC cells incubated with 375 nM ELRCTA5* over a period of 18h. 
 
Upon interaction with ELRCTA3 and ELRCTA5 a different behavior is obsereved. 
Initially, the ELR particles are more aggregated and over time a distribution 
within the cellular membrane is observed (Figure 67 and Figure 68). 
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Figure 69: Life cell imaging of HUVEC cells incubated with 375 nM ELRCTA0* over a period of 18h. 
 
Figure 70: Life cell imaging of HUVEC cells incubated with 375 nM ELRCTA1* over a period of 18h. 
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Figure 71: Life cell imaging of HUVEC cells incubated with 375 nM ELRCTA3* over a period of 18h. 
 
HUVECs showed no interaction with ELRCTA0, ELRCTA1 and ELRCTA3 as 
visualized by the flourescent particles sticked rather to the TCPS of the 
cultureplate than to the cells, and their unchanged localization over time 
(Figure 69, Figure 70, and Figure 71). 
 
 
Figure 72:Life cell imaging of HUVEC cells incubated with 375 nM ELRCTA5* over a period of 18h. 
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Incubation of HUVECs with ELRCTA5 on the other hand revealed a similar 
distribution of ELR in the cell membrane as observed in HASMCs (Figure 
72). In general, live cell imaging of all cell types supported the hypothesis 
whereby the larger agglomerates, which bind to the cell membranes, are still 
mobile and tend to bind to each other upon contact. High cholesteryl 
contents led to ELRs very finely dispersed throughout the membrane. The 
marked mobility of the ELRCTAs in the cell membrane indicates that the 
interaction with the membrane does not reduce cell mobility. Moreover, 
HUVEC cells did not interact with ELRs CTA<3 and the agglomerated ELR, 
with these ELRs binding to the well-plate and their organization remaining 
unchanged over time (Figure 69 and Figure 70), which is in accordance with 
the FACS data. In contrast, in HASMC cells the ELR fragments adhere to 
the membrane and are moved around by the cells, thus resulting in the 
growth of the agglomerates as a result of increased probability of ELR-ELR 
contacts, together with the reduced proliferation in HASMC cells with ELRs 
CTA<3 the bigger agglomerates on the cell surface might increase morbidity 
of cells or hamper proliferation. The increased membrane affinity for 
cholesteryl groups overcomes the ELR-ELR interaction, thus resulting in 
more dispersed particles in solution as well as on the membrane and 
increasing the number of fluorescent-positive cells. HASMCs are less 
selective than HUVECs and actively bind low cholesteryl ELRs (Figure 65 
and Figure 66), with the amount of bound ELR per cell appearing to be 
higher, as characterized by a second population of right-shifted cells with a 
fluorescent intensity of 102-103. However, the tendency of ELRCTA3 and 
ELRCTA0to be dispersed in the membrane was observed in both cell lines 
(Figure 68 Figure 72). The distribution of the ELRs is shown in detail in the 
confocal images, which show how the agglomerates of ELRCTA0 or ELRCTA1 
are bound to the membrane as micrometer-sized particles, changing with 
increasing cholesterol content into a myriad of submicron-sized small ELR 
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dots ELRCTA0within the membrane. Confocal imaging also supports the fact 
that most of the ELR remains in close proximity to the membrane and is not 
fully incorporated into the cells. In light of the data obtained from flow 
cytometry, the incorporation of ELRs into the membrane, or the association 
of ELR with the membranes, does not negatively affect cell proliferation, as 
would be indicated by an increased amount of cell debris in ungated dot 
plots. 
 
 
Figure 73: Schematic interaction of cholesteryl ELR with the cell membrane. Upon incubation the 
cholesteryl-ELR adsorbs to the membrane. Over time the ELR either agglomerates on the cell 
membrane or are further distributed on the membrane. Top right: ELRCTA0* incubated with 
HASMC, ELRCTA0* sticks to the membrane and agglomerated due to ELR-ELR contacts. Bottom 
right: ELRCTA5* incubation, cells maintain mobility and ELRCTA5* is distributed in small dots 
throughout the membrane. The left images indicate t0 after incubation, the right images t = 6h.  
 
Although elastin-like proteins (ELPs, also referred to as ELRs) with a similar 
constitution to ELRCTA0 presented herein have been reported to be tunable 
in terms of membrane interactions due to changes in temperature, thereby 
resulting in changes of hydrophobicity and the good interaction of ELRCTA0 
(T>Tt) with HASMC cells, it should be noted that much lower 
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concentrations were used in our work449. Simnick et al. further showed that 
integrin receptor-like interactions could be used to further increase cell-
ligand interactions449. The augmented affinity to cell membranes with 
cholesteryl anchors was further reported with modified hyaluronan454, or 
DNA455. The differences in CTA groups on cellular uptake might be 
explained by the involvement of cells in lipid uptake. Cholesterol can interact 
with other proteins via both covalent456 and non-covalent mechanisms457,458, 
thereby regulating protein stability, localization426 and activity70. Cholesterol 
accumulation is one of the primary events in atherosclerosis within specific 
and specialized cell types such as SMCs, where it results in uncontrolled 
uptake, whereas endothelial cells maintain tight cholesterol homeostasis459, 
which might explain the selectivity of HUVECs for high ELRCTA  
concentrations. Furthermore, it has been shown that, in contrast to SMCs, 
endothelial cells do not undergo the foam cell phenotypic change in 
atherosclerotic plaques, a change characterized by the unrestricted 
accumulation of cellular cholesterol460, which would explain the cytostatis of 
HASMC at 750 nM ELRCTA. It should be noted that ELRCTA0 and ELRCTA1 have 
a more cytostatic effect on HASMCs, which in turn means that cholesteryl 
groups improve the cytocompatibility of ELRCTA0. Although the interaction 
of ELRCTA0 and ELRCTA1 with cells is possibly mediated by electrostatic 
interactions with the remaining free lysines of the ELR, this interaction is 
not strong enough to disrupt the hydrophobic ELR-ELR interaction above 
the LCST, thus resulting in the growth of bound aggregates over time. 
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5 Conclusions 
 
5.1 ELR Zymography 
 
We could demonstrate, that by the meticulous design of protein sequence, 
a substrate for IGZ was generated, that allows for embedding into gel 
matrices, CBB detection and displays a single specific proteolytic sequence. 
Already with the presented two different groups, differences in serin 
protease and MMP activity could be revealed. It is worth to mention that, 
ELR-Control is not a target of selected MMPs but was slightly degraded by 
trypsin in the control experiment, which was possibly due to the presence 
of lysines which are important for the detection with CBB, since lysines are 
a favored target of serine proteases. For the binary output of this method, 
specificity is of importance, that is why the method might be limited to MMPs 
only. 
Additionaly, we presented a new method for the screening of proteases by 
translating the IGZ into a well-plate zymography (IWZ), allowing for fast and 
quantitative read-out. We could show that already with two different 
functional groups we could determine differences in degradation profiles by 
IWZ, where positive and negative control served as an additional feed-back 
loop in terms of derived pattern. Degradation over-time could be tracked 
enabling the measurement of distinct kinetics by this method. The specificity 
of the substrate brings several advancements to gel-based zymographic 
techniques, due to the binarity of the results, even without electrophoretic 
separation, samples can be analyzed in terms of “if” or “if-not” they target 
to the presented substrate. 
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The presented method has the potential as a protease screening, which gains 
significance directly proportional to the number of protease targets (ELRs) 
used. The presented IWZ method has a high throughput potential, 
therefore, further substrates are currently developed to generate a library 
of substrates that allow discovering new cleavage patterns of proteases, and 
might have relevance to detect abnormalities in clinical samples. Since 
diffusion out of a static well plate gel is an issue, trans-well systems are part 
of future investigations. 
 
5.2 Structural deductions of cholesterol modified 
ELRs 
 
Recombinant protein-based materials have attracted increasing attention 
over the past few years due to their natural origin and the fact that myriad 
properties can be incorporated. We have demonstrated that novel 
properties such as self-assembly and thermoreversible gel formation can be 
achieved by selective modification of IDPs with tandem repeats of low 
complexity, thereby resulting in novel materials that can exhibit both UCST 
and LCST behavior in which the ordered secondary structure is favored 
both above the LCST and below the UCST for enhanced cholesteryl-
cholesteryl interactions. On the basis of our results, cholesteryl groups 
appear to act as structural mediators, in this case either as micelle stabilizers 
under entropy-driven conditions above the LCST, or as exposed micelle 
connectors under enthalpy-driven conditions below the UCST. In both 
cases, cholesteryl groups accelerate the structural organization of ELRs over 
time. The fact that similar secondary structures are obtained with either 
inward- or outward-facing cholesteryl groups might be explained by the 
underlying protein backbone, which governs the structural motifs that can 
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be accessed. This can further be fostered by the repetitiveness of the protein 
sequence, with lysines at every 30th amino acid residue, which lead even with 
randomly distributed cholesteryl residues to potentially higher probabilities 
of equidistant cholesteryl side-chains, thereby improving intermolecular 
cholesteryl-cholesteryl π-π-like stacking of the oligocyclic steroid backbone. 
Although maintenance of the secondary structure while changing cholesteryl 
orientation seems counterintuitive, the low number of cholesteryl groups 
driving organization compared with the size of the polypetide backbone, 
which is intrinsically disordered below the LCST, has to be considered along 
with the relatively small degree of order added by those groups (approx. 
+5%, below and above the UCST/LCST). The low-temperature formation 
of UCST-type gels induced by a pseudo-zwitterionic cholesteryl phenotype 
was supported by ZP, CMC, Herschel-Bulkley index, viscosity and storage 
modulus, along with the underlying changes in secondary structure derived 
from deconvoluted CD data. Although these data have been reported in 
part in other studies related to cholesteryl modification, or UCST gels, 
herein we present a model system that sheds light on the various effects 
resulting from the incorporation of cholesteryl side-chains by relating 
structural changes to macroscopic observations. The possibility to introduce 
a thermo-reversible gel transition into protein-based materials will have 
potential applications in biomedical applications such as smart bioactive 
surfaces, selective bioseparation, phase separation immunoassays, enzyme 
recycling, protein chromatography, controlled bioadhesion, hyperthermia-
induced drug delivery, and tissue engineering438. Moreover, such 
modifications could be used to forge micelle interactions, thus making 
macroscopic hierarchical structures accessible. The effect of cholesteryl 
side-chains on proteins as potential membrane-anchored cell coatings is the 
subject of ongoing studies. suitable for trapping the hydrophobic drugs.231 
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5.3 Cellular interactions with Cholesteryl-ELRs 
 
The general mechanisms of cell-substrate binding are based on Integrin–
substrate binding, or polycation LbL coatings, and phagocytosis of positively 
charged polyplexes. However, this work provides an additional cue by using 
hydrophobic entities as mediators of cell–substrate interactions. In this 
work, cholesterol groups are used as a cellular anchor to enhance the 
membrane substrate interaction of an elastin-like recombinamer (ELR). The 
resulting materials showed enhanced cellular recognition and matrix 
distribution, in line with the number of CTA groups incorporated.  
To the best of our knowledge, hydrophobic moieties that function as cellular 
membrane anchors for proteins have not yet been investigated to date. Since 
no negative proliferative effect on cells was observed in selected cell types 
at concentrations resulting in >60% of fluorescently labeled cells, the present 
system may lead to a better understanding of hydrophobic membrane–
substrate interactions and the development of novel hydrophobicity driven 
cell coatings that could potentially replace current coatings. Furthermore, 
these novel materials and their versatility in terms of protein sequence have 
high potential as cellular markers, drug carriers, or hydrophobic cell-binding 
domains. The cell specificity also allows for further optimization of the 
process by varying concentrations, incubation times and the number of 
cholesteryl groups. This system may also help to understand the mechanisms 
by which vascular endothelial cells maintain tight cholesterol homeostasis 
and may shed light on the mechanisms of cellular sterol transport, or high-
density lipoprotein (HDL)-dependent RCT. Future studies will focus on 
ELR-cholesteryl systems with fewer ELR-ELR attractions at 37ºC to extract 
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the driving force of membrane distribution and the related contribution of 
cholesteryl groups, or the ELRs themselves.  
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Table 18: Datapoints of BeStSel algorythm fit to CD data. 
Sample VKV 
Temp. (°C) 5   10   15   20   25   30   35   
Waveln. 
(nm) 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
190,00 
-
3,56 
-
3,19 
-
3,39 
-
3,01 
-
3,12 
-
2,77 
-
2,77 
-
2,51 
-
2,57 
-
2,33 
-
2,35 
-
2,11 
-
2,20 
-
1,93 
191,00 
-
3,98 
-
3,80 
-
3,73 
-
3,57 
-
3,39 
-
3,28 
-
3,08 
-
2,96 
-
2,87 
-
2,76 
-
2,54 
-
2,48 
-
2,26 
-
2,14 
192,00 
-
4,39 
-
4,39 
-
4,10 
-
4,11 
-
3,75 
-
3,78 
-
3,37 
-
3,40 
-
3,17 
-
3,18 
-
2,84 
-
2,85 
-
2,33 
-
2,36 
193,00 
-
4,78 
-
4,91 
-
4,41 
-
4,61 
-
4,12 
-
4,25 
-
3,73 
-
3,82 
-
3,47 
-
3,58 
-
3,09 
-
3,21 
-
2,44 
-
2,57 
194,00 
-
5,09 
-
5,31 
-
4,77 
-
4,98 
-
4,40 
-
4,61 
-
3,99 
-
4,14 
-
3,73 
-
3,89 
-
3,39 
-
3,51 
-
2,53 
-
2,72 
195,00 
-
5,31 
-
5,48 
-
5,05 
-
5,14 
-
4,61 
-
4,77 
-
4,16 
-
4,28 
-
3,95 
-
4,03 
-
3,56 
-
3,65 
-
2,62 
-
2,73 
196,00 
-
5,45 
-
5,47 
-
5,13 
-
5,15 
-
4,78 
-
4,79 
-
4,32 
-
4,30 
-
4,07 
-
4,05 
-
3,70 
-
3,68 
-
2,66 
-
2,66 
197,00 
-
5,52 
-
5,39 
-
5,18 
-
5,09 
-
4,88 
-
4,76 
-
4,33 
-
4,28 
-
4,12 
-
4,03 
-
3,74 
-
3,67 
-
2,68 
-
2,60 
198,00 
-
5,40 
-
5,22 
-
5,12 
-
4,95 
-
4,83 
-
4,64 
-
4,32 
-
4,19 
-
4,09 
-
3,95 
-
3,71 
-
3,60 
-
2,65 
-
2,48 
199,00 
-
5,18 
-
5,04 
-
4,97 
-
4,81 
-
4,68 
-
4,52 
-
4,29 
-
4,10 
-
3,97 
-
3,87 
-
3,68 
-
3,55 
-
2,56 
-
2,44 
200,00 
-
4,93 
-
4,87 
-
4,78 
-
4,67 
-
4,44 
-
4,39 
-
4,03 
-
3,99 
-
3,79 
-
3,78 
-
3,49 
-
3,47 
-
2,43 
-
2,38 
201,00 
-
4,65 
-
4,46 
-
4,44 
-
4,29 
-
4,13 
-
4,03 
-
3,76 
-
3,67 
-
3,57 
-
3,48 
-
3,26 
-
3,18 
-
2,26 
-
2,14 
202,00 
-
4,19 
-
4,11 
-
4,01 
-
3,97 
-
3,72 
-
3,73 
-
3,46 
-
3,41 
-
3,30 
-
3,24 
-
3,05 
-
2,98 
-
2,06 
-
2,01 
203,00 
-
3,76 
-
3,76 
-
3,62 
-
3,64 
-
3,43 
-
3,42 
-
3,12 
-
3,15 
-
3,00 
-
3,01 
-
2,71 
-
2,76 
-
1,87 
-
1,88 
204,00 
-
3,36 
-
3,37 
-
3,27 
-
3,26 
-
3,05 
-
3,08 
-
2,84 
-
2,84 
-
2,69 
-
2,72 
-
2,47 
-
2,50 
-
1,68 
-
1,71 
205,00 
-
2,97 
-
3,01 
-
2,91 
-
2,91 
-
2,74 
-
2,75 
-
2,53 
-
2,54 
-
2,42 
-
2,44 
-
2,22 
-
2,25 
-
1,50 
-
1,55 
206,00 
-
2,64 
-
2,68 
-
2,54 
-
2,59 
-
2,44 
-
2,44 
-
2,21 
-
2,26 
-
2,16 
-
2,18 
-
2,00 
-
2,01 
-
1,33 
-
1,39 
207,00 
-
2,31 
-
2,44 
-
2,25 
-
2,36 
-
2,15 
-
2,25 
-
1,99 
-
2,08 
-
1,94 
-
2,00 
-
1,78 
-
1,85 
-
1,20 
-
1,30 
208,00 
-
2,05 
-
2,21 
-
1,98 
-
2,14 
-
1,94 
-
2,05 
-
1,79 
-
1,89 
-
1,76 
-
1,83 
-
1,62 
-
1,70 
-
1,12 
-
1,22 
209,00 
-
1,86 
-
2,01 
-
1,81 
-
1,96 
-
1,77 
-
1,90 
-
1,63 
-
1,77 
-
1,62 
-
1,73 
-
1,54 
-
1,61 
-
1,07 
-
1,19 
210,00 
-
1,70 
-
1,83 
-
1,67 
-
1,80 
-
1,61 
-
1,77 
-
1,53 
-
1,67 
-
1,52 
-
1,66 
-
1,43 
-
1,57 
-
1,06 
-
1,24 
211,00 
-
1,59 
-
1,66 
-
1,57 
-
1,65 
-
1,55 
-
1,63 
-
1,50 
-
1,55 
-
1,46 
-
1,55 
-
1,39 
-
1,48 
-
1,07 
-
1,19 
212,00 
-
1,51 
-
1,53 
-
1,51 
-
1,52 
-
1,48 
-
1,51 
-
1,41 
-
1,45 
-
1,42 
-
1,46 
-
1,38 
-
1,41 
-
1,09 
-
1,17 
213,00 
-
1,46 
-
1,42 
-
1,45 
-
1,42 
-
1,44 
-
1,42 
-
1,39 
-
1,37 
-
1,42 
-
1,40 
-
1,35 
-
1,36 
-
1,13 
-
1,16 
214,00 
-
1,42 
-
1,39 
-
1,42 
-
1,40 
-
1,42 
-
1,40 
-
1,37 
-
1,37 
-
1,41 
-
1,40 
-
1,38 
-
1,37 
-
1,18 
-
1,22 
215,00 
-
1,39 
-
1,35 
-
1,42 
-
1,37 
-
1,42 
-
1,38 
-
1,37 
-
1,35 
-
1,42 
-
1,40 
-
1,38 
-
1,37 
-
1,24 
-
1,25 
216,00 
-
1,37 
-
1,32 
-
1,39 
-
1,34 
-
1,40 
-
1,36 
-
1,39 
-
1,34 
-
1,43 
-
1,39 
-
1,42 
-
1,37 
-
1,31 
-
1,28 
217,00 
-
1,34 
-
1,32 
-
1,38 
-
1,34 
-
1,40 
-
1,37 
-
1,39 
-
1,35 
-
1,44 
-
1,40 
-
1,41 
-
1,39 
-
1,38 
-
1,33 
218,00 
-
1,35 
-
1,30 
-
1,38 
-
1,33 
-
1,42 
-
1,36 
-
1,40 
-
1,34 
-
1,45 
-
1,40 
-
1,43 
-
1,39 
-
1,44 
-
1,36 
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219,00 
-
1,32 
-
1,25 
-
1,37 
-
1,29 
-
1,39 
-
1,32 
-
1,39 
-
1,32 
-
1,46 
-
1,38 
-
1,44 
-
1,37 
-
1,49 
-
1,37 
220,00 
-
1,31 
-
1,27 
-
1,36 
-
1,30 
-
1,40 
-
1,34 
-
1,41 
-
1,33 
-
1,46 
-
1,40 
-
1,46 
-
1,39 
-
1,53 
-
1,41 
221,00 
-
1,30 
-
1,24 
-
1,34 
-
1,28 
-
1,39 
-
1,31 
-
1,37 
-
1,31 
-
1,44 
-
1,37 
-
1,45 
-
1,36 
-
1,54 
-
1,42 
222,00 
-
1,25 
-
1,22 
-
1,29 
-
1,27 
-
1,34 
-
1,31 
-
1,36 
-
1,30 
-
1,42 
-
1,37 
-
1,41 
-
1,36 
-
1,55 
-
1,44 
223,00 
-
1,23 
-
1,23 
-
1,29 
-
1,27 
-
1,32 
-
1,31 
-
1,32 
-
1,31 
-
1,39 
-
1,38 
-
1,40 
-
1,36 
-
1,55 
-
1,48 
224,00 
-
1,20 
-
1,21 
-
1,23 
-
1,26 
-
1,29 
-
1,30 
-
1,29 
-
1,30 
-
1,36 
-
1,37 
-
1,34 
-
1,36 
-
1,53 
-
1,50 
225,00 
-
1,15 
-
1,19 
-
1,19 
-
1,24 
-
1,27 
-
1,28 
-
1,25 
-
1,29 
-
1,31 
-
1,36 
-
1,32 
-
1,35 
-
1,49 
-
1,53 
226,00 
-
1,11 
-
1,18 
-
1,15 
-
1,23 
-
1,19 
-
1,27 
-
1,19 
-
1,28 
-
1,25 
-
1,35 
-
1,26 
-
1,34 
-
1,44 
-
1,54 
227,00 
-
1,05 
-
1,15 
-
1,09 
-
1,19 
-
1,13 
-
1,23 
-
1,12 
-
1,24 
-
1,19 
-
1,31 
-
1,19 
-
1,30 
-
1,38 
-
1,51 
228,00 
-
0,98 
-
1,10 
-
1,03 
-
1,14 
-
1,07 
-
1,18 
-
1,08 
-
1,19 
-
1,13 
-
1,25 
-
1,12 
-
1,25 
-
1,32 
-
1,47 
229,00 
-
0,93 
-
1,00 
-
0,97 
-
1,04 
-
1,01 
-
1,08 
-
1,01 
-
1,09 
-
1,07 
-
1,15 
-
1,07 
-
1,15 
-
1,25 
-
1,36 
230,00 
-
0,88 
-
0,91 
-
0,91 
-
0,94 
-
0,93 
-
0,98 
-
0,96 
-
1,00 
-
1,01 
-
1,06 
-
1,02 
-
1,06 
-
1,18 
-
1,27 
231,00 
-
0,82 
-
0,82 
-
0,85 
-
0,86 
-
0,89 
-
0,89 
-
0,90 
-
0,91 
-
0,94 
-
0,97 
-
0,93 
-
0,97 
-
1,11 
-
1,18 
232,00 
-
0,75 
-
0,71 
-
0,79 
-
0,75 
-
0,80 
-
0,78 
-
0,83 
-
0,80 
-
0,87 
-
0,85 
-
0,86 
-
0,86 
-
1,03 
-
1,05 
233,00 
-
0,70 
-
0,60 
-
0,73 
-
0,63 
-
0,75 
-
0,67 
-
0,76 
-
0,69 
-
0,80 
-
0,73 
-
0,81 
-
0,74 
-
0,95 
-
0,91 
234,00 
-
0,64 
-
0,49 
-
0,65 
-
0,52 
-
0,67 
-
0,55 
-
0,69 
-
0,57 
-
0,73 
-
0,61 
-
0,72 
-
0,61 
-
0,87 
-
0,76 
235,00 
-
0,57 
-
0,38 
-
0,61 
-
0,41 
-
0,60 
-
0,43 
-
0,62 
-
0,45 
-
0,66 
-
0,48 
-
0,65 
-
0,49 
-
0,79 
-
0,61 
236,00 
-
0,52 
-
0,26 
-
0,55 
-
0,29 
-
0,57 
-
0,31 
-
0,57 
-
0,33 
-
0,60 
-
0,35 
-
0,61 
-
0,36 
-
0,72 
-
0,46 
237,00 
-
0,47 
-
0,22 
-
0,48 
-
0,24 
-
0,50 
-
0,26 
-
0,52 
-
0,27 
-
0,54 
-
0,29 
-
0,54 
-
0,30 
-
0,65 
-
0,38 
238,00 
-
0,42 
-
0,20 
-
0,42 
-
0,22 
-
0,45 
-
0,24 
-
0,45 
-
0,26 
-
0,49 
-
0,28 
-
0,48 
-
0,29 
-
0,58 
-
0,37 
239,00 
-
0,37 
-
0,15 
-
0,39 
-
0,17 
-
0,40 
-
0,19 
-
0,41 
-
0,21 
-
0,44 
-
0,23 
-
0,44 
-
0,24 
-
0,52 
-
0,31 
240,00 
-
0,34 
-
0,11 
-
0,35 
-
0,13 
-
0,35 
-
0,15 
-
0,37 
-
0,17 
-
0,39 
-
0,18 
-
0,38 
-
0,19 
-
0,46 
-
0,25 
241,00 
-
0,29 
-
0,07 
-
0,30 
-
0,08 
-
0,30 
-
0,10 
-
0,32 
-
0,12 
-
0,34 
-
0,13 
-
0,34 
-
0,14 
-
0,40 
-
0,18 
242,00 
-
0,26 
-
0,02 
-
0,28 
-
0,03 
-
0,27 
-
0,04 
-
0,28 
-
0,06 
-
0,30 
-
0,07 
-
0,29 
-
0,08 
-
0,35 
-
0,11 
243,00 
-
0,23 
-
0,03 
-
0,24 
-
0,04 
-
0,24 
-
0,05 
-
0,24 
-
0,06 
-
0,26 
-
0,07 
-
0,26 
-
0,08 
-
0,30 
-
0,10 
244,00 
-
0,21 
-
0,02 
-
0,21 
-
0,03 
-
0,21 
-
0,04 
-
0,21 
-
0,05 
-
0,23 
-
0,06 
-
0,23 
-
0,07 
-
0,26 
-
0,08 
245,00 
-
0,16 
-
0,01 
-
0,18 
-
0,02 
-
0,16 
-
0,02 
-
0,17 
-
0,03 
-
0,21 
-
0,04 
-
0,18 
-
0,04 
-
0,22 
-
0,05 
246,00 
-
0,15 0,01 
-
0,16 0,00 
-
0,15 
-
0,01 
-
0,16 
-
0,01 
-
0,18 
-
0,02 
-
0,16 
-
0,02 
-
0,19 
-
0,03 
247,00 
-
0,14 0,01 
-
0,14 0,00 
-
0,14 0,00 
-
0,14 
-
0,01 
-
0,16 
-
0,01 
-
0,15 
-
0,02 
-
0,16 
-
0,03 
248,00 
-
0,11 0,04 
-
0,13 0,03 
-
0,11 0,03 
-
0,12 0,02 
-
0,15 0,02 
-
0,12 0,01 
-
0,15 0,00 
249,00 
-
0,13 0,07 
-
0,14 0,07 
-
0,13 0,06 
-
0,12 0,05 
-
0,14 0,05 
-
0,13 0,04 
-
0,13 0,03 
250,00 
-
0,11 0,08 
-
0,11 0,08 
-
0,10 0,07 
-
0,11 0,07 
-
0,13 0,06 
-
0,10 0,06 
-
0,12 0,05 
Sample CTA0 
Temp. (°C) 5   10   15   20   25   30   35   
Waveln. 
(nm) 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
190,00 
-
4,76 
-
3,83 
-
4,46 
-
3,62 
-
4,26 
-
3,43 
-
3,75 
-
3,14 
-
2,78 
-
2,44 
-
2,44 
-
2,15 
-
2,20 
-
1,93 
191,00 
-
4,95 
-
4,48 
-
4,62 
-
4,21 
-
4,32 
-
3,96 
-
3,83 
-
3,58 
-
2,90 
-
2,77 
-
2,55 
-
2,42 
-
2,26 
-
2,14 
192,00 
-
5,17 
-
5,10 
-
4,82 
-
4,76 
-
4,42 
-
4,44 
-
3,95 
-
3,96 
-
3,06 
-
3,08 
-
2,68 
-
2,68 
-
2,33 
-
2,36 
193,00 
-
5,38 
-
5,62 
-
4,99 
-
5,22 
-
4,55 
-
4,84 
-
4,05 
-
4,28 
-
3,20 
-
3,36 
-
2,80 
-
2,93 
-
2,44 
-
2,57 
194,00 
-
5,56 
-
5,96 
-
5,15 
-
5,52 
-
4,76 
-
5,09 
-
4,15 
-
4,46 
-
3,34 
-
3,56 
-
2,90 
-
3,11 
-
2,53 
-
2,72 
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195,00 
-
5,67 
-
6,01 
-
5,24 
-
5,55 
-
4,83 
-
5,09 
-
4,23 
-
4,42 
-
3,46 
-
3,57 
-
2,98 
-
3,12 
-
2,62 
-
2,73 
196,00 
-
5,72 
-
5,86 
-
5,29 
-
5,39 
-
4,88 
-
4,94 
-
4,27 
-
4,27 
-
3,50 
-
3,49 
-
3,05 
-
3,05 
-
2,66 
-
2,66 
197,00 
-
5,70 
-
5,64 
-
5,27 
-
5,19 
-
4,86 
-
4,75 
-
4,24 
-
4,11 
-
3,49 
-
3,40 
-
3,06 
-
2,98 
-
2,68 
-
2,60 
198,00 
-
5,60 
-
5,35 
-
5,18 
-
4,93 
-
4,76 
-
4,53 
-
4,16 
-
3,95 
-
3,45 
-
3,28 
-
3,04 
-
2,86 
-
2,65 
-
2,48 
199,00 
-
5,41 
-
5,12 
-
4,99 
-
4,74 
-
4,62 
-
4,37 
-
4,03 
-
3,85 
-
3,34 
-
3,21 
-
2,95 
-
2,81 
-
2,56 
-
2,44 
200,00 
-
5,12 
-
4,97 
-
4,72 
-
4,60 
-
4,39 
-
4,25 
-
3,82 
-
3,75 
-
3,19 
-
3,14 
-
2,79 
-
2,74 
-
2,43 
-
2,38 
201,00 
-
4,76 
-
4,51 
-
4,40 
-
4,18 
-
4,05 
-
3,86 
-
3,53 
-
3,41 
-
3,00 
-
2,86 
-
2,60 
-
2,47 
-
2,26 
-
2,14 
202,00 
-
4,35 
-
4,13 
-
4,03 
-
3,84 
-
3,70 
-
3,56 
-
3,25 
-
3,17 
-
2,75 
-
2,67 
-
2,38 
-
2,31 
-
2,06 
-
2,01 
203,00 
-
3,93 
-
3,83 
-
3,65 
-
3,57 
-
3,36 
-
3,30 
-
2,96 
-
2,96 
-
2,49 
-
2,47 
-
2,15 
-
2,15 
-
1,87 
-
1,88 
204,00 
-
3,51 
-
3,41 
-
3,27 
-
3,19 
-
2,99 
-
2,95 
-
2,69 
-
2,66 
-
2,21 
-
2,24 
-
1,92 
-
1,95 
-
1,68 
-
1,71 
205,00 
-
3,13 
-
3,05 
-
2,92 
-
2,86 
-
2,68 
-
2,64 
-
2,43 
-
2,39 
-
1,97 
-
2,01 
-
1,71 
-
1,75 
-
1,50 
-
1,55 
206,00 
-
2,77 
-
2,75 
-
2,59 
-
2,57 
-
2,40 
-
2,38 
-
2,17 
-
2,14 
-
1,73 
-
1,80 
-
1,52 
-
1,57 
-
1,33 
-
1,39 
207,00 
-
2,46 
-
2,47 
-
2,31 
-
2,34 
-
2,16 
-
2,19 
-
1,95 
-
2,01 
-
1,55 
-
1,66 
-
1,36 
-
1,47 
-
1,20 
-
1,30 
208,00 
-
2,20 
-
2,28 
-
2,08 
-
2,17 
-
1,94 
-
2,03 
-
1,75 
-
1,87 
-
1,40 
-
1,54 
-
1,25 
-
1,36 
-
1,12 
-
1,22 
209,00 
-
1,99 
-
2,10 
-
1,90 
-
2,02 
-
1,77 
-
1,91 
-
1,61 
-
1,77 
-
1,31 
-
1,47 
-
1,17 
-
1,31 
-
1,07 
-
1,19 
210,00 
-
1,83 
-
1,93 
-
1,77 
-
1,88 
-
1,67 
-
1,80 
-
1,53 
-
1,69 
-
1,25 
-
1,44 
-
1,14 
-
1,33 
-
1,06 
-
1,24 
211,00 
-
1,72 
-
1,78 
-
1,69 
-
1,75 
-
1,60 
-
1,68 
-
1,48 
-
1,59 
-
1,23 
-
1,36 
-
1,14 
-
1,27 
-
1,07 
-
1,19 
212,00 
-
1,64 
-
1,65 
-
1,63 
-
1,63 
-
1,54 
-
1,58 
-
1,46 
-
1,50 
-
1,23 
-
1,30 
-
1,16 
-
1,23 
-
1,09 
-
1,17 
213,00 
-
1,60 
-
1,55 
-
1,59 
-
1,54 
-
1,56 
-
1,51 
-
1,47 
-
1,44 
-
1,26 
-
1,27 
-
1,19 
-
1,21 
-
1,13 
-
1,16 
214,00 
-
1,57 
-
1,54 
-
1,58 
-
1,54 
-
1,55 
-
1,51 
-
1,48 
-
1,46 
-
1,29 
-
1,30 
-
1,23 
-
1,25 
-
1,18 
-
1,22 
215,00 
-
1,56 
-
1,52 
-
1,57 
-
1,53 
-
1,54 
-
1,51 
-
1,50 
-
1,46 
-
1,34 
-
1,31 
-
1,28 
-
1,28 
-
1,24 
-
1,25 
216,00 
-
1,56 
-
1,49 
-
1,58 
-
1,51 
-
1,56 
-
1,50 
-
1,53 
-
1,46 
-
1,39 
-
1,33 
-
1,34 
-
1,30 
-
1,31 
-
1,28 
217,00 
-
1,56 
-
1,49 
-
1,58 
-
1,52 
-
1,58 
-
1,52 
-
1,55 
-
1,49 
-
1,43 
-
1,36 
-
1,40 
-
1,34 
-
1,38 
-
1,33 
218,00 
-
1,56 
-
1,48 
-
1,59 
-
1,51 
-
1,61 
-
1,52 
-
1,58 
-
1,50 
-
1,46 
-
1,38 
-
1,45 
-
1,37 
-
1,44 
-
1,36 
219,00 
-
1,55 
-
1,44 
-
1,59 
-
1,48 
-
1,62 
-
1,50 
-
1,59 
-
1,48 
-
1,49 
-
1,38 
-
1,49 
-
1,37 
-
1,49 
-
1,37 
220,00 
-
1,54 
-
1,46 
-
1,58 
-
1,51 
-
1,62 
-
1,53 
-
1,61 
-
1,51 
-
1,51 
-
1,42 
-
1,52 
-
1,41 
-
1,53 
-
1,41 
221,00 
-
1,52 
-
1,44 
-
1,57 
-
1,49 
-
1,63 
-
1,52 
-
1,60 
-
1,50 
-
1,52 
-
1,41 
-
1,53 
-
1,41 
-
1,54 
-
1,42 
222,00 
-
1,49 
-
1,43 
-
1,54 
-
1,48 
-
1,59 
-
1,52 
-
1,59 
-
1,51 
-
1,52 
-
1,43 
-
1,53 
-
1,43 
-
1,55 
-
1,44 
223,00 
-
1,46 
-
1,43 
-
1,51 
-
1,49 
-
1,58 
-
1,53 
-
1,56 
-
1,53 
-
1,50 
-
1,46 
-
1,52 
-
1,47 
-
1,55 
-
1,48 
224,00 
-
1,42 
-
1,41 
-
1,48 
-
1,47 
-
1,53 
-
1,52 
-
1,53 
-
1,53 
-
1,47 
-
1,47 
-
1,50 
-
1,48 
-
1,53 
-
1,50 
225,00 
-
1,37 
-
1,38 
-
1,44 
-
1,45 
-
1,49 
-
1,51 
-
1,49 
-
1,52 
-
1,43 
-
1,48 
-
1,46 
-
1,50 
-
1,49 
-
1,53 
226,00 
-
1,33 
-
1,38 
-
1,38 
-
1,44 
-
1,42 
-
1,50 
-
1,43 
-
1,52 
-
1,38 
-
1,48 
-
1,41 
-
1,51 
-
1,44 
-
1,54 
227,00 
-
1,27 
-
1,33 
-
1,32 
-
1,40 
-
1,37 
-
1,46 
-
1,37 
-
1,48 
-
1,33 
-
1,45 
-
1,35 
-
1,48 
-
1,38 
-
1,51 
228,00 
-
1,22 
-
1,28 
-
1,26 
-
1,34 
-
1,30 
-
1,40 
-
1,31 
-
1,43 
-
1,27 
-
1,40 
-
1,29 
-
1,43 
-
1,32 
-
1,47 
229,00 
-
1,14 
-
1,14 
-
1,19 
-
1,20 
-
1,22 
-
1,27 
-
1,25 
-
1,31 
-
1,20 
-
1,29 
-
1,23 
-
1,32 
-
1,25 
-
1,36 
230,00 
-
1,07 
-
1,02 
-
1,12 
-
1,08 
-
1,17 
-
1,16 
-
1,17 
-
1,21 
-
1,12 
-
1,19 
-
1,16 
-
1,22 
-
1,18 
-
1,27 
231,00 
-
1,00 
-
0,91 
-
1,05 
-
0,98 
-
1,11 
-
1,05 
-
1,10 
-
1,10 
-
1,05 
-
1,10 
-
1,08 
-
1,13 
-
1,11 
-
1,18 
232,00 
-
0,93 
-
0,79 
-
0,98 
-
0,85 
-
1,02 
-
0,92 
-
1,03 
-
0,98 
-
0,98 
-
0,97 
-
1,00 
-
1,01 
-
1,03 
-
1,05 
233,00 
-
0,86 
-
0,65 
-
0,91 
-
0,72 
-
0,95 
-
0,78 
-
0,95 
-
0,84 
-
0,90 
-
0,84 
-
0,92 
-
0,87 
-
0,95 
-
0,91 
234,00 
-
0,80 
-
0,53 
-
0,84 
-
0,58 
-
0,88 
-
0,64 
-
0,88 
-
0,69 
-
0,82 
-
0,70 
-
0,83 
-
0,73 
-
0,87 
-
0,76 
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235,00 
-
0,74 
-
0,41 
-
0,77 
-
0,46 
-
0,80 
-
0,51 
-
0,81 
-
0,56 
-
0,74 
-
0,56 
-
0,76 
-
0,59 
-
0,79 
-
0,61 
236,00 
-
0,68 
-
0,27 
-
0,71 
-
0,32 
-
0,74 
-
0,36 
-
0,74 
-
0,41 
-
0,67 
-
0,41 
-
0,69 
-
0,43 
-
0,72 
-
0,46 
237,00 
-
0,62 
-
0,22 
-
0,65 
-
0,26 
-
0,68 
-
0,30 
-
0,68 
-
0,34 
-
0,60 
-
0,34 
-
0,62 
-
0,36 
-
0,65 
-
0,38 
238,00 
-
0,57 
-
0,17 
-
0,60 
-
0,22 
-
0,61 
-
0,26 
-
0,62 
-
0,31 
-
0,53 
-
0,33 
-
0,55 
-
0,35 
-
0,58 
-
0,37 
239,00 
-
0,51 
-
0,12 
-
0,55 
-
0,16 
-
0,56 
-
0,19 
-
0,56 
-
0,24 
-
0,47 
-
0,27 
-
0,49 
-
0,29 
-
0,52 
-
0,31 
240,00 
-
0,47 
-
0,09 
-
0,49 
-
0,12 
-
0,50 
-
0,15 
-
0,51 
-
0,19 
-
0,42 
-
0,21 
-
0,43 
-
0,23 
-
0,46 
-
0,25 
241,00 
-
0,43 
-
0,04 
-
0,45 
-
0,07 
-
0,44 
-
0,10 
-
0,47 
-
0,13 
-
0,36 
-
0,15 
-
0,38 
-
0,17 
-
0,40 
-
0,18 
242,00 
-
0,39 0,02 
-
0,41 
-
0,01 
-
0,42 
-
0,03 
-
0,42 
-
0,06 
-
0,32 
-
0,09 
-
0,33 
-
0,10 
-
0,35 
-
0,11 
243,00 
-
0,35 0,00 
-
0,37 
-
0,02 
-
0,37 
-
0,04 
-
0,38 
-
0,07 
-
0,27 
-
0,08 
-
0,28 
-
0,09 
-
0,30 
-
0,10 
244,00 
-
0,33 0,00 
-
0,34 
-
0,02 
-
0,34 
-
0,04 
-
0,35 
-
0,06 
-
0,24 
-
0,07 
-
0,24 
-
0,08 
-
0,26 
-
0,08 
245,00 
-
0,30 0,01 
-
0,32 
-
0,01 
-
0,30 
-
0,02 
-
0,32 
-
0,04 
-
0,21 
-
0,04 
-
0,20 
-
0,05 
-
0,22 
-
0,05 
246,00 
-
0,28 0,02 
-
0,29 0,01 
-
0,29 0,00 
-
0,29 
-
0,02 
-
0,19 
-
0,02 
-
0,18 
-
0,02 
-
0,19 
-
0,03 
247,00 
-
0,27 0,02 
-
0,27 0,01 
-
0,28 0,00 
-
0,27 
-
0,02 
-
0,16 
-
0,02 
-
0,16 
-
0,03 
-
0,16 
-
0,03 
248,00 
-
0,26 0,06 
-
0,26 0,05 
-
0,24 0,04 
-
0,26 0,02 
-
0,14 0,01 
-
0,14 0,00 
-
0,15 0,00 
249,00 
-
0,24 0,09 
-
0,26 0,09 
-
0,26 0,08 
-
0,24 0,06 
-
0,13 0,05 
-
0,12 0,04 
-
0,13 0,03 
250,00 
-
0,23 0,10 
-
0,25 0,09 
-
0,24 0,09 
-
0,23 0,08 
-
0,12 0,06 
-
0,11 0,06 
-
0,12 0,05 
Temp. (°C) CTA1 
Temp. (°C) 5   10   15   20   25   30   35   
Waveln. 
(nm) 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
190,00 
-
2,91 
-
2,61 
-
2,66 
-
2,42 
-
2,39 
-
2,12 
-
2,13 
-
1,95 
-
1,36 
-
1,26 
-
1,17 
-
1,05 
-
1,04 
-
0,92 
191,00 
-
3,20 
-
3,06 
-
2,96 
-
2,84 
-
2,49 
-
2,45 
-
2,42 
-
2,28 
-
1,49 
-
1,44 
-
1,23 
-
1,18 
-
1,06 
-
1,02 
192,00 
-
3,54 
-
3,52 
-
3,27 
-
3,24 
-
2,86 
-
2,81 
-
2,63 
-
2,60 
-
1,68 
-
1,66 
-
1,33 
-
1,37 
-
1,17 
-
1,18 
193,00 
-
3,77 
-
3,95 
-
3,54 
-
3,62 
-
3,02 
-
3,15 
-
2,80 
-
2,92 
-
1,95 
-
1,89 
-
1,53 
-
1,58 
-
1,37 
-
1,37 
194,00 
-
4,10 
-
4,29 
-
3,65 
-
3,92 
-
3,26 
-
3,44 
-
3,02 
-
3,18 
-
2,00 
-
2,12 
-
1,76 
-
1,79 
-
1,38 
-
1,56 
195,00 
-
4,26 
-
4,44 
-
3,99 
-
4,03 
-
3,44 
-
3,56 
-
3,23 
-
3,28 
-
2,03 
-
2,21 
-
1,74 
-
1,87 
-
1,55 
-
1,63 
196,00 
-
4,51 
-
4,45 
-
3,99 
-
4,03 
-
3,54 
-
3,57 
-
3,19 
-
3,28 
-
2,21 
-
2,22 
-
1,87 
-
1,89 
-
1,69 
-
1,63 
197,00 
-
4,51 
-
4,41 
-
3,94 
-
3,98 
-
3,67 
-
3,54 
-
3,39 
-
3,26 
-
2,26 
-
2,24 
-
1,92 
-
1,90 
-
1,65 
-
1,64 
198,00 
-
4,41 
-
4,29 
-
4,14 
-
3,88 
-
3,57 
-
3,43 
-
3,25 
-
3,15 
-
2,31 
-
2,15 
-
1,97 
-
1,80 
-
1,64 
-
1,54 
199,00 
-
4,39 
-
4,18 
-
3,98 
-
3,78 
-
3,47 
-
3,34 
-
3,22 
-
3,09 
-
2,22 
-
2,12 
-
1,88 
-
1,77 
-
1,65 
-
1,52 
200,00 
-
4,08 
-
4,06 
-
3,64 
-
3,67 
-
3,30 
-
3,24 
-
3,11 
-
3,02 
-
2,17 
-
2,11 
-
1,87 
-
1,75 
-
1,60 
-
1,52 
201,00 
-
3,79 
-
3,71 
-
3,48 
-
3,34 
-
3,02 
-
2,94 
-
2,79 
-
2,74 
-
2,01 
-
1,90 
-
1,58 
-
1,57 
-
1,47 
-
1,35 
202,00 
-
3,47 
-
3,43 
-
3,09 
-
3,10 
-
2,76 
-
2,72 
-
2,61 
-
2,55 
-
1,85 
-
1,80 
-
1,46 
-
1,48 
-
1,30 
-
1,29 
203,00 
-
3,16 
-
3,15 
-
2,82 
-
2,85 
-
2,50 
-
2,51 
-
2,39 
-
2,37 
-
1,64 
-
1,69 
-
1,44 
-
1,40 
-
1,22 
-
1,22 
204,00 
-
2,83 
-
2,82 
-
2,59 
-
2,56 
-
2,23 
-
2,26 
-
2,16 
-
2,13 
-
1,57 
-
1,53 
-
1,26 
-
1,28 
-
1,13 
-
1,12 
205,00 
-
2,50 
-
2,51 
-
2,31 
-
2,28 
-
2,01 
-
2,01 
-
1,80 
-
1,90 
-
1,32 
-
1,36 
-
1,11 
-
1,14 
-
0,92 
-
1,00 
206,00 
-
2,17 
-
2,21 
-
1,95 
-
2,02 
-
1,73 
-
1,78 
-
1,61 
-
1,69 
-
1,12 
-
1,21 
-
0,98 
-
1,02 
-
0,84 
-
0,90 
207,00 
-
1,92 
-
2,01 
-
1,71 
-
1,84 
-
1,53 
-
1,63 
-
1,47 
-
1,55 
-
0,98 
-
1,09 
-
0,80 
-
0,91 
-
0,73 
-
0,81 
208,00 
-
1,68 
-
1,81 
-
1,54 
-
1,67 
-
1,38 
-
1,48 
-
1,33 
-
1,42 
-
0,92 
-
1,00 
-
0,75 
-
0,84 
-
0,61 
-
0,76 
209,00 
-
1,51 
-
1,67 
-
1,43 
-
1,56 
-
1,27 
-
1,40 
-
1,22 
-
1,35 
-
0,86 
-
0,96 
-
0,70 
-
0,82 
-
0,67 
-
0,76 
210,00 
-
1,40 
-
1,54 
-
1,32 
-
1,48 
-
1,25 
-
1,36 
-
1,18 
-
1,34 
-
0,82 
-
1,00 
-
0,68 
-
0,87 
-
0,66 
-
0,83 
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211,00 
-
1,29 
-
1,42 
-
1,29 
-
1,37 
-
1,17 
-
1,28 
-
1,14 
-
1,27 
-
0,85 
-
0,96 
-
0,72 
-
0,85 
-
0,69 
-
0,82 
212,00 
-
1,25 
-
1,32 
-
1,24 
-
1,28 
-
1,13 
-
1,22 
-
1,18 
-
1,22 
-
0,84 
-
0,94 
-
0,74 
-
0,84 
-
0,74 
-
0,83 
213,00 
-
1,25 
-
1,24 
-
1,24 
-
1,22 
-
1,14 
-
1,17 
-
1,14 
-
1,19 
-
0,91 
-
0,93 
-
0,81 
-
0,85 
-
0,79 
-
0,85 
214,00 
-
1,25 
-
1,24 
-
1,16 
-
1,22 
-
1,18 
-
1,19 
-
1,21 
-
1,23 
-
0,92 
-
0,99 
-
0,87 
-
0,92 
-
0,87 
-
0,93 
215,00 
-
1,24 
-
1,22 
-
1,18 
-
1,22 
-
1,23 
-
1,20 
-
1,26 
-
1,25 
-
1,01 
-
1,02 
-
0,93 
-
0,97 
-
0,92 
-
0,98 
216,00 
-
1,23 
-
1,21 
-
1,24 
-
1,22 
-
1,20 
-
1,21 
-
1,30 
-
1,27 
-
1,08 
-
1,06 
-
1,00 
-
1,01 
-
1,05 
-
1,04 
217,00 
-
1,25 
-
1,22 
-
1,30 
-
1,24 
-
1,29 
-
1,23 
-
1,32 
-
1,30 
-
1,12 
-
1,09 
-
1,11 
-
1,06 
-
1,13 
-
1,09 
218,00 
-
1,26 
-
1,22 
-
1,31 
-
1,24 
-
1,28 
-
1,24 
-
1,39 
-
1,33 
-
1,20 
-
1,12 
-
1,19 
-
1,10 
-
1,23 
-
1,14 
219,00 
-
1,29 
-
1,19 
-
1,35 
-
1,23 
-
1,35 
-
1,23 
-
1,45 
-
1,33 
-
1,22 
-
1,13 
-
1,25 
-
1,12 
-
1,28 
-
1,17 
220,00 
-
1,31 
-
1,22 
-
1,34 
-
1,26 
-
1,32 
-
1,26 
-
1,47 
-
1,38 
-
1,26 
-
1,18 
-
1,28 
-
1,18 
-
1,36 
-
1,23 
221,00 
-
1,29 
-
1,20 
-
1,34 
-
1,25 
-
1,35 
-
1,25 
-
1,48 
-
1,38 
-
1,32 
-
1,19 
-
1,31 
-
1,19 
-
1,40 
-
1,25 
222,00 
-
1,24 
-
1,20 
-
1,32 
-
1,26 
-
1,35 
-
1,26 
-
1,49 
-
1,39 
-
1,32 
-
1,22 
-
1,34 
-
1,23 
-
1,38 
-
1,29 
223,00 
-
1,25 
-
1,21 
-
1,32 
-
1,28 
-
1,34 
-
1,28 
-
1,50 
-
1,43 
-
1,35 
-
1,26 
-
1,36 
-
1,28 
-
1,43 
-
1,35 
224,00 
-
1,22 
-
1,21 
-
1,29 
-
1,29 
-
1,30 
-
1,29 
-
1,45 
-
1,45 
-
1,32 
-
1,30 
-
1,36 
-
1,32 
-
1,43 
-
1,40 
225,00 
-
1,18 
-
1,21 
-
1,25 
-
1,29 
-
1,30 
-
1,31 
-
1,42 
-
1,47 
-
1,30 
-
1,35 
-
1,34 
-
1,38 
-
1,39 
-
1,45 
226,00 
-
1,13 
-
1,21 
-
1,22 
-
1,30 
-
1,21 
-
1,32 
-
1,37 
-
1,48 
-
1,29 
-
1,38 
-
1,30 
-
1,41 
-
1,38 
-
1,49 
227,00 
-
1,09 
-
1,18 
-
1,19 
-
1,27 
-
1,21 
-
1,29 
-
1,33 
-
1,45 
-
1,27 
-
1,37 
-
1,29 
-
1,41 
-
1,38 
-
1,48 
228,00 
-
1,03 
-
1,14 
-
1,12 
-
1,23 
-
1,14 
-
1,25 
-
1,27 
-
1,41 
-
1,21 
-
1,34 
-
1,24 
-
1,39 
-
1,30 
-
1,46 
229,00 
-
0,99 
-
1,05 
-
1,06 
-
1,13 
-
1,08 
-
1,16 
-
1,22 
-
1,31 
-
1,14 
-
1,27 
-
1,20 
-
1,31 
-
1,24 
-
1,38 
230,00 
-
0,91 
-
0,96 
-
1,00 
-
1,05 
-
1,00 
-
1,07 
-
1,16 
-
1,22 
-
1,11 
-
1,19 
-
1,12 
-
1,24 
-
1,18 
-
1,30 
231,00 
-
0,85 
-
0,88 
-
0,91 
-
0,97 
-
0,94 
-
1,00 
-
1,08 
-
1,13 
-
1,02 
-
1,12 
-
1,08 
-
1,16 
-
1,10 
-
1,22 
232,00 
-
0,78 
-
0,77 
-
0,85 
-
0,85 
-
0,87 
-
0,88 
-
0,99 
-
1,00 
-
0,96 
-
1,00 
-
0,99 
-
1,04 
-
1,04 
-
1,09 
233,00 
-
0,71 
-
0,66 
-
0,78 
-
0,74 
-
0,80 
-
0,76 
-
0,89 
-
0,87 
-
0,89 
-
0,88 
-
0,91 
-
0,91 
-
0,98 
-
0,95 
234,00 
-
0,66 
-
0,55 
-
0,71 
-
0,61 
-
0,72 
-
0,63 
-
0,82 
-
0,72 
-
0,81 
-
0,73 
-
0,84 
-
0,76 
-
0,91 
-
0,80 
235,00 
-
0,58 
-
0,43 
-
0,63 
-
0,49 
-
0,66 
-
0,51 
-
0,74 
-
0,58 
-
0,74 
-
0,59 
-
0,77 
-
0,61 
-
0,79 
-
0,64 
236,00 
-
0,53 
-
0,31 
-
0,59 
-
0,36 
-
0,59 
-
0,37 
-
0,68 
-
0,43 
-
0,69 
-
0,43 
-
0,74 
-
0,45 
-
0,76 
-
0,48 
237,00 
-
0,46 
-
0,25 
-
0,53 
-
0,29 
-
0,53 
-
0,31 
-
0,62 
-
0,35 
-
0,63 
-
0,36 
-
0,67 
-
0,38 
-
0,70 
-
0,40 
238,00 
-
0,44 
-
0,25 
-
0,49 
-
0,29 
-
0,49 
-
0,30 
-
0,53 
-
0,34 
-
0,57 
-
0,36 
-
0,59 
-
0,37 
-
0,62 
-
0,39 
239,00 
-
0,38 
-
0,20 
-
0,42 
-
0,23 
-
0,42 
-
0,25 
-
0,50 
-
0,28 
-
0,51 
-
0,30 
-
0,55 
-
0,31 
-
0,54 
-
0,33 
240,00 
-
0,32 
-
0,16 
-
0,36 
-
0,19 
-
0,37 
-
0,20 
-
0,43 
-
0,23 
-
0,45 
-
0,24 
-
0,48 
-
0,26 
-
0,50 
-
0,27 
241,00 
-
0,26 
-
0,11 
-
0,31 
-
0,13 
-
0,35 
-
0,14 
-
0,39 
-
0,17 
-
0,39 
-
0,18 
-
0,41 
-
0,19 
-
0,42 
-
0,20 
242,00 
-
0,24 
-
0,05 
-
0,29 
-
0,07 
-
0,28 
-
0,08 
-
0,30 
-
0,09 
-
0,31 
-
0,10 
-
0,37 
-
0,11 
-
0,35 
-
0,12 
243,00 
-
0,19 
-
0,05 
-
0,22 
-
0,07 
-
0,24 
-
0,08 
-
0,26 
-
0,09 
-
0,28 
-
0,10 
-
0,29 
-
0,11 
-
0,31 
-
0,11 
244,00 
-
0,18 
-
0,04 
-
0,19 
-
0,06 
-
0,21 
-
0,06 
-
0,25 
-
0,07 
-
0,23 
-
0,08 
-
0,26 
-
0,09 
-
0,26 
-
0,09 
245,00 
-
0,16 
-
0,03 
-
0,16 
-
0,04 
-
0,17 
-
0,04 
-
0,19 
-
0,05 
-
0,22 
-
0,05 
-
0,23 
-
0,06 
-
0,23 
-
0,06 
246,00 
-
0,14 
-
0,01 
-
0,16 
-
0,01 
-
0,17 
-
0,02 
-
0,20 
-
0,02 
-
0,20 
-
0,03 
-
0,21 
-
0,03 
-
0,21 
-
0,03 
247,00 
-
0,12 
-
0,01 
-
0,13 
-
0,01 
-
0,13 
-
0,02 
-
0,17 
-
0,03 
-
0,16 
-
0,04 
-
0,19 
-
0,04 
-
0,19 
-
0,04 
248,00 
-
0,08 0,02 
-
0,08 0,02 
-
0,13 0,01 
-
0,12 0,00 
-
0,15 
-
0,01 
-
0,15 
-
0,02 
-
0,15 
-
0,02 
249,00 
-
0,10 0,06 
-
0,10 0,05 
-
0,13 0,04 
-
0,15 0,04 
-
0,13 0,02 
-
0,15 0,02 
-
0,15 0,02 
250,00 
-
0,09 0,07 
-
0,09 0,06 
-
0,11 0,06 
-
0,10 0,06 
-
0,08 0,04 
-
0,11 0,04 
-
0,11 0,04 
VIII 
ACCESSING NEW BIOMEDICAL APPLICATIONS BY COMBINING GENETIC 
DESIGN AND CHEMICAL MODIFICATION OF ELASTIN-LIKE RECOMBINAMERS  
 
 CTA5 
Temp. (°C) 5   10   15   20   25   30   35   
Waveln. 
(nm) 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
Exp
. Fit 
190,00 
-
1,82 
-
1,62 
-
3,13 
-
2,77 
-
3,08 
-
2,71 
-
2,82 
-
2,45 
-
2,19 
-
1,93 
-
1,99 
-
1,76 
-
1,82 
-
1,62 
191,00 
-
1,83 
-
1,74 
-
3,31 
-
3,15 
-
3,22 
-
3,08 
-
2,91 
-
2,77 
-
2,25 
-
2,13 
-
2,02 
-
1,92 
-
1,83 
-
1,74 
192,00 
-
1,88 
-
1,88 
-
3,48 
-
3,51 
-
3,40 
-
3,42 
-
3,03 
-
3,06 
-
2,34 
-
2,34 
-
2,09 
-
2,09 
-
1,88 
-
1,88 
193,00 
-
1,92 
-
2,02 
-
3,65 
-
3,84 
-
3,55 
-
3,72 
-
3,16 
-
3,33 
-
2,42 
-
2,54 
-
2,16 
-
2,27 
-
1,92 
-
2,02 
194,00 
-
1,97 
-
2,14 
-
3,84 
-
4,06 
-
3,69 
-
3,92 
-
3,27 
-
3,52 
-
2,51 
-
2,71 
-
2,24 
-
2,42 
-
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7.1.1 ABBREVIATIONS 
 
AA: amino acid 
A: absorbance 
BMP: bone morphogenic protein 
CA: contact angle 
CD: circular dichroism 
CT: computed tomography 
CTA: Cholesteryl triethylenglykol azide  
DLS: Dynamic light scattering 
DSC: differential scanning calorimetry 
ECM: extracellular matrix 
ELbcR: elastin-like block co-recombinamer 
ELP: elastin-like protein 
ELR: elastin-like recombinamers 
ELRCTAx: ELR modified with x CTA groups 
FGF: fibroblast growth factor 
FN: Fibronectin 
FP: fluorescent protein 
FRET: Förster resonance energy transfer 
HASMCs: human aortic smooth muscle cells 
hMSCs: human mesenchymal stem cells 
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HPLC: high-performance liquid cromatography 
HUVECs: human umbilical vein endothelial cells 
IGZ: in-gel zymography 
ITC: inverse transition cycle 
ITT: inverse temperature transition 
IWZ: in-well zymography 
LCST: lower critical solution temperature 
MALDI-TOF: matrix-assisted laser desorption/ionization-time-of-flight 
MCST: multi-slice computed tomography 
MMP: matrix metalloproteinase 
MQ: milliQ ultra-pure water 
Mw: molecular weight 
NMR: nuclear magnetic resonance 
PA: plasminogen activator 
PBS: phosphate buffered saline 
pKa: dissociation constant of acids 
pKb: dissociation constant of bases 
PTH: parathyroid hormone 
ROI: region of interest 
SEM: scanning electron microscopy 
SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
SELR: silk-elastin-like recombinamers 
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TEM: transmission electron microscopy 
TGF-b: transforming growth factor beta 
TIMP: tissue inhibitors of metalloproteases 
TNFα: tumor necrosis factor α 
tPA: tissue plasminogen activator 
Try: Trypsin 
Tt: transition temperature 
uPA: urokinase plasminogen aktivator 
ε: extinction coefficient 
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7.1.2 TABLE OF STANDARD AMINO ACID ABBREVIATIONS 
 
Amino acid 3-letter code 1-letter code 
Alanine Ala A 
Arginine Arg R 
Asparagine Asn N 
Aspartic acid Asp D 
Cysteine Cys C 
Glutamic acid Glu E 
Glutamine Gln Q 
Glycine Gly G 
Histidine His H 
Isoleucine Ile I 
Leucine Leu L 
Lysine Lys K 
Methionine Met M 
Phenylalanine Phe F 
Proline Pro P 
Serine Ser S 
Threonine Thr T 
Tryptophan Trp W 
Tyrosine Tyr Y 
Valine Val V 
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